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FORB\ORD 
Since  the  adootion  of  Directive  90/220/EEC  in  Apri_i  1990,  experts  on 
biotechnology  from  tne  twelve  Member  States of  the  European  Community  have 
met  regularlyp  at  first  as  the  Group  of  National  Expert~ 6n  Biotechnology 
and  then  as  the  Committee  of  Competent  Authorities.  to  d·iscuss  details of 
impler:1enting  the  Directive.  The  objective· has  been  to  reach  agreement  by 
consensus  on  a  uniform  and  clear  interpretation  <?f  the  text.  and· also  to 
prepare  a  number  of  documents  referred  to ·in  the  Di~ective.  This  handbook 
brings  together  the  results so  far  achieved  jointly by  all  the Member  State 
Authorities,  who  have  discussed  and  agreed  the  texts  as  formulated.  Some 
of  the ·texts  have  forma I  I  ega I  status  and  others  not.  but  the  principles 
are  incorporated  ei.ther  in  national  legislation  or  in  the  administrative 
~ractice  in  i~plementing the  Directive  in  the Member  State~. 
The  Competent  Authorities  and  representatives  from  the  Commission  will 
continue  to meet  regularly  to discuss  aspects of  implementation not  covered 
by  the  present  handbook  and  to  revise  the  existing  notes  i~  tight  of  the 
experience  gained  by  the  implementation  of  the  Directive.  The  handbook 
will  be  revised  and  supplemented  accordingly. 
The  handbook  is  a  ~ompi tat ion  o.f  existing documents·,  providing guidance  for 
the  implementation  of  the  Directive.  It  is  ihtended  to.  assist  the 
Competent  Autho'rities  in  their  work,  to  guide  those  intending  to  release 
GMOs,  and  to  generally  inform  interestea  groups  and  the  public  a_t  la·rge. 
It  should  be  noted  that  the  content  of  th.is  handbook· Is  for  Information 
only.  None  of  the texts modify  in  any  way  the  text of. the· Dirbctive nor  do 
they ,Prejudice  the  legal  interpretation of  the  Directive which  ~'ln only  be 
provided  by  the  Court  of  Justice. 
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COUNOL DIRECilVE 
of 23 April 1990 
on the ddibcrate release into the environment of genetically modified organisms 
{90/220/EEC) 
·TiiE COUNCIL OF THE EUROPEAN COMMUNITIES. 
Having regard  to  the  Treaty  establishing  the  European 
Economic  Community,  and  in  particular  Article  lOOa 
thereof, 
Having regard to the propo~ from the Commission (1 ), 
In cooperation with the European Parliament (2}, 
Having regard to the opinion of the Economic and Social 
Committee (3), 
· Whereas,  under  the  Treaty,  action  by  the  Community 
rC:laring to the environment should be based on the principle 
that preventive aaion should be taken; 
Whereas  living  organisms,  whether  releas'ed  into  the 
environment in large or sma.11  ~ounts for c.xperimenul 
. pilrposes or as commercial produas, may reproduce in the 
environment and aos.s national frontiers thereby affecring 
other Member States; whereas the dfeas of such "releases on 
the environment may be irreversible; 
Whereas  the  protection  of  human  health  and  the 
environment  requires  that  due  attention  be  given  to 
conttolling risks  from the deliberate release of genetically 
modified organisms {GMOs) into the environment; 
Whereas disparity between the rules which arc in effect or in 
preparation in the MemLcr States c:onc:eming the deliberate 
rdease into the envirr  a.ment of GMOs may create unequal 
conditions of competition or barriers to ttade ~  produas 
containing such organisms, thus affecting the funaioning of 
the common market; whereas it is therefore necesSary  to 
approximate  the  laws  of  the  Member  States  in  th'is 
respect; 
Whereas measures for the approximation of  the provisions of 
. the  Member  States  which  have  as  their  object  the 
establishment and functioning'of the internal market should, 
inasmuch as they concern health, safety, environmental and 
consumer protection, be ·based on a high levd of protcaion 
throughout the Community; 
Whereas it  is  n~ssary to ensure the safe development of 
industrial products utilizing GMOs; 
(I) OJ No C 198,28. 7. 19889  p. 19 and 
OJ No C 2-46,27. 9.  1989, p. 5. 
(') OJ N~  C 158, 76. 6. 1989. p. 225 2nd 
OJ No C 96, 17. 4. 1990. 
(') OJ No C 23~ 30. I. 1989, p. 45 .• 
I 
Whereas  this  Directive  should  not  apply  to  organisms 
obtained through c.enain ~echniqucs  ·of genetic modification 
v.hich  have  conventionally  been  used  in  a  number  of 
applications and have a long safety record; 
Whereas it is necessary to establish harrnoniz.~ procedures 
and criteria for the case-by-case evaluation of the potential 
risks arising from the deliberate release of GMOs into the 
environment; 
Whereas  a  case-by-case  environmental  risk  assessment 
should always be carried out prior to a release; 
\  ~ :  •. -:re2s the ddiberate release of  GMOs auhe research stage 
is in mOSt casc:S a necessary step in the devdopment of new 
products derived from, or containing, GMOs; 
Whereas the introduaion of GMOs into the enyironment 
should be carried out .according to the 'step by step' principle; 
whereas this means that the containment of  GMOs is reduced 
and the scale of release inaeased gradually, step by step, but 
only if evaluation of  the earlier steps in terms of  protection of 
human health and the enVironment indicates that the next 
step can be taken; 
Whereas no product containing, or  consisting of, GMOs and 
intended for deliberate release shall be considered for placing 
on  the  market  without  it  first  having lx-en  subjC\:ted  to 
satisfactory field  testing at the research tand  development 
stage in ecosystems which could be affeacd by its use;  · 
•  l 
Whereas  it  is  necessary  to  establish  a  \ll)mmunity 
authorization procedure for the placing on the market of 
produas containing, or consisting of, GMOs where the 
'intended use of the proquct involves the ddiberate release of 
the organism(s} into the environment; 
Whereas any person, before undertaking a deliberate relc.ase· 
into the environment of a GM 0,  or the placing on the market 
of a product containing, or consisting of, GMOs, where the 
inten9cd use ·of that product involves its deliberate rdease 
into  the environment, shall  submit a  notification  to the 
national competent authority; 
Whereas that notification should contain a technical dossier 
of  information  including  a  full  env.ronmental  risk 
.asscs~mcnt, :1ppropri;1tc  s;afcty  and  cmcr~cncy  rcs1)(m~. 
and,  in  the  case  of  products,  precise  instructions  and 
con~iti~ns for usc, and proposed labelling and packaging; 
J  ,. 
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WhereaS 9  aftc.r notific.auon, no ddiberate release of GMOs 
should be carried out unless the consent of the competent 
authority has been obtained;  ·  · 
· Whereas the competent authority should give its con5cnt only 
~ftcr it has been  satisfied that the release will  be  safe for 
human health and the environment; 
Whereas it may be considered appropriate in certain cases to 
consult the public on the deliberate release of  GMOs into the 
environment; 
Whereas  it  is  appropri2te  for  the  Commission,  in 
consultation  with  the  Member  States,  to  establish  a 
procedure for  the exchange of information on deliberate 
releases of GMOs notified under this Directive; 
Whereas it is important to follow closely the development 
and use of GMOs; whereas a list should be published of ail 
the produas authorized under this Directive; 
Whereas,  when  a  prosh,1a  containing  a  .GMO  or  a 
combination vf GMOs is placed on the market, and where 
s~  a  produa has been  properly  authorized under  this 
Directive, a Member State may not on grounds relating to 
. matters covered by this Directive, prohibit, restrict or  impede 
the deliberate release of the organism in that product on its 
territory where the conditions set out· in the consent are 
respeaed;  whereas  a  safeguard  procedure  should  be 
pf<?vided  in  case  of  risk  to  human  health  or  the 
environment; · 
Wherw the provisions of this Directive relating to placing· 
on the market of produas should not apply to produas 
containing,  or coasisting  of, ·  GMOs  oove:red  by  other 
Community  legislation  which  provides  for  a  specific 
environmental risk asSessment similar to that laid down in 
this Directive;· 
Whereas  a  Committee  should  be  set  up  to  assist  the 
Commission on matters x:datiilg to the implementation of 
this Directive and to its adaptation to technical progress, 
.. 
. HAS ADO,PTED TIUS DlRECTIVE: 
PART A 
General pro.visions 
Article 1 
1.  The objeaive of this Directive iS to approximate the . 
laws;- ~egulations  and · administrative·  provisions  of the 
Member  States  and  to  protea  human  health  and  the 
environment:  ' 
- when carrying out the deliberate release of genetically 
modified organisms into the environment~ 
- when  placing on the market produas containing, or 
•COnsisting of, genetically modified organisms intended 
for subsequent deliberate release into the environment. 
2.  This  Directive  shall  not apply to  the  carriage  of 
genetically  modified  organisms  by  rail,  rpad, ·inland 
waterway, sea or air. · 
Article 2 
For the purposes o~  this Directive: 
(1)  'organism' is apy biological entity capable of  replication 
or of transferring genetic material; 
(2)  •genetically  modified  organism  (GMOr  means  an 
organism in which the genetic material has been altered 
in a way that docs not occur naturally by mating and/  or 
natural recombination. 
Within the terms-of this deijnition: 
(i}  genetic modification OCOlrS at ieast through the US( 
of the te:chniques listed in Annex I A Part 1; 
(ii)  the techniques listed in Annex I A Part 2 are no 
considered to result in genetic modification;  . 
(3)  'deliberate release" means any intentional inuoduaio 
into the environment of a GMO or a combination c 
GMOs without provisions  for containment su.ch  2 
physical barriers or a combination. of  physical barrie1 
together with chemical and/  or  biological barriers use 
to  limit their  contaa  with  the  general population and  d 
environment; 
(  4)  •product•  ~eans  a  preparation  consisting  of,  < 
containing, a GMO or a combination of  GMOs, whi< 
is placed. on the market; 
(5)  •placing on the market' means supplying or makit 
available to third  ·parties; 
(  6) . -notification•  means .  the  pre.~t.ion of documcr 
containing the requisite infOI'IDa.tion to the compett 
authority of a Member State. Th  .. peison making t 
presentatio'n shall be referred to as 'the notifier·; 
· (7)  'use· means the deliberate release of  a product whrch l 
.been placed on the mafket. The. persons carrying < 
this usc will be referred to as &users'; 
(8)  &environmental risk assessment' means the evaluatior 
~e  risk to human health and the environment ( wl  . 
. includes plants and animals) connected with the relt 
of GMOs or products containing GMOs. 
•  Article 3 
This Direaive shall not apply to  organisms obtained tbrc 
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Article 4 
1.  Member  States  shall  ensure  that  all  appropriate 
measures arc taken to avoid adverse cffeas on human health 
and the environment which might arise from the deliberate 
release or placing on the market"of GMOs. 
2.  Member States shall designate the competent authority 
or authorities responsible for carrying out·  the requirements 
o£ this Directive and its Annexes. 
3.  Member  States  shall  ensure  that  the  competent 
authority organizes inspeaions and other control measures 
as appropriate~ to ensure compliance with this Directive. 
PART B 
Ddibcrarc  release  of  GMOs  into  the  environment  for 
research and development purp&ses or for any other purpose 
than for placing o~ the market 
Article 5 
Member States shall adopt the provisions ncCCSS4ry to ensure 
that: 
( 1)  any person~  before undertaking a ddiberate release of a 
G,l\..iO or a combination of GMOs for the purpose of 
research  and  development~ or for any other purpose 
than  for  placing  on  the  market,  must  submir  a 
notification to the competent authority referred.  to in 
An  ide 4 {2) of  the Member State within whose territory 
the release is to take place; 
(2)  the notification shall include: 
(a)  a  technical  Jossier  supply~g  the  informacion 
specified ic.  Annex U n~  for evaluating the 
foreseeable risks, whether immediate or delayed., 
which the GMO or combination of GMOs may 
pose to human health or the cnvirorunent, tOgether 
with  the· methods  used  and  the  bibliogra.phic 
rdcrcnce to them and covering, in  panicubr: 
(i) ·general information including information on 
per~onnel and training, 
(ii) · information relating to the GMO(s), 
(iii)  infqrmation  relating  to  the  conditions  of 
·release and the receiving environment. 
(iv)  irtformition on.  th~ interactions betw~n the 
GMO(s) and the environment, 
(v)  information on monitoring, control, waste 
trcarment and emergency response plans; 
{h)  a statement evaluating the impacts and risks posed 
by  the  GMO(s)  to  human  health  or  the 
environment from the u~  envisaged; 
. (~)  the  competent  a.uthority  may  accept  that  releases 
of a combination of GMOs on the saine site or of the 
·same GMO on different sites for the same purpose and 
within  a  limited period  may  be  notified  in  a  single 
notification;  . 
(4}  the notifier shall include in the notification information 
o,n data or results from releases of the same GMO~  or the 
same combination of GMOs previously or  currently 
notified anei/  or· carried  out by  him  either  inside  or 
outside the Community. 
(5) 
The notifier may  also  refer  to  data or  results  from 
notifications previously $Uhmitted  by  other notifiers, 
provided that the latter have given their agreement in 
writing; 
in the case of a subsequent release of the same; GMO or 
combination of  GMOs previously notified. as part of the 
same research programme, the notifier shall be required 
to submit a  new notification. In this case, the notificr 
may refer to data from previous not_ificarions or results 
from previous releases; 
in the event of any modification of the deliberate release 
of GMOs pr a combination of GMOs which could have 
consequence~  with regard to the risks for human health 
or the environment or if new information has become 
available on such risks, either while the notification is 
being examined by the competent authority or after that 
authority has given its written consent, the nocifier shall 
immediately: 
(a)  revise the measures specified in the noti!:cation; 
(b)  inform the competent authority in advance of a~y 
modification or as soon as the new infonnarion is 
available, 
(c)  take  the  measures  necessary  to  prorect  human 
health and the environment. 
Article .6 
1.  On  receipt  and  after  acknowledgment  of  the 
nmific:Hion  tl~c O)Jnpc·rt·m  :tuthority  sh~ll: 
examine it  for compliance w1th  th•~ D•rcct•vc, 
evaluate the risks posed by the release, 
record its conclusions in  writing, 
and, if necessary,  . 
carry out tests or inspections  as  may  be  necessary  for 
comrol purposes. 
2.  The competem authority  •.  having  cons~dered, where 
appropria~e.  any comments by other Member  St~tes made in 
accordance with Anide 9, shall  respond ln writi.ng to the 
notifier  within 90 days  o£  receipt  of the  notificatior.. by 
ei£her: 
4. 
-~ 
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(a)  indicating that it is satisfied that the notification is in 
compliance with this Directive and that the release may 
pr~,or 
(b)  indicating that the release does not fulfil the conditions 
of  this  Directive  and  the  notif•c.arion  ts  therefore 
rejected. 
3.  For the  purpose  of  ~culating the  90-day  period 
ref~ed  to in paragraph 2, any periods of  time: during which 
the competent authority:  · 
is  awaiting  further  information  which  it  cay  have 
requested from the notifier, 
or 
is  carrying  out  a  public  inquiry  or  consultation  m 
accordance with Article 7 
shall not be taken inco account. 
4.  ·  Thenotifiermayproceed with the: release only when he 
has received th~ written consent of the competent authority, 
and  in  conformity  with .13-ny  conditions  requiTed  in  this 
consent. 
5.  If the competent authority considers  that sufficient 
experience has been obtained of releases of  certain GMOs, it 
may submit to the Commission a request for the: application 
of  simplified pr~urcs  for releases of such types of GMOs. 
The:  Commission shall, in accordance with the:  procedures 
laid down in Artidc: 21, establish appropriate criteria apd 
take a decision accordingly on each application. The criteria 
shall be based on  safety to human health and the environment 
and on the evidence available on such s.afery. 
6.  If  information becomes available subsequently to the 
competent . authority  which  could  have  . .significant 
consequences  for  the  risks  posed  by  the  rdease,  the 
competent authority may require the norificr to modify the 
conditions of, suspend or termi~ate the ddibcrat(: x:deasc:. 
Artic.le 7 
Where a  Member State considers it  appropriate,  it  ~ay 
provide that groups or the public shall be cons\llted on any 
aspect of the·proposcd deliberate release. 
Artic.le 8 
After completion of a  release~ the not:ifier shall  sc:~d to the 
competent authority the result of the release in respc:et of any 
risk to human health or the environment, with particular 
reference to any kind of produet that the notifier intends to 
notify at.a later stage. 
Article 9  · 
1.  The Commission shall set up a system of ccchange ·of 
the  information  contained  in  the  notifications.  The 
competent authorities shall send to the: Commission, within 
30 days  of its  receipt~ .a  summary  of each  notification  · 
received·. The format of this summary will be established by 
the Commission in accordance wit}\ the. procedure laid down 
in Article 21. 
2.  The  Commission  shall  immediately  forward  these 
summaries to the other Member States, which ~ay  ~ within 
30 days, ask for further information or present obse-rvations 
through the Commission or directly. 
3.  The  competent  authorities .  shall  inform  the  other 
Member States and the Commission of the final decisions 
taken in compliance with Article 6 (2). 
PARTC 
Placing on the ~arlcct of products containing GMOs 
Artick 10 
1.  Consent may  only  be  given  for  th~ placing on the" 
market of products containing, or co~isting of, GMOs, 
provided that: 
wrinen consent has been given to a  notification under 
Part B or if  a risk analysis has been carried out based on 
the ~lements outlined in that Part; 
the  products  comply  with  the  relevant  Community 
pr~ua  legislation;  · 
the products comply with the: requirements of  this Pan of' 
this  Dir~v~.  concerning  the  environmental  risk 
assessment. 
2.  Articles 11  to  18 shall  not  apply  to any· products 
covered  by Community legislation  which  provides for a 
specific environmental risk assessment similar to that laid 
down in this ~irecrive. 
3.  Not later than 12 months. after notification of thi! 
Directive,  the  Commission,  in  accordance  with  th( 
procedure laid down in  Article 21, shall establish a  list o 
Co~unity  legiSlation covering the products referred to ii 
paragraph 2. This list will be re-cx;unined periodically and 
as  necessary,  revised  in  accorQ~noe  with  the  sai( 
procedure  .. 
Article 11 
1.  ·  Before: a GMO·or a co~bination  of GMOs are place: 
on the market a_s or in a produet, the manufaaurer or tl 
importer to the Community shall submit a notification to  t1 
competent  authority of the  Member State where such 
product is to be placed on the market for the first time. n 
notification shall contain: 
the  information  required  in  Annex II,  extended 
necessary to take into account ·the diversity of  sites of" 
of  the product, including information on data and resll 
obtained  from  research  and  developmental  relea 
oonccming  the ecosystems which could be affeac:d by ! 
usc of  the product a_nd an assessent of  any risks for burr. 
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combination  of  GMOs  cont2ined  in  the  product. 
including information obtained from  the  research  and 
development stage on the impact of  the rde2se on human 
health and the environment; 
the conditions  for  the  placing on the  market of the 
produa,  .including  specific  conditions  of  use  and 
handling and a  proposal  for  labelling and packaging 
• which should comprise at least the requirements laid 
down in Annex m. 
· If  on the basis of the results of any rc:leasc  notified under 
t Part B of  this Directive, or  on subsuntive, reasoned scientific 
grounds, a notifier considers that the placing on the market 
and usc of  a produa do not pose a risk to human health and 
the environment., he may propose not to comply with one or 
more of the requirements of Anna Ill B. 
2.  The  norifier  shall  include  in  this  notification 
infonnarion on data·  or results from releases of the  same 
GMOs or the same combina~qn of GMOs previously or 
currently notified and/  or carried out by  the norifier either 
inside or outside the Community~ 
3.  The notificr may also refer to data or results from 
notifications  previously  submitted  by  ocher  notifiers, 
· provided  that  the  latter  have  given  their  agreement  in 
writing. 
4.  Each new product which, conuining.or consisting of 
the same GMO or  combination of GMOs, is intended for a 
diffcren~ usc, shall be notified scparatdy. 
5.  The notifier may proceed with the rdea.se only when he 
has rec.c:ived the written consent of the competent authority 
iq accordance with Article 13, and in conformity with any 
conditions,  induding  reference  to  particular 
ecosystems/  environments. required in that consent. 
6.  If new  information has become available with regard to 
the risks of  the produa to human health or the environment, 
either before or after the written consent~ the notifier shall 
.  immediately:  • 
revise  the  information  and  conditions  specified  m 
paragraph 1, 
infonn the compcten~ authority, and 
take the measur(S necessary to protect human health and 
the environment. 
Article 12 
1.  On  receipt  and  after  acknowledgement  of  the 
notification  referred  to  in  Anic:le  11  ~  the  competent 
. 2uthoricy shaU n •  .&mi~  at for compliance with this Directive~ 
giving  p2nirular  anrntion  to  the  environmental  risk 
assessment and the recommended. precautions related to the 
safe use of the produa.  · 
2.  At the latest 90 days after receipt of the notification~ 
the competent authority shall either: 
(a)  forward  the  dossier  to  the  Commission  with  a 
favourable opinion, or 
(b)  inform the notifkr that the proposed rdease dQeS  not 
fulfil  the conditions of this  Directive  and· that  it  is 
therefore rejcaed. 
3.  In the case referred to in paragraph 2  (a)'~ the dossier 
forwarded to the Commission sha.Jl include a summary of  the 
notification  together  with  a  statement of the  conditions 
under which the competent authority proposes to consent to 
the placing on the market of the product.  . 
The format of this  summary  shall  be  established  by  the 
Commission in accordance 'Yo'ith  the proce:dure laid down in 
Article 21. 
In parrirular where the competent authdrity has acceded to 
t:  ,  request  of the  notifier,  under  the. terms· of the  last 
subparagraph of Article 11  ( 1 ), not to comply with some of 
the requirements of Annex III  B,  it shall at the same time 
inform the Commission thereof. 
4.  Jf  the  com~tenr  authority  receives  additional 
infonnarim~ pursuant to Anide 11  (.6)., 'it shall  immedi~tcly 
inform the Commission and the other Member States. 
5.  For  the  purpose of calculating  the  90-day  period 
referred to  in paragraph 2, any periods of  time during which 
the  competent  authority  is  awaiting  further  information 
which it may have requested from the notifier shall not be 
taken inco account. 
Article 13 
1.  On receipt of the dossier referred to in Article 12 (3), 
the  Commission  ~hall  immediatdy  forward  it  to  the 
competent authorities of  all Mem0er  States together with any 
other information it has collected pursuant to this Directive 
and  advise  the  competent  authority  responsible  for 
forwarding the document of the distribution date. 
1.  ·1  he  t:ompctcnt  ;autlwuty,  in  chc- oah~nc..<"  (•f  :411)' 
indicarion to the contrary from another Member State·within 
60  days  followi~g  the  distribution  date  referfed  w  in 
paragraph 1,  shall  give  its  ~onsent  in  writing  ·,o  the 
notification so that the product ~n  be placed on the market 
and  shall  inform  th.e  other  Member  States  and  ·the 
Commission thereof. 
3.  ln  cases where the competem authority  of another 
Member State raises an objection - for which the reasons 
must  ~  stated - and should  it  not be  possible  for  the 
competent. authorities  concerned  to  reach  an  agreement 
within the period specifieP in paragraph 2,  'the Commission 
sha,l take a decision in accordance with the procedure laid 
down in Article 21. 
I'· 
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4.  Where  the  Commission  has  taken  a  favourable 
decision. the competent authority that received the original 
notification shall give consent  in  writing to the notification so 
that th~ p~~~  may ~  p~  on the market and shall 
inform  the  other  Member States  and  the  Commission 
thereof. 
5.  Once a produa has received a written consent, it may 
be  used  without  funher  notification  throughout  the 
Community in so far as  th~  specific conditions of usc and the 
environments and/  or geographical areas stipulated in these 
conditions are strialy adhered to. 
6.  Member States shall take all necessary  me~sures to 
ensure that users comply with the conditio~s of use specified 
in the written consent. 
Article 14 
Member States shall  tak~  ,.all  necessary measures to ens~re 
that products containing, or consisting 'of, GMOs will  be 
placed on the market only if  their labelling and  .. packaging is 
that specified in  the written consent referred to in Articles 12 
and 13. 
Article 15 
Member  States  may  not,  on  grounds  rdating  to  the 
notification and written consent of  a deliberate release under 
this Dircaive, prohibit, restria or impede the placing on the 
market of produas containing, or consisting of, GMOs 
which comply with the requirements of this Direaive. 
Article 16 
1.  Where  a  Member State  has  justifiable  reasons  to 
consider that a produa which has been properly notified and 
has received written consent under this Directive constitutes 
a  risk  ·to  human· health  or  the  environment,  it  may 
provisionally r~a  or prohibit the use and/or sale of that 
product on its territory. It shall  immc:diatdy  inform  the 
Commission and the other Member States of such aaion and 
give reasons for its decision.  · 
2.  A decision shall be taken on the matter within three 
months in  accordance with the  procedure laid  down  in 
Article 21. 
Article 17 
The Commission shall publish in the Official Journal of  the 
European Communities a list of all the:  products receivirfg 
final written consent under this-Directive. For each product, 
the GMO or GMOs contained therein and the use or uses 
shall be dearly specified. 
Article 18 
1.  Member States shall send to the Commission, at the 
end of each year, a brief faaual report on the conuo1 of the 
use  of  all  produas  placed  on  the  market  under  this 
Direaive. 
2.  .  The . Commission  shall  send  to  the  European 
Parliament and the Council, eyery three years, a report on the 
control by the Member States of the products plao:d on the 
market. under this Directive.  · 
3.  When  sub~tting this  repon for the fU"St  time, the 
Commission shall at the same  time submit  a specific repon  on 
the operation of this  Part of this Directive including an 
assessment of all its implications.  · 
PARTD 
Final provisions 
Article 19 
1  .  The ~ommission and the co~petent authorities shan 
not divulge  to third  parties any confidential  infonnarion 
notified or  exch~ged  under this Directi~e and shall protca: 
intc:llecrual property rights relating to the data rec:cived. 
2.  The  norifier  may  indicate  the  information  in  the 
notification submitted under this Dircaive, the disdosure of 
which  might  harm  his competitive  position, that should 
therefore be ueated as confidential. Verifiable justification 
must be given in such cases. 
3,  The  competent  authority  shall  decide,  'after 
consultation with the notifier, which information will be 
kept  confidential  and  shall  inform  the:  notifier  of  its 
decisions. 
4:  In  no  case  .may  the  following  .infonnation  when 
submitted  according  to  Articles  5  or  1.1  be  kept 
confidential: 
.  . 
description ol th.c GMO or GMO~.  name ~nd  <~dtlrc~~ uf 
the  notific:r.  purpose  of  the  release  and  location  of 
release;. 
methods and plans for monitoring of  the GMO orGMCh 
and for emergency response; 
the. evall1ation of foreseeable effects, in particular' an} 
pathogenic arid I or ecologically· disruptive: effects. 
5.  If, for whatever reasons, the notifier withdraws th1 
notification. the competent authorities and·  the Commissio• 
must  resR~ct  the  c<:>nfidentiality  of  the  inform:uior 
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Article 20 
According to the procedure lai.d  down in Article 21~ the 
Commission shall  adapt Annexes II  and  Ul  to technical 
progress  in  particular  by  amending  the  notification 
requirements to take into account t~e potencial hazard of the 
GMOs. 
Article 21 
The Commission shall be assisted by a  committee composed . 
of the representatives of the Member States and chaired by 
the representative of the Commission. 
The representative of the Commission shall submit to the 
committee  a  draft  of  the  measures  to  be  taken.  The 
commirtee shall deliver its opinion on the draft within a rime 
limit which the chairman may lay down according to the 
urgency of the matter. The opinion shall be delivered by the 
majority laid down in Article 148' (2) of the Treaty in the case 
of decisions which the Council  is  required to adopt on a 
pJOposal  from  the  Commission.  The  votes  of  the 
representatives of the Member States within the commirtec 
shall be weighted in the manner set out in that Article. The 
chairman shall not vote. 
The Commission shall a,dopt the measures envisaged if they 
are in accordance with the opinion of the commirtec. 
If the measures envisaged arc not in  accordance with the 
opinion of the committee, or if no opinion is delivered, the 
· Commission shall, without delay, submit to the Council a 
proposal relating to the measures to be taken. The Council 
shall act by a qualified majority. 
If,  on the expiry of  a period of three months &om the date of 
referral  to the Council,  the  Council  has  not aacd,  the 
proposed measures shall ~  adopted by the Commission. 
1.  Member  States  and  the  Commission  shall  meet 
regularly  and  exchange  informa-tion  on  the  ~xperiencc=­
acquired with regard to the prevention of risks·related to th< 
release of GMOs into the environment. 
2.  . Every  three  years,  Member  States  shaJl  send  the 
Commission a repo~  on  the measures taken to implement the 
provisions  of ·this  Direaive,  the  first  time  being  on 
1 September 1992. 
3.  Every  threl years,  the  Commission shall  publish  a 
summary based on the repons  referred to in paragraph 2, the 
first time being in 1993. 
ArrjcJe 23 
1.  Member  States  shall  bring  into  force  the  laws, 
regulations  and  admmistracive  provisions  necessary  to 
comply with this Directive before 23 Octo~r 1991.  _ 
2. .  Member  States  shall  immediately  inform  the· 
: •. mmission  of! all  laws,  regulations  and  administrative 
provisions adopted in implementation of this Directive. 
Article 24 
This Direcrive is  addressed co  the Member States. 
Done at Luxembourg, 23 April 1990. 
For the Council 
The President 
A.  REYNOLDS 
1 
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ANNEX IA 
.. 
·TECHNIQUES REFERRED TO IN ARnCLE 2 (2) 
PART 1 
T ~ques  ~{  gc;Detic. modifiqtion rcfcncd to in Altide 2 (2) (i) arc int.tr 111iD: 
(1)  reComb~  DNA  ceclmfques  using  vector  systems  as  previously  covered  by  Council 
. Rccommcodati.oo 82/472/EEC ('  ); 
(2)  techniques involving the di.rttt introduction into an orpnism of heritable material prepared outside the. 
organism induding micro-injeaion, macro-injection and mi~psuution; 
(3)  ·oe11 fusion (md~  pn)cop~  fuSion) or  hybridization techniques where live~  with riew combinations of 
hcriabJc  genetic mataUl are formed through the fusion of  two or  mo~e  cdls by means of  methods that do not 
•  occur naturally.  · 
PART1 
T ochniques referred to in Arrick 2 (2) (ii} which are nOt considered to result in generic modific.acion, on condition 
that they do not involve the usc of recombinant DNA mol~  '?r GMOs, arc: 
(1)  in vitro fertilization, 
(2)  conjugation, ttansduction, transformation or any ocher n2tur.al process, 
(3)  polyploidy induction.  .· 
.· 
ANNEXIB  .· 
TECHNIQUES REFERRED TO IN ARTICLE 3 
Techniques of  genetic modification to  be cxduckd from this Dircaivc, on  condition that they do not involve the u~ 
of GMOs as rccipi~t or paccntal org•n.i.sms, arc:  · 
( 1)  mutagcnc:sis, 
(2). o:ll fusion (including prOtoplast fusion) of plant cells ·where the resulting organi;ms can  at~-, be produced by 
ttadition.a1 breeding methods  . 
.  • 
.· 
.· 
.· 
.· 
(') OJ NO l2ll. 21. 7. 1982. p. IS. 
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COMMISSION  DIRECTIVE :4/15/EC 
or  15  April  1994 
adapting to technical progress for the  fi~st time  Co~ncil Directive 90/220/EEC 
on the deliberate release into the environment of genetically modified organisms 
THE COMMISSION  OF  THE  EUROPEAN  COM~1UNITtFS. 
Having  regard  to  the  Treaty  establishing  the  European 
Community, 
Having  regard  to  Council  Directive  90/220/EEC  of  23 
April 1990 on the deliberate release into the envirunment 
of  genetically  modified  organisms C).  and  in  particular 
Article  20  thereof, 
\X'hereas Annex  II  to  Directive 90/220/EEC contains the 
information require-d  to_ be pro,idsd ir:  a no:iilca:ion for  a 
deliberate  relea~e  of  genetically  modified  organisms 
(GMOs); 
~'hereas the  information  requorements  for  n:)tlflcations 
for a  deliberate  release  of  GMO:;, as  set  ou;  1n  :1-nncx  II, 
are  very  broJd  i:-1  order  to  ap?ly  to  all  ryp::~  c: .GMO::.. 
'V:hereas  some  of  the  informatiOn  is  only  a?~·l;.:-ablt  or 
appropriate  for  spe(ifJC  rypes  of  organisms : 
\);'hereas. on  the  bJsis of  the  e):Derience  gai::d with  the 
releases oi genetically modified  higher pla  ...  nt3:  1t  is  appro-
priate to adapt Annex  II  to  tech~1cal progress by  making 
provision  for  a  sub-An_nex  specliiC  ro  h1gh::r  plant~ : 
'\Y.
1 here~s :t  is  :here!:;:e  C??:~F~=~~e  ~~;,;:  ..  ~-:-:.:--.:. .':  !  ~  s~c,~ij 
be divided in two sub-.~nnexes: Annex II  -~ OlJ:lining the 
information  required  in  the  notifications  concerning 
releases of G~10s other than higher plants, an:i  ..  ~.nnex II 
B  outlining the  information required  in  the  notiiications 
concerning releases of genetically modtfied hig!-ler  plants; 
Whereas the measures provided  for  in  this  Directive  are 
in  accordance  with  the  opinion  of  the  committee 
provided  for  in  Article  21  of  Directive  90/220/EEC, 
(')OJ  No  l  117,  8 ..  Ci.  19'JO.  p.  15 . 
Ht\S  ADOPTED  THIS  DIRECTIVE: 
Artich  1 
Annex  II  to  Directive  90/220/EEC  is  replaced  by  the 
Annex· hereto. 
Artich  2 
Me-mber  S~ares shall brine into. force  the laws. regvlations 
and  admtnJstratlve  pr'ovi~ions  necessary  to  comply  ~·ith 
thi5- Direc~ive  b\·  30  lune  1994. They shall  immediately 
ir.:2rm  th::  Co;.rr.tssion  thertof. 
\l:'hc-n  Mo::-mb~:r  States  adort  thest:  provisions,  these  s·hall 
contam  a  reference  to  this  Dne-crive  Of  shall  be  accom-
ranied t-.y  such  reierence- at  t}}e  t1011~ of their  of!Je~al pub-
IJcation.  Tht  p:-o.:edure  for  such  reference  shall  be 
adopted  by  Member  StJtes. 
A r! ide  3 
This  DirtGive  shJil  enter  ir.to  force  on  the  20th  day 
following its  publication 'in  the  Ojfzc:"al Journal of th-e 
Eun·p{."i.ll· Communzt;.c\. 
Done  at  Brusseis.  15  April  1994. 
For  the  Commission 
Yannis  P.-'.LEOKR.A,SSAS 
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'ANNEX II 
INFORMATION  REQUIRED  IN THE  NOTIFICATION 
The notif1carion for a deliberate release refe-rrec  to  •n  Article  .~  and of the  p!acmg on the market referred to 
in  Article  II  is  to  include,  as  appropriate.  the  mformation  set  out"  bel~~·  ir.  the  sub-Annexes. 
Not all  points included will apply to every case  It is  to be expected that indiv1dual n-otifications will address 
only  the  particular  subset  of  consideration~  wh1ch  is  appropriate  to  individt:al  situations. 
The level of detail requirt>d in responst' to each subset of considerations" is  also hkely to vary according to tht' 
nature  and  scale  of  the  proposed  rt'lt>ase. 
'.A.nnex  II  A applies to releases of all  types of genetically mod1fied orp:-mms 0!:-;er than hight>r  plants. ~nnex 
II  B  applies  to  rt>leases  of  !!ene[lcally  modlf.ec  htght>r  plants 
The  term  Mh:gher  pbn.rs·  means  plants  v. 11:-:-r·  bdor\g  to  thr  taxo;-;om1~  g~oups  G_;  •nJJO.•j>t  m,.;~"'  and 
.-1 ll_!:JC..•f'< '11/.;t 
.·. 
.  .. 
-~ I 
I 
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.-1. SNEX II A 
INFORMATION  REQUIRED  IN  NOTIFICATIONS  CONCERNING  RELEASES  OF 
GENETICALLY  MODIFIED ORGANISMS  OTHER THAN  HIGHER  PLANTS 
·1.  GENERAL  JN.FORMATION 
A.  Name  and  address  of  the  notifier  (company  or  institute) 
B.  Name,  qualifications  and  experience  of  the  responsible  scientist{s) 
C.  Title  of  the  project 
ll.  INFORM./\TJON  REL:\TING  TO  THE  G~fO 
A.  Charactemtics  of  (a)  the  dor:o~. (b)  the  recipi~nt  or  (c)  (where  appropriate)· parental  organisrn(s): 
I.  scJer.~Iflc  name: 
2.  taxonomy: 
3.  other  names  (usual  nu:.t.  stram  nar.:t,  etc.), 
4.  pheno~·pic and  geneuc  r:iarkers: 
6.  descnpllon  of  Jdentlflot;o:;  anc  detection  techniques; 
7.  sensltl'.:iry.  reliabih~· (in  quantitative terns) and  speciflc1~·. of  detection  and ,dentificauor.  tech-
niques; 
8.  description  oi' the  geog-:-a;:':--:~·:  d:str:bt.:::on  and of the  ~zt~ra!  habit2~ c!  :..~e  N?:Jr:is~  i!'1d:.H:i~r:g 
•_nt~rmat1or.  on  natural  preda:ors,  pre~:s,  parasites  and  competitors,  symbiontS  and  h0sG., 
9.  potential  ior  genetic  trans~er  and  exchange· 'lj,'ith  other  organisms; 
l 0.  venilcation  of  the  genetiC  subillry  oi  the  organisms  and  factors  affecting  it : 
1 I.  pathological,  ecological  a::d  physiological  traits : 
(a)  classification of hazard according to existing Community rules concerning the  protection of 
human  heaith  andtor  the  environment; 
(b)  generation  time  i~  natural  ecosystems,  sexual  and  asexual  reproductive  cycle ; 
(c)  in~ormatidn on survival,  including seasonability and the abiliry  to fonn  survival  strucrures 
e.g·.  =.  seeds,  spores  or  sclerotia ; 
(d)  pathogenicity :  infectivity,  toxigenicity, virulente, allergeniciry, carrier (vector)  of  pathogen, 
possible  vectors,  host  range  including  non-target  organism.  Possible  a_ctivation  of  latt'.O( 
viruses  (proviruses).  Abi!Jry  .to  colonize  other organisms ; 
(e)  antibiotic  resistance,  and. potential  use  of  these  antibiotics  in  h~mans  and  domestic 
organisms  for  prophylaxis  and  therapy; 
(t)  involvement in environmental processes: primary production, nutrient turnover, decomposi-
tion  of  organic  mauer.  respiration.  etc. 
12.  Nature  of  indigenous  vectors : 
(a)  sequence ; 
(b)  frequency  of  mobilization ; 
(c)  specificity ; 
(d)  presence  of genes  which  conkr  res1stance. 
t3:  H1story  of  previous  gencttc  modif•otJons. 
B ..  Characteristics  of  the  vector: 
I. nature  and  source  of  thc  vector; 
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2.  sequence  of  Hansposons. vectors  and  othl"r  non-cod•nE  ~enet1c segment:.  used  to construct  the  • 
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3.  frequency of mobilization of  mserted ·.,.ector  and/or genetic  transfer capabilities and methods of 
determination; 
4.  information on  the  degree  to  ..,·hich  the  vector  is  limited  to the Di\:\ 'required ·to  perform  the 
intended  function. 
C.  Characteristics  of  the  modified  or~anism : 
1.  Information  relating  to  the  genetic  modification : 
(a)  methods  used  for  the  modification ; 
(b)  methods  used  to  construct  and  introduce  the· ms~n(~) into  the  recipient  or  to  delete  a 
sequence; 
(c}  description  of  the  insert  and/or  vector  construction .  ... 
(d)  purity of the insert from  an~· unknown sequence and information on the degree to which the 
inserted  sequence  is  limtted  to  the  DN:\ requned  to  perform  the  intended  function ; 
(.:)  sequence.  functional  identlly  and  locatiOn  of  the  altered·t~~~rted!deleted  nucleic  actd 
• segment(s}  tn  question  with  pantcuL::.:  ;ctcrence  t0  any  know:~  i':J:rnlul  stquenct 
,  ln:ormatlor.  on  :he  ftr.a!  G:--.10 
(a)  descnptton o! Fenettc trat:(s1 or  phenotyrtc .:-har.;.:r:::::-:tc5  ar.c  ,~  ;-~r:!ct.:!::tr am  new tra::' a!id · 
charactenstic~  wht.:h  m:w  t>e  expressed  or  n0  k·::r:-:  exp:c-s~ec. 
(b)  sr:-ucture an.::  amo'...!~! of am  vector andtor dor:o~ nt.:(;::tc  actc  re:-:-:2:nmr  tn  tht' f:n.1l  co:;s:n.tc-
!!On  of  the  r.lC'd1f::-d  org:=:-,:;:m. 
men:. 
(e)  a.:t:•tt:- 0!  the  ex?r~ssed potezn(s). 
(f)  dt>scription  of  tdentlitca:tor:  and derecllor.  techntc·..:~o  t!ic!u~::-,f  :~.:!in1quc~ tor the Jder.!ILca_-
liOn  and  detectlo~  of  the  msenec  sc:q~ence  anc.  •t.:tor: 
(g)  sen·siti-.ity.  reltat.dir:-·  (tr.  qu:mtit.Jtlve  rerms;  an~  s;:-e.:·it1.:1~  o~  ::i:::t.:uon  and  tdcnt:ft.:<HiN:. 
tcch-r.tque~: 
(1)  hc.-a!:h  constderations: 
(I)  !Oxic  or  alle:gentc  efk:b  of  the  non-viabk  G\10s  anc  ~·  tnt';~  metabohc  pr·:>d\.!Ct~ . 
(it)  product  hazards: 
(tii)  comrar:son  of  the  modtited  orga:-1tsm  to  the  donor,  rectp::::o:  or  (.,.,here  approrn<Ht) 
parental  organism  regardmg  pathogenicity ; 
(tv)  capaciry  for  cofonization ; 
(v)  if  the  organism  is  pathogenic  10  humans  who  are  immunocompetenr: 
dtseases caused and mechanism of pathogemcity including invasiveness and vir.;lence, 
communicability. 
infe.:-tive  do~e. 
host  range.  possib1ltty  of  alteration, 
possib1liry  of  sur;·ival  outside  oi  h'uman  host. 
presence  of  veCtOrS  Of  means  of  diSSemin:rttOn, 
biological  stability, 
an11 biotic. re!'>istancr  pattl.'rns,  • 
alkrgeniciry. 
av.:lilal,ility  of  appropn:ttc  tht·rapil·~. 
Ill. INFORM:\TION  RELATING  TO  THE  CONDITIONS  OF  RELEASE  AND  THE  RECEIVING 
• ENVIRONMENT 
A.  Information  on  the"  n.•k.:1sc: 
I.  tksnqHion ol  thl·  propo~t·d dl'ltl~l·r.tll'  h·k.•:-.l·,  •m ludlll}:!  thl·  purpO!>l'(~) and  forl'~n·n product::.; 
2.  forl·..,n·n  J:ll'l·..,  of  rlw  rl'k.tw  and  tllllt'  pl.ltlnlll_l!  ol  tlw  c:xpl'flml'nt  tndudinJ:  fa·qm·nl'\'  and 
dur:t110n  of  rc:k:tst·:- . 
4.  ~•h·  of  tlw  !>ill'. 
I. 
I 
:. 
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5.  method{!>)  to  be  used  tN  the  release ; 
6.  quantities  of  GMOs  to  be  released . 
7.  disturbance on the site (type and method of cult;vataon, mining. irriga:ion, or other activities); 
8.  worker  protection  measures  taken  during  th~  release ; 
9.  post-release  treatment  of  the  site ; 
10.  techniques foreseen for elimination or inact•vit•on of the GMOs at the end of the experiment;  .  .  . 
11.  information on, and results of, previous rcka~es of  the GMOs, especially at different scales ahd in 
different  ecosystems.  · 
B.  Information  on  the  environment  ~bOth on  the  site  and· in  the  wider  environment): 
1.  geographical location- and grid reference of  th~ site{s} (in  case  ef notifications under Part  C  the 
site{s)  of  release  will  be  the  foreseen  areas  of  use  of  the  product); 
2.  physical· or  biological  proximity  to  humans  and  orher  significant  btot.a ; 
3.  proximity  to  significan:  b:otopes  or  protected  areas; 
..;_  saze  of  local  populario:-: . 
5.  economic activities of loca:  po?ulat;ons ....,hich  are  bas~d on the natural resources of the area; 
6.  distance  to  closes:  area~  protected  for  dr,r~lung  water  and/or  envtronmental_ purpos:; 
- climatic  charac:ensti:s  o:  the  region[o.)  l,kely  to  be  affected; 
8  geographical.  geolog1cal  a:-.  .J  pedological  charactemtics; 
9.  flora  and  fauna.  includi:'\g  crops.  livestock  and  migratory  species; 
10.  description  of  target  an.=  non-target  eco~ystems likely  to· be  affected; 
11.  a comparison .of  the natural habitat of the recipient organism -.;a.·ith  the  prop~sed sit~s) of  relea~e; · 
12.  any  know'~ planned  ciev~icpments or changes in  lar.d  use  in the  regio:1  -.;a.·hich  could influencf' 
the  environmental  impact  of  the  release.  . 
1\l.  INFORM:\TION  RELATING  TO  THE  INTER:\CflONS  BETWEEN  THE  GMOs  AND  T:HE 
ENVIRONMENT 
A.  Characteristics  affecting  survaval,  multiplication  and  dissemination : 
1.  biological  fea~res which  afiect  survival,  multiplication  and dispersal ; 
2.  known  or  p'redicted  en  ..  ·ironment.al  conditions  which  may  affect  suNival,'  multiplication  and 
dissemination  (wind, water.  soil,  temperature,  pH, etc.); 
3·.  sensitivity  to _specific  agents. 
B.  Interactions  with  the  environmen.t : 
1.  predicted  habit2t  of  the  GMOs ; 
2.  studies of the behaviour and characteristics of the GMOs and their ·ecological impact• carried out 
in  simulated  natural  em·ironments.  such  as  microcosms. growth .rooms.  greenhou~s;  .  -
3.  genetic  transfer  capability : 
(a)  post-rele~e transfer of genetic material from GMOs into organisms ~n affected ecosystems; 
(b)  post-release  transfer. o!  genetic  material  from  indigenous organisms  to  the GMOs ; 
4.  likelihood  of  post-release  selection  lcadi.ng  to  the expression  of unexpccced and/or undcsitable 
traits  in  the  modified  organism ; 
5.  measures employed to ensure and  to verify. .genetic stability. Description of genetic traits .,h.ich 
may  prevent  or  minimize  dispersal  of  genetic  mat.erial.  Methods  ro  v~rity. genetic st.abihty; 
6.  routes  of  biological  dispersal.  known  or  potential  modes  of  interaction  with  th~ disseminating 
agent, includmg  inhalation.  ing('stion,  sulface  contact,  burrowing.  ~tc.  ~ 
7.  description  of  ecosystems  to  which  the  GMO~ could  be  d1ss~minated. 
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C  Potrn:.~l  ~n  ...  ·ironm~ntal  impact · 
potcntr~l  for  ~xc~ssive  population  incr~ase  m  the  ~nvironm~nt ; 
2.  competitive  advantage  of  th~  GMOs  in  relation  to  the  unmodified  recipient  or  parental 
organism(s) ; 
3.  id~ntification  and  description  of  the  target  organisms: 
4.  anticipated  mechanism  and  result  of  interaction  berween  th~  released  GMOs  and  the  targ~t 
organism; 
5.  identification  and  description  of  non-target  org:1nisms  whi~h.  may  b~ affected  unwittingly; 
6.  likelihood  of  post-release  shifts  in  biological  interactions  or  in  host  range; 
7.  known or pred1cted  effects on  non-target organisms  in  the environment. impact on  populatiol_l 
levels  of  competitors :  preys,  hosts,  symbionts.  predators.  parasites  and  pathogens; 
8.  known  or  predicted  involvement  in  biogeochemrcal  processes; 
9.  orh;r  potentJ311y  significant  interactions  with  :he  envHonmrnt. 
\'  lf\:FORM:\TIO!\:  0!\:  MONITORI:\G.  CO:'\/TROL.  'X:.-\STE  TREATI·fE!\T  :\ND  EMERGE!"CY 
RESPONSE  PLA~S 
A.  Mon1tormg  techniqut-S 
method.~  lor  tracing  th<.>  G!'.'iO~.  and  ior  mon:tvnng  tht:r  eifecrs; 
,  speCJfi~I!'\  (tc  identdv  the  G~-10s, and  to  d•stmgu1sh  ther.  from  the· donor, recip1ent  or,  ';I, here 
appropnare.  the  paren:a!  O~f2:":Isms).  sensitJ\'1~  and  reh2tiili~  of  the  monrtormg  techniques: 
3.  techniques  for  detecong  transfer  of  the  donated  genetiC  material  to  other  organisms; 
...  durauon  and  i~equency of  tht  monitonr.g. 
B  Control  of  the  relea~t> . 
I. methods ;nd. procedures' to  avo1d  and/or  minir.me the  S?read  of  the GMOs beyond  the  s1te  of 
release  or  the  des1gnated  area  for  use ; 
2.  methods  and  procedures  to  protect  the  site  from  intrusion  by  unauthorized  tndividuals: 
3.  methods  and  procedures  to  prevent  other  organisms  from  entering  the  site. 
C.  ~'aste treatment : 
I.  ry~ of  waste:  generated ; 
2.  expected  amount  of  waste ; 
3.  possible  risks ; 
4.  description  of  treatment  envisaged. 
D.  Emergency  response  plans : 
J.  methods  and  procedures  for  controlling· the  GMOs  in  cas~ of  unexpected  spread ; 
2.  methods  for  de~ontamination of  the  areas  affected.  e.g.  erad1cation  of  the  GMOs; 
3.  mC'thods  for  disposal  ~r san1ta110n  of plants. animals,  etc~ that were  exposed during or after the 
spread; 
4.  methods  for  the  isolation  of  the:  area  affected  by  the  spread ; 
5.  plans  for  protecting  human  health  and  the  environment  in  case  of  the  occurrence  of  an 
undr.:sirable  effc.-ct. 
.-
l r 
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.ANNEX II B 
INFORMATION REQUIRED IN NOTIFICATIONS CONCERNING RELEASES OF GENETI-
CALLY MODIFIED HIGHER PLANTS (GMHPs) (GYMNOSPERMAE AND ANGIOSPERMAE) 
A  GENERAL  INFORMATION 
1.  Name and  adc;fress  of the notifier (company or institute) 
2.  Name, qualifications  and experience of the  responsible  scientist(s) 
'  3.  Title  of the  project 
B.  INFORMATION  RELATING  TO  (~)  THE  RECIPIENT  OR  {B}  (WHERE  APPROPRiATE) 
PARENTAL  PLANTS 
1.  Complete  name : 
{a)  family  name ; 
(b)  genus; 
(c)  species ; 
(d)  subspecies ; 
(e)  cultivar/breedmg  line ; 
(f)  common  name. 
2.  (a)  Information  concerning  reprodvct10n : 
(i)  mod"e{s)  of  reproduction ; 
(ii)  specific  factors  affecting  reproductio:..  if  any; 
(iii)  generation  time. 
(b)  Sexual  compatibility  with  other  cultivated  or wild  plant  species. 
3.  Survivability : 
(a)  ability  to  form  ~tructures for  survival  or  dormancy; 
(b)  specific  factors  atfeC:ting  survivabil1ry.  i! any. 
4.  Dissemination : 
(a)  '9;ays  and  extent  of dissemination ; 
{b)  specific  factors  .affecting  dissemination,  if  any. 
5.  Geogr:aphical  distribution  of  the  plant. 
6.  In the case of plant species not normally grown  in the Member  State(s~ description of the natural 
habit.at of the plant. including information on natural predators, parasites. competitors and symbioncs. 
7. Potentially significant interactions  of  t.h~  plant with organisms other than  plants in the ecosystem 
where  it. is  usually' grown.  including information  on  toxic  effects  on  humans. animals and other 
organisms. 
C.  INFO~MATION RELATING TO THE GENETIC MODIFICATION 
1.  Description of the  methods used  for  the genetic  modification. 
2.  Nature and  source of the vector  u~d. 
3. Size. source (name of donor organism(s) and  intended function  of each constituent fragment of the 
.  · region  intended  for  insertion.  . 
D.  INFORMATION  RELATING TO THE GENETICALLY  MODIFIED  PLANT 
I. Description  of the trait(s) and characteristics which  have  bttn  introduced or  modified. 
2.  Information  on  the  sequences  actually  inSt"rted/deleted: 
(a)  size and structure of the insert and ·methods used for its char:acterization. induding infonnation 
.on any pans of the vector.introduced in the GMHP or any carrier or foreign DNA remaining in 
the GMHP; 
(b)  in  case  of deletion. sire and  function  of  the ddc:ted  region(s) : 
(c)  &ocation  of the inscn in the plant cells (inttgratcd in the chromosome. chloroplasts, mitochon-
dria..  or maintained  in  a  non-integnted  form).  and  methods  for  its  determination; 
(d)  copy number of the  inscn: 
3.  Information  on  the expression  o( the  inse-rt : 
(a)  information  on  the expression  of  the  insc-n  and  mC'thods  uS<'d  for  its  charactcr~z.ation ; 
(b)  pans of the  pbnt where  the  inSC'rt  is  npresscd  (c.f!  roots.  stem,  polkn  etc.) 
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41.  Information  on  how  the:  genetically  modified  plant  differs  from  the  recipient  plant  in : 
(a)  modc(s) and/or  rate  of  reproduction ; 
(b) dissemination ; 
(c)  survivability. 
5.  Genetic  stability  of the  insert. 
6.  Potential for transfer o{ genetic material from the genetically modified plants to other organisms. 
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7. Information on any toxic or harmful effects on hum:an health and the environment., arising from the 
genetic  modification.  · 
8.  Mechanism of interaction between the genetically modified plant :and target or~nisms  (if applicable). 
9. Potentially  significant  interactions with  non-target organisms. 
10.  ~scription of  detection  and  identification  techniques  for  the  genetically  modified  plant. 
t 1.  lnformat~on :about  previous  rc:leases  of  the  genetially  modif1ed  pbnt.,  if  applicab.lc. 
E.  lNFORM."'.TlON·  RELATING  TO  THE  SITE  OF  RELEASE  (ONLY  FOR  NOTIFICATIONS 
SUBMITTED  PURSUANT TO  ARTICLE  5) 
1.  Location  and  size  of  the  release:  site{s). 
2.  Description  of  the  release  site  ecosystem,  including climate,  flora  and  fauna. 
3.  Presence  of  ~exually compaoble  -.;~:ild  relatives  or  culw.-ated  plant  species. 
4.  Proximity  to  officially  recognized  b1otopes  or  protected  areas  -.;~:hich  may  be  affected. 
F.  lNFORJ-.1...&-,TlON  REU.TING  TO  THE  RELEASE  (ONLY  FOR. NOTIFICATIONS  SUBMI~ED 
PURSUANT TO ARTICLE  5) 
I. Purpose  of  the  rele~. 
2.  Foreseen  date{s)  and  duration  of  the  release. 
3.  Method  by  ""·hich  the  genetically  mod:iled  plants  v.-il!  be  relea~ed. 
4. Method for  preparing and m•naging the release site, prior to, during and post-release. including culti-
vation  practices  and  harvesting  method5.  · 
5.  Approximate  number of  plants  (or  plants  ~r m-). 
G.  INFORMATION ON  CONTROL. MONITORING. POST-RELEASE  AND WASTE  TREATMENT 
P~NS  (ONLY  FOR  NOTIFICATIONS SUBMITTED PURSUANT TO ARTICLE  5) 
1.  Any  precautions  taken : 
(a)  distancc{sl from  sexually  compatible. plant species; . 
(b)  any  measures  to minimize/prevent  pol1en  or seed  dispersal. 
2.  Description  of  methods  for  post-release  ucatmcnt of  the  site. 
3.  Description of prist-release  treatme.nt methods for  the genetically modified plant material -including 
wastes. 
-4.  Description  of  monitoring  plans  and  technique;. 
5.  Description  of any  ~ergency plans. 
H. INFORMATION ON THE POTENTIAL ENVIRONMENTAL IMPACT FROM THE RELEASE  OF 
THE GENETICALLY MODIFIED PLANTS  • 
1.- likelihood of the GMHP becoming more persistent than the recipient or parental  pl~nts in· agricul-
tural  habitats or  mo~ invasive  in  natural  habitats. 
2.  Any selective advanta~ or dis.advanta~e conferred  t~ ocher scxu:ally compatible plants species. which 
m:ay  re-sult  from  ~netic tr:ansfcr  from  the  genetically  modified  plant. 
·3.  Potential environmental impact of the:  inte-raction bct...,ecn  the genetically modified plant and target 
orl!3nt!>ms  (if  applicable)  . 
...  Po~~ibk environmental  impact  re-sulting  from  pocential  interaction~ with  non-target  organism~: 
.  ... 
.. 
.  (. ANNEX Ill 
ADDmONAL INFORMATION REQUlRED lNTHE CASE OF NOTIFlCATION FOR PLACING ON TilE 
MARKET 
A.  The following information shall be provided in the notification for placing on the market of products, in 
addition to that of Annex ll: 
1.  name of the product and names of GMOs contained therein; 
2.  name of the manufactUrer or distributor and his address in the Community; 
3.  specificity of the product, exact conditions of use including, when appropriate, the type of  environment 
and/or the geographical area(s) of the Community for which the product is suited; 
4.  type of expected use: industry, agriculture and skilled trades, consumer use by public ~t large. 
B.  The following information shall be provided, when relevant, in addition to that of point A, in accordance with 
Article 11  of this Directive: 
1.  measures to take in case of unintended release or misuse; 
2.  specific instructions or recommendations for storage and handling; 
3.  estimated production in and/or imports to the Community; 
4.  proposed packaging. This must be appropriate so as to avoid unintended release of the GMOs during 
storage, or at a later stage; 
5.  proposed labelling. This must include, at least in summarized form, the information referred to in points 
A.  1, A.  2, A. 3, B.  1 and B.  2. .• 
1  .. 
, ... 
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COUNCIL  DIRECTIVE  90/220/EEC  ON  THE 
DELIBERATE  RELEASE  OF  GENETICALLY  MODIFIED  ORGANISMS 
EXPLANATORY  NQTES 
(to be  read together  with  the  text of  the Directive) 
.  . Preface 
EXPLANATORY  NQTES  FOR  CQUNGIL  DIRECTIVE  90/220/EEC 
ON  THE-DELIBERATE  RELEASE  INTO  THE  ENYIRO~ENT OF 
GENETICALLY  UQOIFIED  ORGANISMS 
On  23.04.1990,  the  COuncil  of  the  European  Communities  adopted 
legislation  in  the  form  of  Directive  90/220/EEC  laying  down  _the 
procedure  and  conditIons  for_  obtaining  the  consent  to  · release 
genetically modified organisms  into  the-environment  in  any  part  of  _the 
European  Convnun i ty.  EC  Member  States  must  imp I ement  this  Community 
legislation at  the  latest  by  23  October  1991. 
The  legal  text  of  the  Directive  is  published  in  all  the  Community 
languages  in  the  Official  Journal  of  the  European  Communities, 
no.  L  117,  dated  8.5  .• 1990  and  Is  available  free  of  charge.  (The 
Ita  1.1 an  and  Greek  texts  were  subsequent I y  corrected  in  the 
OJ  L  7,  10.1.91  and  other  linguistic  corrections  are  still  to  be 
pub I i shed). 
These  EY;_,lanatory ·Notes  offer  practical  guidance  to  assist  in  the 
understanding  and  im~lementation  of  the· Directive.  Although  the 
guidance  Is  based  on  legal  .requirements,  it  is  not  intended  to  be  a~ 
author i tat lve  lnterpretat ion  of  the  1aw;- such  interpretation  can  ou ly 
be  made  by  the  European Court ef Justice. 
• . 
;..-
I 
Preamble 
The  preamble  ~o the Article of  the Directive summarlses.the contents of 
the Articles and  highlights the significant points.  It  ts  the Articles 
fhat  lay down  the  legal  requirements  but  the  preamble  can  help clarify 
and  Interpret  the main  body of  the  legal  text. 
The  legal  basis  bt'  the  Direct lve  Is  Art lcle  100  a  of  the  Treaty 
establ.lshlng  the  European  Economic  Convnunlty,  which  states  •  amongst 
others.  the  following: 
" .•..  The  counc 1 1  sha II.  actIng  by  a  Qua I If i ed  majority  on  a  .Proposal 
from  the  Convnission  In  cooperation  with  th~  European  Parliament  and 
after  consulting  the  Economic  and  Social  :Committeet  adopt  the  me~sures 
for  the  approximation of  the  provisions  laid down  by  taw,  regulation or 
administrative  action  in  ~ember  States  which  have  as  their  object  the 
establishment  and  functioning of  the  internal  market. 
The:  Commission.  in  its  proposals  envisaged  in  .Paragraph  1 .concerning 
health.  safety.  environmental  protection  and  consumer  protection.  wilt 
take as a  base  a  high  level  of  protection. 
,f. after  the  adoption of  a  harmoniz~tion mea~ure by  th~ Council  acting 
.by  a  Qua ll  f ied  majorIty.  a  Member  State  deems  it  necessary  to  app 1 y 
national  provisions  on  grounds  of  major  needs  referred  to  in  Article 
36,  or  relating  to  protection  of  . the  envir~nment  or  the  working 
environment.  it shall  notify the Commission  of  these provisions.  .  . 
Tile  Commission  ·shall  confirm  the  provisions  involved  after  ha·ying 
verified  that  they  are  not  a  means  of:  arbitrary  discrimination  or  a 
disguised restriction on  trade  between  Member  States.  · 
By  way  of  derogation  from  the  procedure  laid  down  in  Articles "169  and 
170,  the  Commission  or  any  Member  State  may  bring  the  matter  directly 
before  the  Court  of  Justice  if  it  considers  that  another  Member  State 
is making  imp{oper  us~ of  the  pow~rs provided  for  in: this Article." 
Article 1 
The  dual  objective  of  this  Directive  is  ~o  provide  ~  harmonised 
regu Ia tory framework  for  a II  r~  leases of  GMOs  Into  the env i ron•.~ent  (.for 
both  exper I  menta I  and  commerG"I a I  purposes).  and  to  provide  ,·..,r  the 
·protection of  human  health  and  the  environment.  Transport  of  GMOs  is 
excluded  from  the  scope  of  this  Directive  and  the  Commi~sion  is 
pr~paring a  seperate proposal  to cover  this aspect .. 
Article 2 
(1)  The  definition  of  •organism"  covers.  micro-organisms,  including 
virus~s a·nd  viroids;  plants  and  ani.mals;  including  ova,  seeds.  pollen. 
cell  ~ultures  ·and  tissue  cultures. from  plants  .and  animals.  This 
definition does not  cover  naked  r  DNA·and  naked  r-plasmids. 
(3)  The  intentional  'introduction  into· the  environment  means  the 
introduction  by  whatever  means,  directly  or  indirectly,  by  using. 
storing.  disposing.  or  making  available to a  third party. of  a  GMO  or  a 
combination  of.  GMOs.  Further  guidance:  on  the  interpretation  of 
"storing•  and  "disposing"  is under  preparation. 
17_ (5)  Despite  the  wide  definition  of.  ~placing on  the  market".  there  are 
carefully  considered  cases  In  certain  circumstances  where  a  GMO-
contalnlng, product  within  the  scope  of  90/220/EEC  which  is  supplied or 
made  available  to  a  third  party·  can  nonetheless  be  considered  as  not 
reQuiring  approval  under  Part C of  the  Directiv~~  One  such  is the case 
of  GMOs.  specifically  developed  for  a  user  on  a  bilateral  agreement 
between  a  supplier  and  a  user.  provided  Its  use  in  research  is 
subsequently notified under  Part  B of  this Directive.  Further  exampie~ 
are  given  in  the  Guidance  Document  for  the  interpretation of  the  term 
"Placing on  the Market"  (Document  Xl/57/92). 
Article  3 
Certain GMOs  are excluded  from  the  scope of  this Directive. 
Article  4 
Member  States  have  the  ob II  gat ion  both  to  take  measures  themse I ves 
(I  ega I,  administrative  and  practical)  and  to ··tay  down  measur<?~  that 
need  to  be  taken  by  those  carrying  out  a  GMO  release  of  any  kind  in 
order  to  avoid  adverse  effects  on  human  health  and  the  environment. 
The  measures  referred  to  cover  both  genera-l  and  specific  measures,  and 
can  be  before.  during  and  after  a  release.  as  appropriate. 
Competent  authorities responsible  for  GMO  releases  had  to be  designated 
by  Member  States at  the  latest  by  23.10.1991.  Annex  I  gives  detai Is of 
the  authorities  so  far  formally  designated  in  the  Community  under  this 
Directive. 
The  other  control  measure·s  mentioned  In  this  Article  could  include, 
where  this  is  consistent  with  national  practice.  arrangements  for 
consultation  with  a  workplace  biological  safety  committee  or  other 
appropriate  bodies  in  preparing  the  evaluation  mentioned  in  Article 
5(2)(b). 
Note:  Articles  5.  6,  7.  8  and  9  (part  B)  refer  to  releases  of  GMOs 
for  research  and  development  purposes or  for  any  other  purposes 
th~n for  placing on  the market. 
Articles 
Notification of  proposals  to-carry out  a  GMO  release  must  be  submitted· 
prior  to  the  release  to  the  competent  author lty  appointed  for  this 
purpose  In  the  Mem9er  State  where  .. the  release  is  planned.  Annex  I 
lists,  for  information.  the authorities so far  formally  notified  to  the 
Commis~_ion.  Potential  notlflers  need  to  identify  directly  who  the 
competent  authorities  are  in  the  Member  States  not  mentioned  in-this 
1 i st. 
Responsibility  for  providing  the  reQuired  information  on  the  proposed 
release  I ies  wi_~h  _the  person  who  wi  II  carry  out  the  release.  In 
practise,  the  •person"  will  generally  be  a  body  corporate.  e.g.  a 
company,· University or  l'nstltute.  As  wei I  as  the  information  indicated 
in  Annex  II  of  the  Directive.  a  statement  evaluating  imp~ct  and  risks 
posed by  the GMO(s)  to human  health or  the environment  must  be  included 
I~ the  dossier.  This  will  be  an  element  assisting  the  authortries  In 
making  their  environmental  risk assessment of  the proposed  release. 
18. 
• 
I .  .. 
.-
In  order  to  facilitate  the  procedures  and  reduce  possible  costs.  the 
authorities  can  accept  that  a  number  of  releases  falling  within  the 
same  experimental  programme  ln.a  specified period  (e.g.  one  year)  can 
be  treated  as  one  notification.  This  does  not  alter  the  requirements 
for  specific  information on  the  different sites or  the different  GMOs • 
. but  can simplify the procedures. 
Appl ieants  are  encouraged  to  re·fer  to  data  ·from  their  own  previous 
releases or  those of other notiflers.  It  is  Important  that unnecessary 
animal  experimentation  Is  ·avoided  and  that  Direct·ive  86/60~/EEC  of 
24.11.1986 on  the protection of  animals used for  experimental  and other 
scientific  purpose  Is  adhered  to.  Animal  experimentation  that  may  be 
required  In  order  to  supply  data  under·  this  Directive  should  be 
minimised  as  far  as  possible  by  avoiding  repetltlo!'  of  experiments. 
Maximum  use of  available data  should  be  made. 
Even  after  the  notification  has  been  submitted,  or  even  approved,  the· 
notifier still  has  the responsibility  to provide  to the authorities any 
additional  Important  information  as  specifieu,  and  take  additional 
protection measures  as  necessary. 
Articl«}  6 
A notifier  may  only  proceed  with  tr"  release  after  a  written  consent 
has  been  given  by  the  competent  authority  in  the  country  Where  the 
experimental  release  will  take  place.  This  is  glven  within  the 
specified·  period  after  that  authority  has  examined  the  application, 
made  its risk evaluation,  and  noted  any.  comments  from  o_ther  authorities 
or  interested  par.ties.  The  authority  retalf1S  the  possibility  to ·come 
back  to  the  notlfler  subsequent  to  an  approval  If  new  significant 
information  related to risks becomes  available. 
Article 7 
Member  States  have  the  possibi I ity  to  make  wider. consultations  before 
giving approval  for  a  particular  release under  Part  B ~f the Directive, 
provl~ed that confidentiality ·is  respected as outlined  In  Article  1~. 
Article 8 
In-order  to  help  authorities  approve  subsequent  releases  and  to  have  a 
feedback  on  their  assessment.  relevant  l~for~ation  resulting  \rom  the 
release  concerning  risks  and  indicating future  Intentions of  not~fyi.ng 
the  GMO  as  a  product must  be  communicated  to the authorities. 
Article 9 
Member  States  authorIties  in  .countries  other.  than·  the .one  where  the 
. release  is  taking  place  wi  11·  have  the  opportunity· to  make  relevant· 
observations within a  3Q-day  per lod on  the bas.is of  summ~ry  information 
~rov  I ded.  These . obserya  t ions  are  not .  binding  in  any  way.  The 
competent  authorities approving  the  release must  inform  the authorities 
of other  Member  States and  the Commission of  their  final  decision. 
To  fac iIi tate  the  exchange  of  informatIon  on  ex per imenta I  releases 
between  Member  States,  a  Summary.  NotifIcation ·Information  Format  has 
been  establIshed  as  foreseen  by  the  procedure  of  Art icla 21.  and  was 
adopted as Counc i I  Decision 91 /596/EEC on  4. 11.91  (OJ  l  322·.  23.11 .91)  ~ 
19_ Note:  Art ictes  10.  11.  12.  13,  14.  15.  16,  17  and  18  (part  C)  refer 
to releases of  GMOs  resulting  from  the  mark~ting of .any  product 
containing or  consisting of  GMOs. 
Article 10 
tn  order  to be  placed on  the market.  a  GMO-contalning  prQduct  must  have 
received  consent  for  testing first  (as  foreseen  under  Part  B).  or  must 
have  undergone  a  risk assessment  based on  the elements outlined  In  Part 
e.  and  must  have  received  clearance  both  as  regards  its environmental 
impact.  as  foreseen  under  Part  C  of  th l s  DIrective.  and  as  .regards· 
aspects which  may  be  covered by  specific Convnunity  product  legislatl.on. 
The  clearance .under  Part  C of  this  Direc~ive for  placing on  the market 
of  products consisting of or  containing GMOs,  concerns aspects relating 
to  the  potential  risks  to· humans,·  plants,  animais  and  th_e  environment 
connected with  the  release of  these  products. 
It  is  possible  ·for  cer·tain  GAo-containing  products  not  to _be  covered 
under  Part  C  of  this  Directive,  if  it  is  decided  under  the  !"r"cedure 
foreseen  under  Article  21  of  this  Directive  that  other  Communify. 
legislation  In  force  provides  for  a  specific  environmental  risk 
assessment  similar  to that  laid down  in  this Directive. 
A  Commission  decision  (91/274/EEC:  taken  in 
procedure  of  Artic~e  21  established  there  is 
Community  legislation  in  force  (OJ  l  135,  30.5.91) 
Article  11 
accordance 
currently 
with 
no 
the 
such 
Before  a  release  is made  by  placing  a  prod~ct on  the  marke(,  a·  written· 
consent  must  be  ·obtained  by  the  importer  or  manufacturer  of  ·the 
product,  Issued according  to the  Community  approval  procedures outlined 
under  Article  13.  This  consent  may  have ·specific  conditions  attached·· 
to  it. 
The  importer  or  manufacturer  will  deal  only  with  one  competent 
authority  in  a  M.ember  State where  the  product  will  be  marketed  for  the 
first  time.  This  authority  •. chosen  by  the  notifier,  will  act  as  a 
.. gateway•  to the  system.  will  receive  the  information  submitted·by  the 
notlfie~·. and  will  be  responsible· for  •~~~~n~ the  final  consent. 
The  information to be  submitted  is  Indicated  in  Annexes  II  and  Ill, and 
reference must  also be made  to data obtained  in  releases carried out· by 
~he  oot If ler  eIther  Ins ide  or  outs Ide  the  Community.  App I I  cants  are 
encouraged  to  refer  to  relevant  data  available  from  their  own  previous 
releases  or  those  from  other  notifiers.  This  may  in  some  cases.  have 
the  positive  ·effect  of  reducing  the  necessity .  for  animal 
experimentation.  It  is  important  that  unnecessary  ani_mal  experiments' 
are avoided  and  that Directive 86/609/EEC of  24.11.86 on.the protection 
of  .animals  used·  for  experimental  and  other  scientific.  purposes  is 
adhered  to.  Animal  experimentation  that  may  ·be·  required  in  order  to 
supply data under  th.ls Directive should minimised as  far  as  poss_ibl~ by 
avoiding  repetition  of  experiments.  Maximum  use  of  available  data 
shou I  d  be made. · 
Even  after  the  nOtification  has  been  submitted,  or  even  approved.  the 
notifier stil·l  has  the responsibility to provide  to  the author-ities· any 
additional  important  information  as • specifi.ed.  and  take  additional 
protection measures as necessary. 
... 
., 
• 
t 
' 1 
.  Article 12 
The  competent  authority  receavang  the  nottfication  Is  responsible  for 
carrying  out  the  main  environmental  risk  assessment  within  a  maximum 
90 day  period.  ·Any period of  time  during which  the competent  authority 
is  awaiting  further  Information  which  It  Is  has  requested  from  the 
notlfier  Is  not  Included  In  the  90  ·days.  If  ·the  assessment  Is· 
satisfactory.  th~  authority  then.  forwards  the  application.  to  the 
Commission  with  a  favourable  opinion.  for  consent.  The  dossier 
forwarded  must  Include  a  summary  of  the  notification;  t~e  format  of 
this  summary·  has  been  established  as  f~reseen.  according·  to  the 
procedures  of  Article  21,  and  has  been  adopted  as  Commission  Decision 
92/146/EEC of  11.2.92  (OJ  L 60,  5.3.92). 
Article  13 
The  Convnission  is  responsible  for  ensuring  that  the  Commun.ity-wide 
consultation  procedure  takes  place  effectively  and  e·fficiently.  The 
consultation  of  the  other  Member  State~  ts  ma~e without  a  meeting.  by 
simply  circulating  tne  dossier  to  the  compet.ent  authorities.  with .the 
necessary  confidentiality  precautions.  A consent  valid ·for  the  whole 
Community  is  given  to  the  applicant  by  the  main  authority  dealing with 
t~e  dossier.  if  within  the  period  of  60  days  no  insurmountable 
difficulties-or objections are  raised. 
If  a  competent  authority  of  a  Member  State  indicates  within  the 
specified  period  that  it  does  not  wish  consent  to  be  given  for  that 
particular  release,  then  a  meeting ·of  the  Article  21  Commi.ttee  wi  1 f  be. 
called  immediately  ~nd a  vote  on  the  matter  shall  be  take·n  as  forese.en 
by  Article ·21.  This  will  be  done  as  soon  as  possible,  and ·no  later 
than 3·months  from  the expiry of  the ·period  laid down  in Article 13(2). 
The  consent  is  issued  to  the  applicant  following  a  favourable  vote  in 
the  Committ.ee  by  QUalified  majority.  No  further  noti(ication  is 
reQuired  as  regards matters within  the  scope of  the· Directive. 
The  consent  may  me.ntion  specif.ic  conditions.  and·Member  States  have  an 
obiigation  ~o ensure that  these conditions are  adher~d to. 
If  produets  receive  environmental  sarety  clearance  an  some  Member 
States before  23  October  1991.  and  are  mar~eted by  that  date.  th~y can 
continue  being  on  the  market  of  those  Member  States  after  o~tober  23. 
but  .they  w  i I I  need  to·· be· approved  by  the  Community  proceo~\res·  of 
Directive  90/220/EEC  before  beIng  pI aced  on  the  ma·rket  of other  Member. 
States. 
Article  14 
Any  conditions of  labelling and  packaging specified on· the  consent  need 
to  be  adhered  to.  and  Member  States  have ·the obligation  to ensure  that 
this  Is so. 
21 . Article  15 
The  scope  of  this  Directive  covers  only  the  aspects  of  the  product 
relating  to  s~fety,  the  environment  and  human  health,  and  ·is  as  far  as 
this  aspect  Is  concerned,  no  Member  State  can  take  action  to prohibit, 
restrict  or  impede  the  release  of  a  GMO-containing  product  ·except  as 
provided  for  in  Article  16.  Compliance  with  other  regulatory 
requirements  (e.g.  for  appearance.  efficiency,  acceptability,  QuaiJty, 
etc.)  l.s  outside  the  scope of  this Directive and  this Article. 
' 
Article  16 
This  .. safeguard  clause"'  in  the  Directive  is"'  intended  to  deal  with 
emergency  cases  where  new  data  or  evidence  concerning  env i ronmen_ta I 
safety  becomes  avai I able  after  a  product  has  been  given  clearance  on 
these  aspects.  The  sale  or  use  of  products  can  be  provisionally 
restricted  by  a  Member  State,  but  within  three  months  a  _binding 
decision  must  be  taken  at  Community  level  on  the  validity or  otherwise 
of  this uni later~:  ~ctior.. 
Article  17 
It  is  envisaged  that  publication  in  the  Official  Journal  of  products 
approved  will  be  done  periodical!>.  every  three  or  six  months,  as 
necessary. 
Article  18 
The  first  report  from  Member  States  on  the  control  of  the  use  of 
products  placed  on  the  r:narket  is  to  be  sent  to  the  Commission  at· the 
end  of  1992  and  the  Commission's  own  report  to  the  EP  and ·the  Council 
will  be  sent  for  the  first  time  in  1995.  Suggested  outlines  for  the 
Member  States  reports  wi II  be  provided. 
Article  19 
The  confidentiality provisions  outlined  in  this Article  are  of  extreme 
importance.  The  Commission  has  put  into  place,  together  ~ith  the 
Member  Stdte  competent  authorities,  a  scheme  with  specific procedures. 
reQulrer~aents  and  measures  to  ensure  the  protect ion  of  confIdential 
Information at all  levels  (Ref:  Doc.  Xl/140/92-fin). 
The  Commission  has  the  . responslb iII  ty  to  ensure  that  the 
confidential lty  provisions  are  adhered  to  and  absence  of  suitable 
measures  in  Member.  States  wi II  be  considered  as  an  infringement.  One 
practical  effect of this will  be  that  confidential  information will not 
be  received  by  that  Member  State  from  the  Commission  or  other  Uemper 
States. 
At  ~he  sa~e time,  it  is also  important  that  certain  information  is not 
kept  confidential  as  out I ined  in  Art.icle  ·19.4.  The  Commission  has 
drawn  up.  together  with  the  Member  State  competent  authorities. 
guida_nce  concerning  this aspect  (Document  Xl/621/91-fin). 
Article  20 
As  new  technical  information  becomes  available.  it  is  foreseen  that 
·sorne·of  the  annexes will  be  adapted  to  t~chnical  progress. 
2'2. 
...  , 
' .  ·-
Article  21 
The  Committee  foreseen  has  several  important  functions.  as outlined  in 
the  Directive.  It  will  be  chaired  by  the  Commission  (DG  XI)  and  will 
· oper•te according to the  interna.l  rules  it adopted at  its first meeting 
·  on  25  March  1991  In  Brussels  (Document  Xl/88/91). 
In order  for  Member  States to participate fully  In  this Committee  after 
the  lmplementat·lo·n  date  of  23.10.1991.  they  must  have  transposed  all 
aspects of this Directive  Into national  law. 
The  votes of  Member  States are  weigh~ed as  follows:  Belgium  5.  Denmark 
3.  Germany  10.  Greece  5.  Spain  8,  France·  10,  ·Ireland  3 •.  Italy  10. 
Luxembourg  2.  Nethe~lands· 5,  Portugal  5  and  United Kingdom  10. 
To·be adopted.  a  proposal  must  receive  54  votes  in  favour~ 
Article  22 
Regular  meetings  organised  by  the  Commission  of  the  Committee  of 
Competent  Authorities  wi II  ensure. that  information  and  experience  is 
exchan~ed. 
Article  23 
In  order  to  be  implemented  in  a  Member  State.  the  Directive  has  to  be 
transposed  in  its entirety  and  in  all  the  regions  of  a  Member  State. 
Member  States which  have  not  fully  transposed  the  Directiv~ will  be  in 
infr lngement  of  the· D·irect lve.  o~e practical  consequence  may  be. that 
.they  will  be·  unabt'e  to  participate  in  the  Community  consuLtation 
procedures  foreseen  in  the Directive.· 
If a  Member  State does  not  implement  fully or  correctly  the  Directive, 
the  Commission  will  take  the  necessary  steps  to  start  infringement 
procedures  as  foreseen  under  Article  169 of  the Trea1y. 
Member  States  have  to  off ic i.a II  y  inform  the  ·Commission  of  their 
legislat.lon  as  s~n as  it.  is  adopted.  Once  the  Commission  has  been 
informed  of  Jegtslat lve measures  taken.  It wl I I  examine  thetn  to ,.n!ltttre 
confirmlty with  the Directive.  If  there  Is no  conformitY Member  States 
will  be  notified and  asked  to  take  the  nece~sary measures.  If they  do 
not  comply,  Infringement  procedures will  be started. 
Art ic.le  24 
The  Directiv~  is  a  piece  of  legislation· addressed  only  to.the  Member 
States· governments who  in  turn are  responsibl.e  fo·r  taking  the  ne·cessary 
action  for  implemetation . 
23. DEt-IAARK 
COMPETENT  AUTHORITIES  FORMALLY  APPOINTED 
BY  MEMBER  STATES  TO  BE  RESPONSIBLE  FOR 
THE  IMPLEMENTATION  OF  DIRECTIVE  90/220/EEC 
The  Ministry of  Environment 
Slotsholmsgade  12 
OK  - 1216  KOBENHAVN  K 
FEDERAL  REPUBLIC  OF  ~~HMANY 
XI/11/.92-Rev.1 
Main  Competent  Authority· for  handling  release notifications 
Bundesgesundheitsamt 
Thielallee  88~92 
D - 1UOO  BERLIN  33 
Authorities Cooperating  with  the  Main  Competent  Authority  above 
Umweltbundesamt 
B 1i smarckp I atz  1 
0-- 1000  BERLIN  33 
Biologische Bunde·sanstait  filr  Land- und  Forstwirtschaft 
Messeweg  11-12 
D - 330  BRAUNSCHWEIG 
Bundesforschungsanstalt  fUr  Viruskrankhelten  der  Tiere 
Paui-Ehrlich-Str.  28 
D - 7400  TUBINGEN  1 
Overall  National  ·AuthoritY  responsible  for  implementation  of  the 
Directive 
Bundesministerium  fUr  Gesundheit 
Referat  353 
D  - 5900  BONN  2 
FRANCE 
Ministere  de  I'Environnement 
DEPPR 
14_,  Bd  du  Genera 1  Lee 1  ere 
F - ~2524 NEUILLY-SUR-SEINE 
Ministere de  J•Agriculture 
DGAL  ·- . 
175  •·  rue  du  Cheva 1  eret 
F  - 75013  PARtS 
24. 
..• I 
..  -· 
SPAIN  (provisional  appointment) 
Secretaria de  Estado para  las Politicas de.Agues 
y  Medio  Ambiente 
Paseo  de  Ia  Castellana-s7 
E - 28071  UAORIO 
ITALY-(provisional  appointment) 
Ministero della Sanita 
~Ia Sierra Nevada  60 
1-00144  ROMA 
NETHERLANDS 
Ministry of  Housing.  Planning  and  Environment  Protection 
Directorate General  for  Environment  Protection 
Po~·~·.!s  450 
NL  - 2260MB  LEIDSCHENOAM 
PORTUGAL 
Oireccao Geral  Qualidade  Ambiente 
Rua  Seculo 51-1. 
P - 1200  LISBOA 
UNITED  KING[)()M 
Department  of  the  Environment 
Rommey  House 
43  Marsham  St. 
UK- LONDON  SW1  _3P4 
Health  and  Safety  Executive 
Baynards  House 
1.  Chepstow  Place 
UK  - LONDON  W2  4TF 
BELGIUM  (Provisiona-l  appointment) 
National  Authorities 
Minist~re de  Ia Sante publlque et de  t•envlronnement 
Service d'Jnspectlon de  Ia  Pharmacie 
·.Service d'lnspection des  Denrees alimentaires 
lnstitut d'Expertise veterinaire 
Minist~r~ de  I~Agricult~re 
Service d·lnspection des Matieres  Premi~res. 
Manhattan  Center 
21  avenue  ~u Boulevard 
B- 1210  Bruxelles 
Flemish  Region 
Administratie  Ui lieu.  Natuur  en 
Landinrichting 
Kunstlaan  43 
B- 1040  Bruxelles 
25. Wallonian Region 
Direction generate des  Ressources naturelles 
et de  I'Environnement 
Division de  Ia  Pr~vention des Pollutions 
Avenue  Albert  1.  187 
B - 5000  Namur 
Brussels-capital  Region 
lnstitut bruxellois pour  Ia  gestion de 
t'Environnement 
Avenue  Louise  149 
B- 1050 Bruxelles 
Contact  Point/Coordination: 
Institute of  Hygiene  and  Epidemiology 
Biosafety  rONA  and  Biotechnology 
J.  Wytsmanstraat  14 
B- 1050  Bruxell~s 
' 
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(Acts  whost publication  is  not  obUgatory) 
CO}AMISSION 
COMMISSION DECISION 
of 15  April  1.9.94 
amending Council Decision .91/5.96/EEC concerning the summary notification 
information format  referred  to in  Article  .9  of Council  Directive 9'0/220/EEC 
(9~/211/Eq 
TiiE COMMISSION  OF TiiE  EUROPEAN  COMMUNmES. 
Having  regard  to  the  Treaty  esublishing  the  European 
Community, 
Having  ~gard ro  Council  Directive  90/210/EEC of  23 
April 1990 on the deliberate release into the environment 
of  genetically  modified  organisms(').  and  in  particular 
Article  9  thereof.  ·  · 
Whereas  the  competent  authorities  appointed  by  the 
· Member  States  have  to  send  to  the  Commission  a 
summary of each  notification  received  under Part  B of 
Directive 90/210/EEC ; 
Whereas.  in  consequence.  the  Council  establishe~  by 
Decision 91/596/EEC (2).  the format of this summary, to 
be used for the release of any type of genetically modified. 
organism (GMO); 
Whereas as a result of experience, and given that different 
information  is  notified  in  relation  to specific  types  of 
GM()s. a  revised  format  is  necessary ; 
Whereas  Decision  91/596/EEC  should  th~fore  be 
amended by subdividing the summary notification format 
into two parts : Pan 1 to be used 'for ~leases of genetically 
{')  OJ No L  117.  8.  S.  1990.  p- IS. 
(2)  OJ No L 321. 22.  J L  1991. p.  1. 
·modified higher plants and Part 2 to be used for releases 
of  any  other GMO; 
Whereas the measures provided for in this Decision are in 
accordance  with the opinion of the committee provided 
for  in  Anicle_ ll of Directive.  90/120/EE~ 
HAS  .ADOPTED THIS  DECISION : 
Artid~ 1 
The Annex to Decision 91/596/EEC is  replaced by the 
Annex  hereto.  · 
A.nicl~ ~ 
This Decision  is addressed  to the Member States. 
Done at  Brussels.  15 April  ~994. 
For  th~ CommissjoJi 
Yannis  PALEOKRASSAS 
Mnnb~r of  th~ Cotnmission Official Journal of  the  European  Commu~ities  No L  105/27 
ANNEX 
PART  1 
SUMMARY NOTIFICATION INFORMATION FORMAT FOR RELEASES OF GENETICALLY 
MODIFIED  HIGHER  PLANTS  (ANGJOSP~RM.AE  AND  GYMNOSPERMAE) 
(in  auordantt u.ith Artidt  9 of DiruliSI(  9f?1110!EEC) 
ln  trOduction 
'Ib~ Summary  Notifiation  Jnfonnation  Format  for  genetiaJJy  modifie-d  higher  plant releases.  has  been 
establishe-d  for  th~  purposes  and  according  to  the  procedures  envisaged  by  Article  9  of  Directive 
90/220/EEC. 
It  is  f'C'COgnized  that the Summary Notification  Information  Format  for  genctialty modified  higher plant 
releases is not designed to contain all  the information required for  carrying out an environmental risk ~  . 
ment. The space provided after tach question is  not indicative of  the depth of the information required for . 
the  purposes of  the Summary  Notification  Information  Format.  · 
·f I 
No  L  105/28  Official  Journal  of  the  European  Com.mumtJcs 
A.  GENERAL INFORMATION 
1. Details of notification 
Noti(iation number:------,------------------------
Date  of acknowledgment of notification: ---------------------
··  Title of. the project : --- -----------------------·-···---· 
----·-·--······-· 
Proposed  period of release=--------------------------
2.  Notifier 
Name  of  institute or company:-·····---------·---·---=-·---~--------···-·-·-
-------------------------
3.  Is the same GMPt release planned elsewhere in the Community (in confonnity with Article S 
(1}) ? 
0  No  0  Not  k.nO'II.'TI 
If )·~.s,  insert  the  country  code{s)  0  0  D  -·---·--··--·······---···-··-··•·r-
4. Has  the  same  GMPt  been  notified  for  release  clsew"here  in  the  Community by  the  same 
norifier? 
Yes  0  No  0 
If .yts.  notification  number=----········  ____________  _._··--·--··--·······-····-·················· 
B.  INFORMATION ON THE GENETICALLY  MODIFIED  PLANT 
I. Complete nan1e of the recipient or parental plant 
(a)  family name 
(b)  genus 
(c)  species 
(d) subspecies 
(e)  cultivarlbrcc:ding ·line 
(f)  common name 
2. Description  of  the  traits  and  characteristics  which  have  been  introd__;ee4  or  modi,fied. 
including marker genes and prcrious modifications 
-----------··------------------------
3. Type of che genetic .iodifieation : 
(a)  Insertion of genetic material 
(b)  Deletion  of genetic materia) 
(c)  Base  substitution 
(d) Cell  fusion 
(e)  Other. please specify 
..  ·o 
0 
0 
0 
0 
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4. In the case of insttrion of gconetic  mat~naJ. giv~ the:  sourc~ and intended function of each 
constituent fragment of the region  co  be  in$cncd 
-------------··---·-------·-·········· 
--------·-------···--·--···-···-·····-··-'-···-·······-··--·-·---··· 
···················-·····-····-·--··-·----············-········································-·-·-·-·····-·-·--·-·----------------
S.  In the:  case of deletion of genetic material. give:  infonnation on the:  function of the deleted 
sequences 
----··-·-··-···-----·------··-········--·-··--····-·-·····-······--··--·---·-···--·········-·-··-----
6.  Brief description of the method used  for  the generic modification 
............................... :  ................ - ... ---··-··-··-··--········--··········-··-·········-:  .......................... ----··-·········-------·-·-··  ... ----·--···· 
C.  INFORMATION  RELATING TO THE EXPERIMENTAL  RELEASE 
1. Purpose of the  release 
--------·-··---·-·-·--··-·-·------···---...... ·------· 
·---···--·-·-·-···--·------···-----·-····-·-·-··----·-··-··-------------------
···-····---······-···-··-------·---·····-······-·------·-·-·-----·--··-·--····--··----· 
2. Geographical Joc:ation of the rc1ease site 
-·---------.  ---·----······--···-···--~---·----···· 
--------·---····--·-----··---··------
----··----------
3. Size of the site (in? 
--·-··--···-··------------···-··--
----···-----------------~----------------------·--·-·----
-·--------';--·-
---··---------·---------------26. -4.  94 
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PART 2 
SUMMARY NOTIFICATION INFORMATION FORMAT FOR RELEASES OF GENETJCALLY 
MODIFIED ORGANISMS OTHER THAN  HIGHER  PLANTS 
(in  accordance  with  Article  9  of  Directive  90/220/EEq 
IntrOduction 
Th~ Summary Notification Information Format has been nt:ablished for  the purpos.cs and according ~o the 
ptoecdures ntvisaged  by Article  9  of  Directive:  90/220/EEC.  · 
lr:  ~  J'e'Cogniz~d that th~ Summary Notification Information ~o~at  is not designed lO CQnt.ain  all the infor-
mation required for carrying out an environment.al risk assessment in the deuil necessary for such an assess. 
mcnL The information mtered should. however, adequately reflect (in  a condensed fotm)  the information 
submitted to the competent authority according  to Articles 5  and 6  of  Directive  90/220/EEC under the 
conditions specified in the prdace to Annex 11.  The space provided after each question 'is not indicative of 
the depth of the information required for the purposes of the Summary Notification Information format. 
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D.  Summary of the potential environmental impact from che  release of the GMPts 
-·--··-··--··--·--·--·-·--·········--·-··-··-------·----·····-···-·····-·-··---·-----·-·,...-·-···-····· 
·-·-·--···-----------·-·-----·--·-·------------------------·-·----------------
E.  Brief description of any measures taken for the management of risks 
----------------··--····--··--·····-·-···-····---
--··---··------------------------------------------··,-----
-.  I I 
I 
• 
I·~ 
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GENERAL INFORMATION 
1.  Details of aotific:atioa 
Member State  of notification=--·-·-------
Notification  number: -----
Ihte of acknowledgment of  notification : --·---····-··--·-
Title  of the  project:-------~---·-----------
Propos-ed  period  of release : ---··-+--·--·-----···-·-·-··-
2.  Notifier 
Name of  institution or company : ···--·----·---·-·--·-····-·-··-·--------------· 
3.  GMO characterization 
(a)  Indicate whether the GMO  is  a : 
viroid  . 
RNA virus 
DNA virus 
bacterium 
·fungus 
animal 
other.  please specify 
--·-·-·-----· 
(b)  Identity of the  GMO: 
0 
0 
0 
0 
0 
0 
0 
--------·-···-··-··-·-----
4. Is the same GMO release planaed.  elsewhere in the Community (in conformity wicb Article S 
(I))? 
Yes  0  No  0  Not  known  D. 
If yts,  inscn the  country code(s)  0  0  0 
S.  Has the same GMO been  a.oti(ied  for release· elsewhere in tbe Commuaity by the same· 
notifier? 
Yes  0  No  0 
If J'CJ! 
- Member Sta~ of notification :---------
- Notification  number:-----------~----------------
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JNFORMATlON  RE~TING  TO ANNEX  II 
A. Information relating to the rccipicnc or parental organisms fro~  which chc GMO u derive~ 
1. Irulitau  tt•hrth~r thr  ruipimt  ~r  par~nlal organism  is  a: 
viroid  D 
RNA  virus  0 
DNA virus  D 
bacterium  0 
fungus  0 
animal  D 
other.  please  specify  0 
2  Compl~tt namt 
(i)  order  and/or  higher  uxon  (for  animals) 
(ii)  &1=nUS 
(iii)  species 
(iv)  subspecies 
(v)  stnin 
(V1)  pathov:ar  (biotype. ecorype. r.ace,  etc.) 
(vii) common  name 
3.  G~ographital distn"bution  of thr organism 
(a)  Indigenous to the country where the notification  is  made : 
Yes  0  No  0  Not  known 
(b}  Indigenous  to  other EC countries : 
(i) Yes  0 
D 
If )'t'S,  indicate  the  type  of ecosystem  in which  it  is  found : 
Atlantic 
Arctic 
0 
0 
0 
Mediterranean  0 
Continenul  0 
Not  known  0 
(c)  Is  it  ~gularl]· MSUl in the counuy where  the  ootifi~tion is  made ? 
Yes  0  No  0 
(d) Is  ~ rtgulariJ· lupt in  th~ country w~re the notification  ~ ma'de ? 
Yes  D  No  0 
~·' 
I 
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-4.  Natural habitat of th~ organism 
M  (a)  If the  organism  is  a  microorganism 
water 
soil.  free-living 
soil  in  association  with  plant-root systems 
in association  with  plant  leaf/stem  systems 
in association  with  animals 
other (specify) 
A  (b) If the organism  is  an animal : 
natural  habiut or -usual  agroec~tem  : 
D 
0 
D 
0 
0 
.o 
·-·-·-···-···-········-······-····-············-····-···-···-·········-·-·····-····--·--:  ..... ___________ .. ___________________ .... __ _ 
S.  (a)  D~ttction tubniftu.rs 
(b)  ldmrificarion  ttchni.qsus 
~--·----:-·-·····-~-eoo:--··-······-········-·-····--·:...-.. --.---··--···-·-·--·-·--···-··-··-·--······-;-·--
6.  Is  th~ rtripirnt  organism  clasnfjtd undu t:risting  Community  ru/~s  relating  to  th~ prottaion of 
human  h~alth aru!/or:  th~ mt:ironmcnt? 
Yes  0  No  D 
If yu, specify: ------
1.  Is  1ht  ncipiml organism  pathogmic  or harmful in.  any  oth~r "-'4.1  (including  its  txtractllular 
.  produas)  ~ithtr lir:ing  or dtad? 
0  ·No  0 
"If yu: 
(a}  to  whid~ of the following  organisms : 
humans 
animals 
plants 
D 
0 
D 
(b) Jive the cdnant infonnation  ·specified under Annex  11,  point D.  {A).(ll).(d) 
------------·-·--·--·----.,......, 
---------·-·---
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8.  Information  conurning  ~produ~ion  : 
(a)  Generation  time in natural  ecosystems : 
·------··-·-··---·-----------
(b) Generation time in the ecosystem where  the release  will  take  place : 
(c)  Way of  ~production: 
Sexual  0  0 
(d)  factors  affe«ing reproduction : 
9.  Sun.ic;abiliry· 
(a)  Ability  to  form  structures er:thancing  survival  or dormancy : 
(i)  endospores 
(ii}  cysts. 
(iii)  sdcroti2 
(iv)  asexual  spores  (fungi) 
(v)  sexual  spores (fung.) 
(V1)  eggs 
(vii)  pupae 
(viii)  larvae: 
(ix) other, please specify 
(b)  Relevant  factors  affecting survivability : 
10. (a)  Wa;·s  of  dissm~ination 
(b)  Factors  affuting "di.s.umination 
0 
0 
0 
0 
D 
D 
0 
0 
D 
It. ~OJIJ  tmff~  moJifwzti01JJ of  IM r«ipinat or  parmt41 organism 4/ndy  rtotifi~d  for rcUII# irt tbt 
Cllfttry ~  tk rtotifiu.tion ;, fJIUUk  (giw flotifiation  ru1mbtn)  · 
• 
-. 
- .. .-
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B.  Information relating to the genetic  modificati~n 
L  7jp~ of th~ gm~lic modification 
(i)  Insertion of  ~netic material  0 
(ii)  Deletion of ~netic material  •  0 
(iii)  Base  substitution  ' 0 
(iv)  Cc:ll  fusion  0 
(v)  Other. pleaSe  specify  0 
-·-----------------·-····--··-·-----·--·:------········-·-···-··-···---·-----···-·-·-····-··--···· 
2.  Intmd~d rtSult  of th~ gmetit modification 
.  ···--····--·---·-····-··········--·····--···--·-·-·····-···-----------··-···--·----·-····-···-··-···---···-··--·· 
3.  (a)  Has  a  c.~ctor bun  us~d in  tht proass of mo.dification? 
Yes  D  No  0 
If  no,  go  stnight to  questiqn  5. 
(b)  .If  JC.C,  is  the vector wholly  or  partially  pre~nt in  the  modified  organism ? 
0  No  D 
If  no.  go  straight to .question  5. 
4.  If tht ansu:tr to  J  (b)  is yes.  supp!J  the follou:ing  inform.:ztion:  · 
(a)  Type  of vector 
plasmid  p 
bacteriophage  D 
virus  D 
cos mid  0 
' 
phasmid  0 
tnnsposable clement  D 
other. please  specify  0 
----------- -·---------------------------------
(b)  Identity of  the ¥eCtOr 
(c)  Host  nngt>  of the vector 
----------------·-----------------------------·---------
-···----·--------------···----------------------·-·-----·--·-···----------
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(d) ~  in the ~or  of scquenc:c:s  giving  •  sdeetablc:  or identifiable phenotype: 
Yes  ·No 
Anu"biotic  resistance:  0  0 
Heavy  metal  resistance  .o  0 
Other~ specify  0  0 
(c)  Constituent fragments  of  the  vector 
------------·-········-··-··-··-·-····-···············-······················"·····--····----·---···-···-··· 
(f)  Method for  introducing the vector  into the  recipient organism 
(i} transformation  0 
(ii)  electroporation  0 
(iii)  macroinjection  0 
(iv)  microinjection  0 
(v)  infection  ·  0 
(vi)  other,  please  specify 0 
S.  If  tht an.sun- to qutstion BJ (a) and {b) iJ no, u.:hat  u.:a.s tht mtt_bod ustd·ro introduu tbt i"'ltr1 into tht 
ruipitntlparmtal cdl? 
(i)  tnnsformation  0 
(ii} microinjection  0 
(iii)  microencapsulation  0 
(iv)  maaoinjection  D 
(v)  other. please  specify  0 
6.  lnjomuJtion  on  tbt insm 
(a)  Composition  of the  insert. 
(b) Source of och constituent  part of the insert 
(c)  Intended function  of each  constituent part  of the insen in the GMO 
----------·----------
.  ' 
;, 
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(d)  Location  of the ins.eri  in the host  or~nism  . 
- on a  free  plasmid  0 · 
- integrated  in the chromosome  0 
- other. please  specify  D 
·---·---··-··--·······-····--·--··--··---·-----------
(c)  Does  the insert contain  parts whose  produtt or function  arc  not known 1 
Yes  0  No  0 
If yts, please  specify : --·---·-··-·----··-···-·-·· 
-----·---·-·------
C.  Information on. the organism(s). from  which· the insert is derived (Donor) 
t. lndicatt whtthtr it is a: 
viroid  0 
RNA virus  D 
DNA virus  0 
bacterium  0 
fungus  0 
plant  0 
aniinal  0 
other. please  specify  0 
2.  Complttt  ruJm~ 
(i)  order andl~r higher taxon (for  animals) 
(ii) family  name (for  plants) 
· ftii) genus 
(i-1)  species 
(v)  subspecies 
(VI) strain 
(vii) cultivu/breeding line 
(viii) pathovar 
(ix)  common  name 26.  -4.  9-4  Official  Journal of the  European  Communities  No_  L  105/39 
3.  Is IM o'iartism p:zrbog~nic or barmful in 41")  ot!Hr ~J  (indauiing its atrtMcllulJJr products).  ~ithcr 
J;,...;ng  or JcaJ? 
0  No  0  Not  known  D 
1£.  jtS, specify  the  following : 
(a)  to which  of the  following 'organisms ? 
humans  D 
animals  D 
plants  0 
· (b)  arc the donated sequmces involved in any way to the pathogenic or h.annful  properties of the orga· 
nism? 
Yes  0  No  D  Not  Jcnown  0 
If )·ts,  give  the  rekvant  information  under Annex  11.  11 A.  11  d : 
-4.  Is tiN donor organism clarsifitd undtr t:risri,g Communiry·  MJits  rrlating to the prorution of human 
health and tht cn•:ironmcnr? 
Yes  0  No  0 
If yts,  please  specify:. 
Yes  D  No  0  Not  known  D 
D. Information relating to the genetically modified organism 
J. Gnutic traits and pb~notypic characteristics  of tbc nripirnt or parrntal organism  f':bicb  ba'-c  bern 
d>Jzngtd  IU a  rt-sult  of the grnctic modtficarion. 
~·) Is  the GMO diffcrerit  from the recipient  as  tar as  ltln:it.:abilil] is  concerned? 
Yes  0  No  0  Not  k~  0 
If )"tS, please  specify 
·-·······--····--·------ ... ···-···--·-"'···-·---····-.. ··--····---·--··-····-···-·····----·--····:···-··-·-··-·;----------~····-··--··---· 
.. 
I .. 
I 
.. 
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(b)  b  the GMO in any WilY  diffcn:nt from  the  n:c:ipi~nt as  far as  mode and/or rate  of  r~productiort is 
concerned?  ·  · 
Yes  0  No  0  .. 
0  ·Not  known 
If yts,  please  specify : 
------------------------------- .. 
(c)  1s  the GMO in any way diHm:nt from  the  recipient as  far ·as  dissnniruuiort  is  concerned ? · 
Yes  0  No  0  Not  mo'llll  0 
If yts,  please  specify : 
2  Gtne:ic stability of tbt gmtti.cally  modifitd organism 
3.  Is tht GMO pathogtni( or harmfJJ/ in any orhn-·u:ay {irui~ding irs  extra(~l/ular  produNs}.  ~ithtr /it-ing 
or  du:d? 
Yes  0  No  0  Not  known 
If yes, 
(a)  to  wh~~h of the .foliowing  organisms ? : 
humans 
animals 
plants 
D 
0 
0 
D 
(b)  give· the  n:levant  information  specified  under Annex II. point II (A)(U)(d) and  II (Q  (2)  (i) 
--------
:4~  Description  of idmtifla!.tion and dtuaion  mtthods 
(a)  Techniques used  to ddea me GMO in  the envii"DDment 
(b) Techniques used to identify  the GMO  · · 
--·-·-···---------------------------
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E.  lnfonnation J"Cle..ting  to lhc l'deasc 
I. hrpoM oftlx nltast 
. 2.  Is tiN  site oftbt n/~au  difftrtnt from  rbt natural habitat or from  th~  ~COS)'SUm in which the recipient 
organism  is ngularly usul,  ktpt or found? 
Yes  D  No  D 
If ytS. please specify: -. ----- ·---------··-----------
3  . .  Inforrruztion  conurning  th~  rtltas~ arui tht surrounding  arta 
(a) Geographical  location (administrative region  and where  appropriate  grid  reference): 
(b)  Size  of the  site  (m~:  · 
(i)  act'Wl  rdc~ site (m:'): 
(ii)  wider  rde~ area  (ml): 
...... _________________________________ __ 
·-----------·-----··-·------·------
(c)  Proximsty to internationally rttOgnized biotopes or protected arr:as  (including drinking ""'atcr  rc:scr· 
voirs). which  could  be affected : 
------·-·--------
(d)  FloD and fauna  including aops.. livestock and migratory species ""'hich  may potentially interact with 
the GMO: 
-4 • .Metlxul ~nJ  4mount of rtl~a.st  ·· 
(a)  Quantities of GMOs to be rclcasc:d : 
I 
(b) Duntion of  the operation : 
--·---·-·------------·----------------
.. 
. (c) Methods and procedures m  ~d  and/or minimize the sprnd of tbc GNOs bcyoQd  cbc ate of the 
re~: 
'. I 
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f. Interaction~ of cbc  GMO with the environment and potcntial.impact on cbc  environment 
1.  Compl~tt ~UZ~ of ttJrgd  organisms 
(i) order and/or higher taxon  (for  animals) 
(ii)  family  name (for plants) 
(iii) pus 
(iv) species 
(v)  subspeci~ 
(vi)  strain 
(vii) cultivu 
(viii)  patbovu 
(ix)  common name 
2.  .Antitipattd mtehanism  t~nti rtsult of  inurattion IHt.atn tbt rtltastil GMOs and.tbt targtt organism 
3.  Orhn- pounti'ai!J significant  inttractions  with  otlxr organisms in IM tn,-ironmmt 
4.  Is post-rtlta.st Stltction  for  tbt GMO  /iluly. to  occur?. 
Yes.  0  No  0  Not  known  D 
If JtS. give details:----···------·-----------------·-------
S.  7)-pts of  «<SjSitTras to rebitb tiN GMO could M Jissnrlinatttl from the silt of  ~eau  11nil in a&hich it 
could  kcomt csttJblishtd  · 
.  . 
6.  Complttt JJtiml  of non-targtt organisms  t&bidJ  IIUij ~  ~tctttl Jtnldttingly 
(i) order and/or higher taxon (for animals) 
(ii) family  name (for plants)  . · 
(iii) genus  · 
(iv) species_ 
(v)  subspecies 
(V11  strain 
(vii)" cultivar 
(viii)  pathovar 
(ix)  common oamc 
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7. I,.ilulihood of  gna~tu ccc~ng~  in vivO 
(a) ~  the GMO to othC1'  .,rganiSms in  th~ reJC&K  ecosystem : 
(b)  from  other ospnisms to the GMO: 
·~  ... 
.· 
8. Ciw rif~rm«s lo nln:ant rtsults from  studits of  tb~ bthaviour ani chariUUristic of  the CMO tznd its. 
~cological imptza. ct1~d out in simulaitd ~tural  ~vironmtnts (e.g.  mi~sm.s, de.): · .·  ·.  .  ... 
---------··-·· 
G.  lnfonnation relating to monitoring 
1.  Mnhods for monitoring tht GMOs 
----------------·-··-----· 
2. Mrthods for monitoring  ~cos;yst~ if/tas 
3. M~thoJs for tkuaing tr:ansfn- of IM Jon4Ud gtnttit ffUJtnial from  tbt GMO to otiHr organisms 
-4  •.  Sp4t~l extmt of tbt monitoring llrt4  {m1 ) 
S  Dvrtztion of  1~  monitoring 
6. FrvJumcy of tiN  ~onitoring 
-----------------------------------------------------------------------------No  L  105/44  Offici2l  j'ournal  of  the  European  Co"?munitic-s 
H. Information oa posc·rclcas.c and wucc treatment 
J.  Post·rd~a.u ttTatm~nt of  th~ siu 
3. (a)  Typ~ IZM amount of waste gmn-attd 
(b)  Tnattnnll of waste  . 
--------------------------··--·--··-·---------
-------------------------------------
------------·----------
1.  lnforma,tion on c'!'crgcncy response  plans 
1.  Mtthods a·rul procedurts for controlling  GMOs  in uzst of rmtxptcud sprca.d 
-----··-----------------------
--·-----···---·-·····--------------
.. _......._ _____________ _ 
2. Mtthods for dtcontamiru:tion  of tlx atTa_s  lljftcttd 
. 3.  Mtthods for dispou:l or saniuztion o{pumts, 11nirruzls,  soils ttc.  that t«rt exposd Juring or  ~ftn- tiN 
~pruul 
------------------------
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II 
(Acts  uhose publie4tion is  not obligatory) 
COMMISSION 
COMMISSION DECISION 
of 11  February 1992 
concerning the summary notification information fofntat refened to. in Article· 
12 of Council Directive 90/220/EEC  · · 
I  (92/146/EEq 
TiiE 'COMMISSION  OF 1liE EUROPEAN  COMMUNmES. 
Having  regard  to  th~ Treaty establishing  the  European 
Economic Community. 
HAS  ADOPTED THIS  DECISION : 
Article  1 
·. 
Having  ·regard  to  Couno1  Directi:ve · 90/220/EEC  of 
23 April 1990 on the delibCrate release into the environ-:-
ment of genetically  modified  organisms{'). and  in  par-
ticular Article  12  thereof.  · 
The competent .authorities appointed by Member States 
under  Di~e 90/220/EEC  must  U$C  the  annexed 
Whereas  the  competent  authorities  appointed  by  the 
Member States shall forward to the Commission dossiers 
for  notifications  received  under  .Part  C  of  Directive 
90/220/EEC ; 
Whereas each dossier forwarded to the Commission shall 
include a summary of the  no~fication ; 
Whereas the Commission is required to. establish. before 
23  October 1991,  the fonnat of this summary; 
Whereas the provisions of this Decision have recdyed the 
fa,-ourable  opinion  of the  Committee of Member State 
Representatives.  in  accordance  with  the  procedure  laid 
down  in Article  21  of Directive  90/220/EEC, 
(') OJ  No l  117.  8.  S.  1990.  p.  15. 
·Summary Not.i.fication Information Fonnat ~hen  sending 
to  the  Commission·  the  summary  of  a , notifrcation 
received,  as  specified  under  Part  C  of  Directive 
90/220/EEC. 
Article 2 
This  Decision  is  addressed  to (hoe  Mem~r  States.. 
Done at  Brussels,·  11  February  1992. 
For the Commission . 
<:arlo  RIPA  Dl MEANA 
~trnbtr of the Co"!mission No L 60/20  Official Joum.al · of the  European  Communities 
.ANNEX 
SUMMARY  NOTIFICATION  INFORMATION  FORMAT  FOR  PRODUCTS  CONTAINING 
GENETIALLY MODIFIED ORGANISMS (GMOS) 
in accordance With  Article ll  of Directive ~/220/EEC 
INTRODUCTION 
The present d«ument is  designed to serote .as the format of the summary of the dossier submitted to the 
Commission for the placing on the market of a product containing GMO$ (Part C, Article 12 (3) of Directive 
90/220/EEq and does  not prejudice  the provisions  of  Directive  90/220/EEC. 
The summary notification information format for products containing GMOs when completed wi~l contain a· 
summary of the information entered under the conc-sponding  points of the  full  dossier. It is,  therefore., 
R"COgnized that the risk assessment .stipulated by Directive 90/llOfEEC. Artic.;le  12. cannot be carried out on 
the basis of the sum  mary. 
A..  GENERAL INFORMATION 
1.  D~tails of notsfication 
(a)  Member State of notification 
(b)  Notification  num~r  ---····~-········---·--·--·--·····---·····································--·-·····················-···· 
(c)  Name of the  product (commercial  ;.,.~  other names) . ---··--····---·····---·--···-···· 
--·---·····----···--··----·-·--.:·-·····-·  -····-···-······-·-·····-·-·········-·········-··-··-····-·-··--···-·---
(d)  Date of acknowledgement of  n~tification  ---······-···-:---··-···············--··········-·-··-···········-········ 
2.  Notifin-i~nufaaur~limportu 
(a)  Name of notifier  -·-···········-····-·······-···-··-·····-·····-·······························-·-······------~············-·····-··· 
(b)  Address  of notifier  -·········-···-···-·····························-··········································································· 
(c)  _The  notifier  is : 
domestic  manuf:acturer 
importer 
(d)  In case  of import 
(i)  Name of manufactUrer 
(ii)  Address  of manutactu-: 
0 
0 
3.  Charadnisation  of th~ GMOs  tontain~d in tht produrt 
Indicate  the  name and  nature of each  type of GMO contained in  the  product 
-----··------·---·---···-··-·--··················--··-·····-········-·--·--·············-······--·-· 
-···-····-···············•·'"'········-··-·-··········--··········-··········· ..............................  ~  ....................•. _  ....................................... : 
4.  G~nn-al damption of tiN produd 
(a)  Type of product 
·-···--··········-·····'"''"'"'•··-·····-········-········--;·-···········································-·····  ... ···········--·-···-····-.. ·············-······· 
......................... -........................ ____ ........................ __ ................................................  :  .................... -........................  :~  ........... _. 
------·-····-·----~··-··-···-·-········---············--········--··-·······-··············-······-·-········-··---······· 
(b)  Composition of the  product 
--..  ···-·-······-----·--··--········-········-········································-··············-····························-·······-····  .  . 
-·····--······················-·-··············-·-·········-·········.····················-·····-····-~·-···-·················-.·················---··-·········· 
.............. -................................ -.. - ..............................................................................................................................  ~  ....................... . 
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(c)  Spccifteity of che  product 
.-··------------- ·--------
····-------·------------.-
-------------·----··-·--------- ··--···---·-···-·---·· 
(d) Types of users 
·-----·----------------------··------------
·(e)  Exact  conditions of use and handling 
(f)  Geographical areas  for  which  the product is _intended 
----------··--·  ---.--·-··--····--.  ·--·-··-·----------------·-·· 
(g)  Type of environment for  which. the  prod  \Oct  is  suited 
····----~--------··-------·····-··-··············--··-·-·-··-·-----··---····---····-
-------·--------···--·····--····---·········~····-························.-······-··-··-·····-··--·-······---···-·--. 
(h) Annual  estimated  production  in  and/or imports  into  the  Community 
··-··-··-·-·············---··-··--.. ·--·--·--·-··················-·············-·······-·-···-·--·········-"·-·-·····-····-···-----··-···· 
S.  Has  1~ combination  of GMOs  containt-d  _;,  tiN produe1  bttn  notifit-d  undtr part B  of Dirtctia:t 
901220/EEC? 
0  No  0 
(i}  If )'tS. give  coun~ and notification  numbe~  : 
-··-····--··--··-····-·-············-····-··--·----·--················-········-···-·-·············-···················"··················-" 
··--··-·----·---·-····-··----····-·····-·-·-..  ···--··-······-·-·----······~·-············-·-·-······-·-··-··-··· 
--·-----·--------··-·-·--····--············  .. ···-················  ...  -····-·············-········-~·-·-······--·-··----··: 
(ii)  If  ~o, refer to risk ~na1ysis data on the basis of the dements of Pan B of Directive 90/220/EEC. . 
··--·······-·······-·-·-·---····-···-··-·--···-················-···················································-·······················--·----· 
··-·······-·············-·-·······-···--·················  ·•····························· ....................................................  ,. .......  _________ _ 
·-··--····-···-----··-·-·-·---·········-···-············---·········-···---···-·······-·-·-·······-·····---···---·· 
6.  Is  tiN  product  bti11g  Jimultatlt-olu~r llotifitd to  tz(lotbu M('mbc-r  Stale-? 
Yes  0  No  0 
If yts,  please specify 
·--···-·······--·-··-···--········-···-···-················-·-···-·········-·····-····················-············-·······--····-··-········ 
·····-····-·····-····-·----·-············-····-·····-·-······-·····-···················'1.·····················-····························-·····-············· 
.  - .  -······-·-··········---~----····-······-··--········-............. _  ........................................................................ -............... _______ ............ . •• 
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7.  HilS 4110tbn produa with 1~  Utmt Rmbint~tion of  GMOs IH~n;~J  on tiN EC m~Zrkd by anorhn-
.  rtotifor?  .  ·  ·  ~ ·  · · .  · 
Yes  0  No  0  Not  known  0 
If ~  please  specify 
----------·--·-------··--·------··---·----... ·----.----·· 
.  - '  ----------------··-----·--------·-·-:·-··  ... ·-----... -------··--·. 
----------·-·-···----·-·-·-·······-·······--··············-·--·····-··-·-····---···-·-···--·-·· 
8. Jnfornuuion  on ~  of tiN  samt GMOs  or of tiH  samt combination  of GMOs  prtviou.slj.·  ·or  . 
Cllrrmtly rtotifitd 11.ndlor carried out  b):  tht notijitr tith~r insidt or outsidt _tiN  (:ommunit)' 
-----·-···-------..:-·--·-··-·-···-----··-t-·--·--··:··-·-·-·--··········-· 
-------------------------
. 9. S~dfy instructions 11.nd  or ruommtndations for storagt and handling 
.  .  --------··-------·-·--·---·-····  ~  ······-····  ........................ _._ ................... ____ ..  _. __________ .,. __________ _ 
-----··--············--··-·······---···········-············-···················································-·········-···,;  ........ _  .....................  .. 
10.  Proposed padulging 
11.  Propostd  Ja~lling 
................................................................................. _. ______________________________ _ 
··---····-··-········--···-··-···-··-·······-·················-··-··-····-················-·-····--·-·····-··--······-···-···················  .  . 
.-.-.  .  ....:  ... - .. ·--...:.--....... ---·--·-···················································-·············-············································· 
12.  Mtasurts lo takt in  cau of uninttndtd rtftast or  missm 
.  ···--·-······-·--·····--·····-··············-····················  .. ···· ................................................................. -...... :·······  .. ·····-·············· 
--------·------·----·"'················-·-···-·····-··  .. ····  .. ····"'····-··--···-··-·-.. --.---......... -..... _  ................... . 
····-·-·  .. -···-·---.r--·--····  .. ··-··-··--···········-···-···················  .. -·······-·····"'···--··-···········  .. ···········--·  .. ················· 
-·-······--···-··-;-·--·-·······--·····-································  .......................................... -....................................... .  . . 
13.  Mtii.Su«s fo·r  111tzslt  disposa_l  and  trtatm~nt 
.  . 
-••••·---·--·--··--•-•oooooooooo•••••••••••••••••••oo••••••••oo••••••••••••oo••••••••••••••••••••••••••:••••••••••••••••••••••••••••••••••"••••••••••••••: 
.................. - .... ---···-··--··-···-····"'······-···  ....................................................................................................... _____ ....................... -..................... .. 
·······-·········-·····-------···-····-·······························-·····-·····················:············-·······"'·-······'"':···························· 
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B.  NA7VR£ OF THE GMOS CONTAINED IN .'PIE ~RODU..CT 
INFORMATION  RELAnNG 1'0 TilE ·RECIPIENT OR PARENTAL ORGANISM(S)  fROM WHicH 
1liE GMO IS  DERIVED 
.. 
1-t. Sdmtifu name tzrul ot~  IUlffUS  . 
IS.  Phenotypic 11rul genetic trails  __________  .....;_ __  , __________ _ 
.  .  . 
16.  .Gfttgrapbiall Jistti"'!tion arul JUJturaJ  habitat of th<  orgaraisms 
·-·---------
---·-------· 
17.  Gftetic stability of tiN orgaraism  and factors  affe~~ng it 
--------·········---------·----
------·--·---·------~  .................... _  ....... _  ...........  _. _____________________________________________ _.. .. 
18.  Potmtia/ for gmetic transfer and exchange  with  otiHr organisms 
·--------··-·-···-·--·····-----------.. ·--·-------------
19.  Info,;,ation  -a~narning ~produaion and factors  a/feding it 
·----····-··------············-·--·--·-···············--·-·--...M-·-··-··----
-----·--- ---·-·--···-··-···-·--·----·--:--·--····-~---------·-···---
·------------··---····-··-··-··---····----·-····--···-·-----------------· 
---··-···-···-···--·-··--·-.·---·-·-··--··-·---·--
20.  Information  on  surviNI atul fadors affeding it 
-----------------·-·······--··----·-···-;------~----·············----·--··-·-·-···-
••'!·······················-·-······-----··-·-··-··················-····----------
----··__...··------···---··········-·····---·-··-····-··---····--·-··········-··········--·----··------:  ..... . 
-··---····--·-·········-··----·--·-··--·-··-·-··················------·-·-···--······ 
21.  WaJ·I of di1snnination ami factors  afftcting ·,-t 
-------·------···---··-·············--······-····•··-·······················-··········-··················------··-······· 
----··-··--------------·······--··--:...  .........  _________________________________________ .  ______  .,. ________________________ . 
-·····-·-------------·-···-··························-... ············-············~---···········••"\·················-···.····························· 
··-··-···-···--·····-·········-·---··········,.·······-·-····-····:···········-··················-··········  .. ········--·  ... ········~-··-···········--N6 L 60/24  Official  )~nial of the .Europan Communities· 
--··-······---·--··-·------··-·-·--·--··  ________  ..;... _______________ _ 
----·  ---------·--=----------··· 
23 (a)  Deuaion  udmUju~ 
.  .  ----------·-··-··-···-·-
·----·····-·--·-·----------··---------·-
23 (b)  /Jmtifi"uion tedmiljJUs 
-----------------------·--······--·-----·---·-·---·-···---· 
24.  Cllusifiauion urukr aisting  ·eomrnuniiJ• rulu conc~rning tht prouaion of  human lualtb andfo,. th~ 
navironmmt  · 
_.....;..--,------···-·------···············---·..-···-···-········-··-·-······~············-······ 
2S (a)  Patbogmic charaanistics 
2S (b)  Ot~  harmful daracttristia of  tht organiSm lilling or thad, including its ex:trac~llular  products 
26.  Naturt llrul J.ucription  of known  extrachromosomal  g~ntlic tlmunts 
--·------~··-··--··-··--··-·--···---···-·······························-······--····-·-·····-··---·-···-······· 
.  .  -------·····----------·-·-·---···--·-·······-·····-·-·-···-··--···-···-·--········----··--··-·-· 
------,----·····-·---··-·--·-····--·-·---···-·····-·-··-
27.  Hi'story  of  pt'nlio~s gmnic ,oJifir4tions 
-·····--------~---------------------------·-·····-:···--···························-··-········--··········-····· 
--·---·····-------··-·;.·-····-·----------·--·-················-········-.. ······························-!  ............. -..................  ., ........................... . 
.................. _  .... ---····-..:..·-····  ....... -·--··-·  ... --·······························-·····································-········-···············:  .......... . 
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tNFORMAnoN RELAnNG ro niE GENrnc i.cootFJCATION 
28._ NetboJs  ~~Ud for the  g~~tic modifi'artion 
-·--·-· _________  _. __ 
-------------------------------------------------------------------------------------------------~ 
---------------------------------··· 
. 2!J. __ Charaaeristic:s  of the wctor 
·(a)  Natun: and souroe of the  veao~ 
-------·-------------··----
--------------·----------
(b)  Description of the vector constnJction 
(c)  Genetic  ma~ and/or restriction  map of the vector 
------------·--------·--·-------·---------···-----··--··-·-·-·-
(d)  Sequcn~ data 
----·----~·-······-··-·.:.------···--·-·····-··-··;  ............... _  .......................................................................... . 
------------------·------·----·-··-·-·-·--·-···--····--·--·--· 
-----··---·-······-·······-····-··--·····-·-·-··-·-············-···-····-·-···········-···········:  ....... _  .....  ____________ _ 
(e), Infonnation on the degtee to which the vector contains scquenc~ whose product or function ,rea is 
not known  · 
(f)  Genetic  transfe.  ~.-bilitics of the  vector 
-------·-····-··-·-··············-················-···-···············-·········-····--··············-····-····--··-···· 
-- .......... ··-----····-····-·---·-··-··-··························-·---··································-·········:  .....•. _  .............. . 
-------·----·-··-····--·---···l---·-···----···-·---··-····--·-------·--·-·-----
(g) :Frequency of mobilization  of  the vector 
-------------·-·····-··--··-·-·--·---·········-··-······----·-············-···············--········--·c--···-
-·---.:-..•..•..•....  ~·--··-·-········-:.  .................................. -......................•................  ; .................. ···········-·······:  .... . 
····---·-···········-···············-········-·······--·····································-··?···························································· 
(h)  Part  of the vector which  remains  in ·the GMO 
-----·---···--··--····--·--··-········-······--········-.,.··-·········--·······--·······-------············-···--·······-
-.  ----··---·--····-·------···-·-·····-··-····:·······--··-··-····-············--················-···-···--··------
-····-·-··-····---··--···············--·······························."············-·················································:··········-·-· 
30.  Information  on  1~ in.ctrt 
(a)  Methods  used  to construct the  insert 
---···-·-······--······················-················-························-··-···············································--····--·-······---
--·······-···········-·--·······  ... ·· ............................................................................................................................................... _. __ 
---············-··························································································-~·················--···-·········-··········-·'\-·······-··· 58. 
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(b) Rc:suicticm  sites 
--~------------·-· 
·(c)  Sequence of the insert 
--------------------------------~--------------------------------·------·-· 
(d)  Origin !"'d function  of each constituent  part of the insert in  the  GMO 
------·--·--·--------·--··--·-···· 
(~) Information on the degree  to Whidt  the ~  is  limited to the  required  function 
'I 
---------------·-----··-·-------
·-------------~··-----·- :..._  .. 
·--":o..··-·-··--···--·----·-·-····-
(f)  l.oation of the  insert  in the GM6 
'-----··-------·--·-··-·-··········-·----····--··--·····-··--·-······ 
INFORMATION  ON 1liE ORGANISM{$)  FROM  WHICH THE  INSERT  IS  DERNED (DONOR) 
31.  Scimtific and ot~r nam~s 
·--···-----·--······---·-----·---·--------·--·········-----~-------------···-···---······-·---··· 
--------------------·-··-"':········-------------···········--·-··-··-·-····-··-····-····················· 
32 (a)  Pathogmic dxzracuristia of tlx. donor organism 
-··-·-·······--·----~-·-··--·-·-··--···--·---.-···--············-····························-······-···························· 
.----:--··-----·-----·-·---·-······--·····-····-··-·······················-··········-·······················-· 
-···---·---·····-····---·-·-·-·····-·-·····---··---·····-···-······-···.-·························-··-················-·········· 
32 (b)  Otbn- harmful  charad~ristics of  tiN organism Jiving or  d~ad, induding its txtractllular products 
-·---------~-------------·····-·····-·-·········--·-·-······················-······················· 
--··-----·-·•<t·---·-··-----···-·--··--···--·········-··-·-········-·-·················  .. ·-:········-·····-··············· 
33.  If  tiN door organinn_  bas any pathogt-nic or h4rmful ~hara~tuistics,  indi~alt'  &~.-lutlxr tht dauaw:l 
~l{fl.tncts a" in any way inPOiwd  in thnn  · 
···-··--··--·--·-··-------
·······--·-···--.A.---·-----------·--·---··--···-·······-·····················---············-····--·-···························· 
··-·------~----····-------------····----·-----·--·--·-··············-·············-················-····················  ..................  .. 
..................................... --.. ---·-··-----····--·-·-····----········----·-··········--···············-·······························-··········  .................... .  ________  ..,__ __ s.  3. 92 
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3-4.  CUusiftauion rnukr existing Community ruks. Rlating to 1/H prouaion of  human IHaltb 4nJ tiN 
fttlironment  · 
--~------·-----·--·---·  .. -------------
.· 
35.  PotmtUzl for natural adJang~ of gtnttic trUI.Uria/  ~twtm tiN_  donor(s)  tuUJ  Rcipient  organism 
-------------------· 
INFORMATION  RELATING TO TiiE GMO(S)  CONTAit:fED IN 1HE PROD~CI' 
36.  Desniption of gnutic traits or phenotypic maracuristics anJ ;, particukzr 4ny ntw traits and 
~racttristics which  ma1·  bt txpr~tJ or no  long~r ccprts.uJ 
---------------·-·---------··---······------------···----
----------·-·····---·-····--·----····-·····---·-·----- ----,..-·-·-·-·-
37.  Ghutic stability of tbt GMO 
-----··--·-·---·--·-·--·------------
38.  Rate and ~~  of expression  of tbt ntw ·gtnttic maun"al 
----·-··--·----··---·-·--··········-···········-······················-···-···--··-·········----··-·--···· 
·--·---·------···------··········---····························-··-···---·-·-··--·······-··----··----·--·-
.  .  ------------·-----···----------············-············--.. -··-···-·-·--···--·-·----·----·-···-
--·--··--·-··--·----·-·-~----···--··-··················-·····-·····-····-·-········---------
39.  Aaivity of tht expresstd prottins 
--·-··-··-·---------·--···-··-·-·-··················-······-··--······---····--··--------
---·····--------····---·-··:···-··-·-···-··-····················-··:----·········--·-········-·-·-----·-·--
--····-·-·-·---·-·----·-··-·····-···-····-·················-·········--···-···--···············-----·----··· 
·············-·····-·-···-~----················-··-························  .. ···········:···················-·······-······-·········---··-·:·--··· 
-40 (a)  Dtscription  of  d~t~ction  ttch11iqu~s for  th~ GMO tin  tht- ~"'-irot~mmt 
······················-··-·-····---······--···-··········-·················-·-·············--··-·-·····························-···---::  ........... . 
···---·············-···············-····---·-··············································.r···································-·····-···-··----···············  .. 
............................................................ __ ... _  ......................................................................................................................................  _____ ._ .... _  ... __________ _ 
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------------------····-·-·--··--·-·------··----·-
-41.  H~h  CDruilln-aliO'IU  • 
(a)  toxic or allergenic effects of tm non-viable  GMOs  and/or their metabolic  products 
-----·-·-···--·--
-~----·-.  --.----·····-·············------~·-·-·----
-......-----------·-·-·-·-·--··-········--····-··--·-·····-·:·······--··---.,.-· 
(b)  product  ~rds 
(c)  comparisoa of the GMO with the donor. n:cipient ~r parental org:a.nism regarding patho~e~city 
----------·----
(d) capacity for colonization 
---...---··-----·---------···---·-··-·-········--········--····································--·-··· 
------·---~-·--·--------··-·-··-··--·-··-··-·-····-··-·········--··························-························· 
·----·--·---····--·-··-·········-·-···········--············-············ 
(e)  If the organism  is pathogenic to humans· who  arc  immuno-competent, supply  the information 
specified  in Annex 11.  Part II  C  2  (i) (v) 
INTERACilONS OF lliE GMO  WITH  THE  ENVIRONMENT 
<42.  S:.tn:iflal,  mubipliauion and jr"s#mination  ~~  tbt GMO(s)  in  tht nu:ironmtnl 
··-···-··------··-····---·--------··-·-·-·-·-·-····-·-·········--···-·····--················---·-· 
··········-·····--··-~---·--·------·····--····--·-··-·-·-·····-~······-···-··-······-····-·-·-·······~·-················--· 
43.  lrutractions of th~ GMOs with tht ttlf:ironmmt 
·-···  ..  ··-------········----------·····-··--··-····-··························-··········~··················-····················· 
··-········-·-···---:  .... ---······-····---:.·--·--·--·····-··-·········--·-······-············-··············-········-············-·······---·-· 
.  .  -······-··-----------------------------·-··············-···········-···:·····-···················--·-·-·. 
4-4.  Du-irutlmniltll impartJ oj  tb~ GMO(') 
·····-·-······------·-···---------------------·--···-·····-······-····················-···································· 
........................  ----·-··-·-····-···-···--·-·------·--·-··-···-··---·····································:·-·················~·:···········-······ 
.......................... --·············----····--·······-·········---·······-···············································-····························-···  .. -· 
60. 
s.  3. 92 
. ' . 
.• 
- .. 
..  . s.  3. 92 
I 
I 
Of(icial  Journal of ~~ Europc:an  Communities 
•  0. 0:  •••  No l  60/2!J 
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~ 2. HUMAN  HEAL11i  EFFECI'S  OF THE P~ODUCT 
D. "INFORMATION RELATING TO PREVIOUS RELEASES 
I. HlSTORY  Of PREVIOUS  RELEASES  NOTIFlED  UNDER  PART  B OF  THE  DIRECTIVE 
t. Notification  num~r: 
2.  R~kast sitt: ----------·----------·--····-·-··················-·-··-··-··--·····---········-··-----········ 
3. Aim of the  R~:  ------, 
-4.  Duration  of tbt .reltaM: 
S.  Duration  of post-rtleast- monitoring:  ······-·····-···-············-············-----·~----········-······-········-~·-···-··:····-·· 
6.  Aim of  post-rtl~~ monitoring:  -·········-····:-··-·-·----·······-····-··-·······:······-·--··---··---······-··· 
7.  Condusions  of  post·r~ltast n1onitori11g:  -············-·························-~---------··-·····-·-···········--··············--···· · 
8. "RtsuJis of  I~  ~Jtast in  ns~n to  41~)' nsk Ia  humtlll bcp/th alit/ tiN tm·irutUllt'lll (submiucd. to  the 
compettnl IJuthoril)·  ~:~ccordi11g to  .An  ide 8 of Dirccti,·c  901210/EEC):  · 
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.-····---------------------··-·········--..... -.................................................................................... ___________________ .............. . 
........  : .....  ______________________________________________ ............................................................................................................... :  ........................... _ 
-~-·············-·--·-·-··············--·-···················--····-·······························································-························-········· 
61. NQ  L 60/30  Official Journal of the  European  Communities 
II. HISTORY Of PREVIOUS RELEASES CARRIED OlTf INSIDE OR. OlJf.SlDE.lli.E COMMUNITY 
I. Relu# "'""''7: . 
2.  .Afllbority Ollm«ini IM  nl~a.u: -....;..------------··----·------·-
3.  Relu.se siu: _.;._ ____________  _ 
4..  .Aim  Of the  ~leJue: -· ------------
5.  l>fl~ion of  post-re~ monitoring: ·---
6..  Aim of  posl·nleau monitoring: -------
7.  CtnrdfiSion.s  of post-nkau lfJOniloring: ------
'---------·----·--
·-----~·-----------
-----·--·  ---·-----· 
-----------·----------······-··---------------- ' 
·-------------·-------·-----
--------·---------·---·····---······-··--·-····-··········-···--·-·-·--······ . 
UL HISTORY OF PREVIOUS WORK RELEVANT TO RISK ASSESSMENT PRIOR TO COMMERCIALI-
ZATION 
. 62. 
5.  3.' 92 
.· 
'· 
.  I I 
XI/619/91-Rev~3 
.  t  • 
.  ,;,,  .. •' 
··-.· ..  -. -·  .:. 
GUIDANCE  NOTES  FOR  THE  NOTIFICATION·  FORUAT 
FOR  PRODUCTS  CONTAINING  GNOs 
<Art  1  c l·e  12  · of DIrect  1  ve 90/220/EEC) 
63. 
., 64_ 
INIROQUCT.ION 
. The .present. notes are  Intended to clar lfy and explain certain points of.  .  .  .·  ,; 
tho  Notlflcatlon··Forut  for· products  containing  GUOs  (Doc.·  ... XI/620/91~:-:.· ...  ··~ -.. ·.'.  . 
ffnf. thus providing gu·ldance  and _'facll_ltatlng  Its Completion·.·;  ·-.·.:_.···::·: ..  _.::~~  ..  ~:~··>~.;::··:·~'-:  .~  :-_.·.,  .· 
.  .  .  :.  ;  .  .  .  .  ·· .• · GENERAL.  I NfQRUAT ION  (pages 4-9) 
Paragraoh  .1 
Meft!ber  $tate  of  not If  teat ton:  Please  use  the  ,standard  country 
codes. 
Belgium  B .....  Italy·.  1 
Denmark.  DK  Luxembourg  L 
· France  F  Netherlands  NL • 
Ireland  IRL  Portugal  p 
Germany  D  Spain  E 
Greece  EL  Unlted.Kingdom  UK 
NQttflcatlon number: 
It w11·1  be  gIven  by  t~e  Competent  Authority  and  for  ·products  i :t 
should be preceded by  C  - for example  C3~. 
Paragraph  2 
c)  If the notlfler  1s  neither a  domestic manufacturer  nor  an  Importer. 
please  indicate his function. 
Paragraph  3 
·Name:  For  each  ~_ype of  GMO  Included  in the product,  need only  include 
the  name  of  the  ·rec1pient  or  parental  organism(s)·  with 
lndlcat  ions. of  the· modified  genetic  func-t ion(s)  and  of  the 
donor  organism(s). 
.  . 
Nature:  For  each  type  of  GMO  included  in  the .product,  indicate  what 
type  of  biological  entity  the  GMO  Is:  viroid,  RNA  virus,. DNA 
vrrus,  bacterium,  fungus,  plant, 'animal,  etc. 
Paragraoh  4 
a)  Indicate  whether  the-product  is  a  vaccine,  pesticide,  crop  plant, 
ornamental  plant, ·bioreme~:~•ion agent,  dl~gnostic reagen~.  food or 
food  jngredlent,  etc.· 
.Information on  the  physical  form  in whtch  the product  exi~ts under·. 
the  condlt Ions  of  pacl<agtng  and  use  (e.g.  powder.  aerosol.  when 
approprIate.  so  1  ut.lon,  so  I i d  crysta  1  tIne..  etc.)·, ·  as  we I t  as 
information  on  the·  p~ystologica  I  form  <.e.g.  seeds.:  .. ).  may  be 
entered here. 
b)  In  addition  to  the  information  entered·  under  paragraph  3 
<concerning .the  GMOs),  give  information  on. the  additives  or  other 
components  contained  In the·product. 
c)  Enter  the  particular  properties.of .t~e product  concerning  •ts  use 
(e.g.  toxic action on  a  parti~ula~ group of Oyptera). 
d)  Indicate whether  the product wi l I  be  used  in  industry.  agr·icu1ture, 
sl<.lll  ed  trades,  contaIned  . ·f  ac i I it  I es,  State  Agenc 1  es  or  i;)y 
consumers,  etc..  If there are multiple users thts·should be  s~ated. 
65  ... · 66  .. 
Amongst  other  relevant  lnformat I  on,  ·here  can  be  -ent~r.t~d  the ...  ~~-'. 
frequency  and  method  of  app II  cat  I on.  dosage.  measures·  to "protect :_·.  :·- : .. 
G) 
·the user  (If applicable).  organisms  on  which  the ·prodUct  Is used,  . 
and restr let tons of use (e.g.  ~t to be used ·In  winter.  in drought_,.  · · 
rainy season. etc.Y. 
Y~  may  select  from  the  list .below  for  the general  .descrlptlon:cif .. 
the  environment  for  which  the  product  Is  suited.  A  detall_ecf  · 
description could be annexed. 
1.  Agricultural  land,  forestry and  horticulture· 
2.  Contamlnat~d tand 
.3.  Mines 
4.  Industrial  fermentors 
5.  Laboratories 
6.  Parts of bufldlngs  (e.g.  cooling  towers) 
7.  Animal  farms 
8.  Fisheries (freshwater. coastal) 
9.  Marine  environment 
10.  Recreation areas 
11.  Medical  and  veterinary practice 
12.  Food  for general  use 
13.  Others 
:.--::ragraph  ~-
I)  RefGrence  to part 0,  subpart~ may  be  made 
II) ·Reference to part  D,  subpart c may  be  made 
Paragraph 7· 
The  Question  refers  to other  products  (with  different  commercial  names 
placed on  the  market  by  another_  notifier), .which,  though,_  contain· the 
same  combination of GMOs. 
-f~Miraph 8 
The  following could_be of  relevance here: 
InformatIon . on  w]lether  the  product  was  ever  wIthdrawn  from  the 
market of a  country outside-the EEC  for  ~easons.of safety. 
... 
.  .... ···;·.-:. 
.  .  .  ~· 
, 
I 
-·-
... I 
lnformat  I on  on  whether  the  product  Is  a I ready  on  the  market  of  a  . 
country or Countries outside the EEC. 
lnformat·lon ·on  whether  the  product  has  been  re.Jected  In  a  country 
outslde·the EEC  f~r reasons of safety. 
67  .. 
paragraPh  10  .  :. -
...  -.  . 
Th4s must  be appropr late so  as  to avoid unintended- release of  th~ GMOs  ·.  · 
dur lng  stor~ge or at  ·.a  later stage.  · . .  : 
Paragraph  11 
This· must  Include,  at  least  In  summarIsed  form,  the  · inforaiafion  · 
referred to  In points A. 1. A.2,  A.3,  B.  1  and 8.2 of Annex  Ill A.  ~··  · 
Paragraph  13 
The  Question  Is  applicable  for  some  p.roducts  only.  Some  .ex~mples:  ~ 
v.accir.,s.· blopest lcldes,  and  b·ioremediat lon agents. 
8.  NADIRE  OF  THE  GM0S  CQNTA I NED  IN  THE  PRODUCT 
INfORMATION  RELATING  TO  THE  RECIPIENT  OR  PARENTAL  ORGANISM<Sl 
Paragraphs  14-27  concern  essential  information  on  the  biology  of  the 
rec  I p 1  ent or parent  a I  organIsm(  s)  pr i or  to genetic mod· if  i cat I on. .  . 
Reclolent  are  the  organisms  which  undergo  a  genetic  modification  (for 
instance,  by  Introduction of  a  *foreign•  gene  transferred ·to  them  from 
a  donor). 
Parental  are  -the  organisms  which  largely  contribute  to  the  genome  of 
the~·  Parental  orQanlsms  ~re those  used  in cell  fusion  experiments 
wher-g  the  ;~:10me  of  the·  GMO  Is  a  hybr ld  of  the  genomes  of  the  two 
parental  organisms,  neither  of  which  can  be  consisted  as  rec.ipient  or 
donor. 
Paragraph  14 
Give sufficient  Information to accurately describe the organism:  order 
or.  higher  taxon  (for  animals),  family  (for  plants).  genus,  spe(:ies; ·.  · 
subspe.cles,  strain,  serotype,  cultivar,  pathovar  (biotype,  ecotype, 
race,  e~c.)  and  common  name.  As  much  as  possible,  reference  to 
taxonomic  I iterature shou·td  be made. 
Paragraph  15 
'  . 
Phenotypic  or  genet tc·  mar.kers  that  can  be  used  to  dlst  lnguish  the 
organism,  from natural  close relatives  m~y be  entered  here.~ Other  Information which may  be entered here.  If retevant: 
Restriction  and/or  genetic  map  When  the  recipient  or  parental 
organism  Is a  virus. 
Natn  restrl~tlon sites.  relevant  genetlc·aod phenotypic  traits for 
·.all other org_anlsms. 
Paragraph 16 
·Tf\e  (nfonuatlon  on  natura·t  habitat  ·could  Include  mentioning  of 
parasites, competitors,  symblonts and.hosts. 
·raragraoh  17 
'The  extent  and  nature "of ·any.genetlc  Instability In  the  organism  and 
the conditions under  which  the·stabltlty o_f  the organlsm  Is known  to be 
affected may  be entered here. 
Paragraph  18 
Describe  whether  the  organism  Is able  to  transfer  or  exchange  genetic 
. Information with other  organisms,  e.g  •. conjugation·,  cross-pollination, 
cross  fert Ill  sat I on  or  other  forms  of  genetic  transfer.  In  m~ny 
·Instances,  understanding  will. ·be  Incomplete,  so  summarise  the  present 
state of knowledge. 
Paragraph  19 
Describe  how.  the  organism  Is·  able  to  repr.oduce  itself  and  if by  more 
than  one  mode,  Indicate  their  relative  importance.  The  relevant 
factors  affecting  the.~ and  rate  of  reproduction,  could  be 
indicated. 
ParagrajJh  20 
The  survival  forms  of  the  organism,  the  time  scale  of  survival 
(e.g.  years  for  seeds  or  spores)  and  the  relevant  factors  affecting  it 
may  be  entered here. 
Paragraph  21 
Oeser I be  how  the·  organIsm  can  spread  In  the  envIronment  and  the 
relevant  factors affecting dissemination  •. 
Paragraph 22 
·for ·  micr-oorganisms.  In  particular.  their  involvement  in  main 
environmental  processes  such  as  primary  production.  nutrient  t~rnover, 
decomposition  of  organic  matter.  respiration.  etc .•.  ct>uld  be· entered 
'here.  · 
68. 
.· 
• 
.• .•. :._ 
.· 
Paragraph  ~3 
The - sens.l t I vI ty  •  reI lab Ill  ty  and  spec  i f .. lcl  ty _of  the  . detect ion  and' 
ldent.lflcatlon  technique~ shOuld a_lso  be given here  • 
. ..  :· 
Relevant ~nlty  legislation Is the following: 
.  . 
D  1  teet  1  ve  QOie79tEEC  on.  the  .. · .,rotect  I on  of  workers  . from  r I sks 
related to-exposure·to biological  agents at work; 
Dfrectlve  77/93/EEC  on  ··the  protective  ~easures  Zlgalnst  the 
Introduction  tnto:the Member  States of organisms  harmful  to plants 
.. or p 1  ant  pr~ucts. as amended  un~  I I  now; 
Dlrecttye -64/  ..  32/EEC  on  antul  health  problems  affecting  Intra-:-. 
Community  trade  ln.bovlne  anl~ls.and swine; 
- Olrectlve  64/433/EEC  on  health- problems  affecting  lntra~unlty 
t·ade  In fresh meat; 
Directive  71/118/EEC  on  health  oroblems  aff,ectlng  lntra~unity_ 
trade  In poultry meat; 
DIrect l.ve  72/462/EEC  on  heat t h  and  veter I nary  .. Inspect I on  prob  I ems 
upon  Importation of  bovine  animals  and  swine  and  fresh  mea~  from 
thi-rd countr les; 
Directive  82/894/EEC  on· the  notification of  animal  diseases within· 
the Community; 
Directive  90/426/EEC  on  animal  health  conditions  governing  the 
movement  and  Import  from third countries; 
Directive  91/67/EEC  concerning.  the  animal  hea·1th  conditions 
governing  the  placl~g  on  the  market  of  aquaculture  animals  and 
products; 
.. 
Directive  91/68/EEC  on  anlmar  health  conditi_.ons  governlf.lg  Intra-
~- Community  trade  In ovlne and caprine animals; 
0 I rectI  ve  91 /69/EEC  amendIng  Direct I ve  72/462/EEC  on  hea I th  and 
veterinary  inspection  problems  upon  Importation  of  bovine  anJmals 
and  swine,_. fresh  meat  or  meat  products,  In order  ~o  include  ovt·ne  .-
and  caprine animals;  · 
Council  Decision 90/424/EEC on expenditure  in the  veterinary field  . 
.  · 
.·  .· 
.· 
.· 
.· 
69. Paragraph 25 
a)  Describe  ~ether the  organism  Is  pathogenic  to  any  other  organism 
and give  lnforcnatiOQ on  Infectivity, virulence. host-range.  abll.l~y 
to colonise other organisms.  Also,  Indicate whether  the particular 
recipient  or  parental  organism  is.a  vector  of  a  ~athogen or  can 
activate· latent  viruses.  which  ·Is  of  Importance, ·in ·case  ·It .has ·a· 
wlde  host  range with possibility to colonise other  o~ganlsms. 
b)  The  question  refers  to  organisms,·  which  living  o~  dead,  have 
harmful  effects.  Give  Information  on_  toxigenicity  and 
allergenlclty (e.g.  type of toxin produced and  organisms affected).· 
Paragraph  26 
=The  question  related  to· the  Particular  genotype .which  serv~d  as  the 
recipient  or  parental· organism  and  not  to  the  species  to..  whlc·h  lt. 
belongs.  The  question  does  not  concern  mitochondrial  or  chloroplastic 
DNA.  It  can,  however,  concern  viruses,·  virolds,  transposons  and 
indigenous plasmids .. 
Paragraph 27 
The  Information  is required only  If  t~e recipient or  parental  organism . 
. is already a  GUO. 
INFORMATION  RELATING  TO  THE  GENET.IC  MODIFICATION  (paragraphs  28-30) 
•vectors•  may  be  RNA  or  DNA  sequences  used  for  introducin·g  the  insert 
into the recipient organism. 
•tnsert• means  all  the sequences derived 
those  of  the  vector  which  remain  In 
organism.  In  the  case  of  plasmids  or 
from  the donor  organism($)  and 
the  genome  of_  the  modified 
pI asmid ·derived  vectors,  the 
donor  organism(s)  and  those 
useful  or  nece~sary  fnr  that 
insert  comorises  sequences  from  the 
sequences  of  the  vector  which  are 
part i cu·t ar genetic mOdification.· 
•constituent part of  the •tnsert• means  any  segment  of  DNA  or  RNA  which 
either  plays  a  role  io  DNA  replication  or  gene  expresion  (e.g. 
regu1atory  genes, .enhancers,  promoters,  e"tc.),  or  codes  for  structural 
proteins. 
Paragraph  29· 
a)  Give  Information.  on  t_he  nature  of  the  vector  (plasmid, 
bacteriophage,  virus,  cosmid,  phagemid,  transposable element, etc.) 
and  its.source. 
b)  Indicate  the  components  of  t-he  vector  and  the  organisms  that 
contributed  DNA  sequences to it. 
e)  The  reI at  i ve  pos l"t ion  of  these  sequence.s  shou I  d  be  shown  on  the 
restriction map. 
70. 
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g)  The  ·f~equeneY. of mobilization of the vector • .nen available. $hould 
~  g 1  ven  together  w  1  th  · the  exp~r  lme.nta 1  cond 1  t loos  for  measurIng 
lt. 
...  ,..  ' ...... 
h)  The  quest lon  concer.ns·' the cases ·when·  part of· the vector  remains  In 
.  the.  GMO  un  1  ntent.lona II  y.  \  . 
.  e,rag·raph  30 
d)  For  each  constituent part _of  the ·lnsert. ·Indicate .Its  or~anlsm of 
=or lgln. 
e)  If the  Insert  Is not  limited to the ·required function.  Indicate the· 
length of the extra sequences.  their relative position ·to. the other 
eonstlt~ent parts and  their possible function. 
•  •  f 
f)  Relevant -lnformatl~. which may  ~  entered here: 
number  o! copies  Inserted;. 
number  of  Insertion sites; 
number  of  func~lonal copies  ~~serted; 
locat lon  of  the  Insert  In  the  GMO.  lnformat I on  on  whether  :the 
Insert  Is ·located on  a  free plasmid or whether  It Is  Integrated 
In  t~e  chromosome.  The  exact  posit ion  of  the  insert. in· the 
chromosome  is not .required here. 
INFQRUATION  ON  THE  ORGANISU!Sl  FROU  WHICH  THE  IN$ERT  IS  DERIVED 
(paragraphs 31-35) 
·This section should  be  filled  In  for  each.of  the donor  organisms  given 
in paragraph 30d. 
. . 
Paragraphs  31.  34 
The .notes of the corresponding paragraphs 25,  24  apply  here. 
Paragraph  32 
The ·notes of  the  correspond.ilig  paragraph  25  also  apply  here,  provi.ded  . 
the  donated  sequer:-ces  are  In  some  way  linked  to·the  pathogenic  or 
harmful  characteristics of  the donor  organism. 
71. 
·· ..... INFORMATION  REl.ATING  TO  JHE  QIQ(Sl  CONTAINED·  1N  THE  PRODUCT 
(paragraphs  36-4~) 
This  s~ctlon should  be  filled  In  for  each  type of  GMO  contained  in  the· 
product; according to paragraph 3; page_  4. 
_Paragraph 36 
Describe  how  the  Introduced or  deleted  gene~lc material  modifies .the 
phenotype of  the organism. 
Paragraph 37 
The-Question relates to the:genetlc stability of  the  Insert  In  the  GMO 
·and  the  degree.  to· which. the·  Introduced  or  deleted  genetic· material 
affe~ted  the  stability  of  other -genes  In  the  organism.  Partict!-lar 
attention ·should be  paid to the extent to ~lch the formulation and  use 
of the product affects. stability~ 
This  should  be  examined  In  both  the  GMO  obtained  Initially  and  the 
final  GMO  product  after  developmet~t  through  large  scale  culture 
. fermentation  stages  or  through  all  propagation  phases  of  transgenic 
plants. 
Paragraph 38 
Give  approximate expression  levels of all  genes  inserted  in  the  GMO,  at 
mRNA  and  protein  level. 
If  the  Inserted  genes  are  expressed  only  In  certain  parts  of  the 
organism or  during  particular  stages of  its development,  data  on  this 
specificity of expression should be_provided. 
Paragraph 39 
The  Questl<?n  concerns  the  biological  activitY  of  the  proteins.  For 
ex  amp I  e.  enzymatic  •.  hormona I or  phys lo  log I  ca I  act tv i ty  . 
.  Paragraoh  40 
Describe  how  the  GMO  can  be  detected  in  the environment  and  how  it can 
be  identlfle~.  The  sensitivity.  rei iabi I ity  and  _specificity.  of  the 
detection and  identification techniQues  should also-be given. 
Paragraph  41 
a)  Toxic effects: Tht's  covers effects on all  classes of organisms: 
AI 1ergen1c  effe_cts:  this  covers  effects on  all  vertebrate  animals  •  (including humans). 
b)  The  product  hazards  refer  to  effects  on  the .blot ic  and  ·abiotic 
natural  environment. 
., 
72. 
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C) 
d) 
Amongst  others.  a  factor  that  could  be  taken  into  account  here  is 
the potential  pathogenicity of the vector  (if the vector  remains  In 
the  GMO).  The  term  pathOgenicity. here  cove~s  effects  on  all 
classes of organisms. 
The  question  co'ncerns  the  capacity of  the  GUO  for  ..  colonisation of 
-other  organisms  present  In  the  environment.  rather  than  its 
capacIty for estab·l 1  shment · In  the environment. 
iNTERACT IONS  ()f THE. Gt49fSl  WITH  THE  ENV I RQt&fENI 
Paragraphs 42.  43.  44 
Give  a- synthetic  presentation  of  the  respective  results  and/or 
conclusions  obtained  from· the  exper lmentat  releases  or  any  other 
. relevant testing work.  Particular  reference should be.made  to any  data. 
_-or· results  lndicat_lng  differences between  the  GMO  .and  the  reclp'lent  or 
parental organisms.  More  ·specifically: 
Par.agra1h  43 
.Amongst  others,  the.  Information  should  also  epver  the  following 
aspects:  gene  transfer.  genet_tc  stability  In  the  environment~ habitats 
where  the_GMO(s)  could  become  established and  sl~nlflcant  Interactions 
· with other organisms  ln  the environment. 
Paragraph  44 
Amongst  others,  the  informatIon  should  also  cover  the· .following 
aspects:  selective  advantage  in  the·  environment  leading  to  excessive 
population growth  and  effects on non-target organisms. 
PART  C 
Enter  under  this .part  the  predicted environmental  \A)  anc  ~~man health. 
(B)  impact  of  the.product  taking  into  account  the  overall  composition 
of the product  and  its use . 
.  PART  0 
Sub~part  A has  tq  be  filled  In  for  each  experimental  re~ease,  carried· 
·out  under  Part  B of -Directive  90/220/EEC.  of  the  GMO(s)  contained  in 
the product. 
Sub-part  B  has  to  be  filled  in  for  experimental  or .other  releases  of 
the  GMOs  contained  in  the  product,  which  were  carried  out  inside  or 
outside  the ·Community  and  were  not  covered  by  part  B  of  Directive 
$0/220/EEC. 
Sub-part  c  h·as  to  be  f i I h~d  in  for  any  oth.er  work  relevaf1t  for 
assessing  the  risk of  the release of  the product. 
73. 7"4. 
XI/635/91  .... 
$TATEMENT  OF  THE  COWPETENT  AUTHORITY 
QOncernlng  Notlf_lcatlon ----------
·.  (notification number) 
submitted according to Article 12.3 of Directive 90/220/EEC. 
.  .. -· 
The  present  statement  Is  transmitted  to  the  -COmmission  of  the 
European  Communities · In  accordance  with  Artlc1e  12  of  Dir-ective--
90/220/EEC by  the  Cocipetent AuthorIty  In  · 
_  (Member  State)  . 
connection with the f'()tlflcatlon numbered---------~·  . 
(not  I f·lca:~ ion _number) 
_·-which  concerns  the  placing·  ()n  the  . market  of 
·.  (commercial  nacne  of product) 
75. 
·There are  annexes attached to this notification.  They  are  :·  · 
numbered· In  accordanCe  with  the  .cOrresponding  entry  number  In  1-hls ·:·._ 
·dossier.  The  Items  Which ·the notlfler  wishes  to· have  cons.ldered  as· 
co~fldentlal  and  have  been  accepted  as confidential  by  the-Competent 
Authority are property marked  In this dossier.  · 
2.  _AccOrding  to  Article  12.3  of  .Directive  90/220/EEC,  the  .Competent 
Authority .accepts the  re•sons given by  the notlfler for not supplying 
~rtaln Information  specified  In  Annexes  II  and_  II_IB  in  accordance 
wi·th  the preamble  to Annex  II and Article 11 •. 
3.  The  COmpetent  Author-ity  proposes  to  ·consent  to  the  placing  on  the 
market of the product  under  the  following conditions:' 
Signature:  ----~------------------
Name  and  position of.the 
responsible ofticial(s): No J. 13l/5t  <;Kf:cial  Journal of th~ &.ropc2.11  Co:r.u:::nctio. .. 
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COMMISSION D£0SJON 
of 21 Moy 19$1  ·  .  .  ~  .  - . 
ccn«min: :  list o! Com'munity legistauo~ tt!crrcd to ~n Anic~c 10 of Council 
Directive ~l.l~/EEC 
(S l/27~/££q 
ntt  c:aa&ISSJO!I: OF THE EUROPEAN cx:>NNUNm£S. 
· ~6  rep-.:!  to che  T~  establishing the ~ 
L.oaomic Communi().  · 
·HninB ~cl  to  Ccu~:·  o:~r.-c 90/2.10/EEC  of 23 
April 1  S90 ()fl the ckli!xnte rclc~  into th~ environment 
'  . of ~ly  modi.~ ors.misms 0. anc!  in  particular 
Anide 10 caco!..  . 
Wn~n:s  C\C' Commission is  ~ui.~  co csttblish. befo~ 
·1M end c! .Apri!  1991.  ~ ·t:st  of Community·tq:sWion 
which ~  fo: a src:ific ~~ul  risk ~­
mer.t. si:r..a1r. to. daat !:id ~  in Oi~~ve  ~lllOlE£C 
. as reprds p:od:!cts :  . 
wr~~  :he Comoissior. h:s ~:nin~  the ~munitv 
k£isi:::On i~ fottt an<! Ius no: ic-<n:ific<! any PJCh  lc~-~­
btion:  ·  ·  ·  · 
~-:r.ec:s dais lis: 1:..-ii:  be ~-examined ;xrlodiaUy :lr.d. 2S 
· n~:~iy.  r~sed  : 
~~er:::s  t~c  Mns-.Jr~  :>~Yi~~  for. in this Decision :arc in 
•  •  •  •  •  •  •  •  I  1-,  r_  •  l 
ac~:c:nce  ,,tr.  tnc  ep:r.:or.  p.  u.c  '-N"mt:Ut:«  c. 
Men,bcr  Sta~C'$  tcp:-cscr.utivt-s  in  accordan:c  ,.~th  chc 
(') Cj ~o &..  n;. t. s.  :9?n. r· 'B  .. 
· ~  bid  ~-n  in  Anicle  21  of  Directive 
~/llO!EEC. 
HAS AOOPT£0 nns DEOS10N: 
.~rticlt  1 
At. the date  of. this  Decis~or.. there  is  n~ Comm~r.ity 
le~  in ~  which provicks fo_r a specific c:1'--iron-
·mct~tal mk 8sscssmcr.t cf pr~ucts ..-hich is  simil~t CC· 
tmt bid d~  in Dim:tn~.  90/220/EEC. 
Artid~ 2 
This  ~mon  · il add:as«i to the  M«:t~  St:~es. 
·Dene at  Bn:sst'ls. ll M2y. 1'91. 
For  tlx Commissi(Ju 
uno }tlPA Dt ME..\NA 
J,!cmb~r of thr Commissicn 
,• ·. 
1 
' 
•  I  ·, 
.· 
~  . 
'. 
.  .  . 
PROCEDURE  FOR  CIRCULATION  OF  NlTIFICATIONS 
· SUBUITTED  tH)ER  DIRECTIVE  90/220/EEC_-
XI/56/92-fin 
'The  ·procedures  out  ll~d  ·below  are  designed  to  allow  for  :the  .secure 
clrculatlon of ·notifications· or· sWtlllarles  which  contain  confid~ntlal 
Information.·  Whlle.ft  Is -recognised  there •ay be  cases  ~ere·there Is 
· no  confidential  Information  Involved,  the  Commis-sion  Intends  to follow 
the  ~ame  procedure  to  avoid  conf'I.Sion  and  recommends  to  COmpeter-t 
Author_i t les to :do  the ·same. 
1.  ProcOsJure  for  Member  · States  gndlno  not If  I eat  Ions  (or 
notification sungrtesl to the Col!!nlssloD 
1.1.  The  Competent  Authorities  send  the  notification  .to- the 
Commlss I on  v_la  the. Permanent  Representation  of  their  country, 
for  the  attention of Ur.  G.  DEL  BINO.  The  ~tification should· 
be  In  an  envelope  within  an  envelope,  and  seal~d with  special 
I abe Is.  ment ion  I  ng  o·l rect I ve  90/220/EEC  <these  w  i I i  be  short 1  y 
available  from DG  XI). 
1.2  A  fax  should be  addressed  to the  Commission  (Mr.  DEL  BtNO)  from 
the  ·.c_.A.  Indicating  that  t_he  notifications  have  been  sent 
(fax n·:  oo-32-2-299.03.13) •. 
1.3  When  the  not.lf.lcation ·contains  confidential_  informatic;:m·:  thi~ 
~hou  I d  ·be  c-1 ear I y  indicated.  -The  conf i den.t i at  Items/ 
paragraphs/dOcuments should be  easily  Identifiable.  by means  of 
a·stamp,  or  a  cover  letter •• 
,  ' 
1.4  Notlf_lcatlons  and/or  notification summar:ies  should  be  clearly 
numbered using  th~ .Ec  nUmbering  system  o~tllned unde·r  polnt.s. 
1.5  Any  additional  Information  concerning  a  particular  release 
should  be  sent  to the  COmmis~ion using  the·same  procedure. 
.  . 
2.  .Procedure for circulation by  the Commission:. 
2  .• 1  On 'receiving the notlflcat'lon,  the .Commission  indicates  d~te of 
receipt  on  the  document  and  numbers  the  pages  received.  It 
acknowledges  recelp~ of the document  by.fax  to the CA·from whom 
the  document  has  been  received.  indicating  the  date  of 
. circulation to other CAs.  · 
n. 
.  ' 2.2 
2~3 
. 3. 
3.2 
Before clrculatlon,  the notifications  ar_e  marked  ~ith the  date 
of  send.lng  and  are  tr~nsmltted  to  the  C.As  In  an  envelope 
Inside. an envelope addressed to the Permanent  Representation  In 
Brussels.  and  .. eaarked  for  the  attention· of  the  appointed  C.As •.  · 
l  . 
. The  envelopes  are  sealed  wl th  spec Ia I,  eas IIY  identifiable 
·  labels  •. ~aentloning the. Directive.  A  numbered .~ve·r. note  inside· .. 
·,the  envelope  Identifies  the  Items  contained  and  helps  keep 
t·rack of the notlflcatlons.clrculated. 
The  Commission  sends· a  telex/fax  to  the  C.A.  lndlcat lng  that 
.the  notification has .been  sent  ~o them  on~ particular  date  • 
.  The  c 1  rcu  1  at  I on  wi II  be  carr led. out  as  soon  _as  . poss i b 1  e  and 
will  normally hot exceed 3  work lng  days . 
Procedure for the C~A.s receiVIng notifications 
.  . 
Acknowledgment  of  receipt. must  be  sent  by·  fax/telex  to  the 
Commission.  lndicat  lng  date  of  ·re~e ipt  (for  the·  at  tent I  on  of 
Ur.  G. ·del  Blno).  It ·Is ·important  that this  Is sent.· 
~nts on·  the  notification/notification  summary  should  be 
sent  e 1  ther  · to the C.A.  concerned wIth a  copy  _to  the  Convn 1  ss ion 
(Mr.  G.  del  Blno), or to the  ~~isslon directly within 30 days 
from  the date of circulation by  the Commission.  The  COmmission 
wll I  forwar-d  lnrnedlatety  any  comments  rece lved.  to  the : C.A.· 
concerned,  and  will, ·as  appropriate,  eventually  circulate  the 
comments  to other  ~.A.s for  information. 
If the  comments  concerning  a  notification contain  confidential 
Information,  they  must  be  sent  by  sealed  letter  via  the 
Permanent  Representations.  For  non-confidential  notifications. 
the comments  can be  sent  by ordinary mail  or  fax. 
4.  EC  Numbering System  for notifications 
For·part  B  notification. this  .i~ 
B/(coun~ry code)/(year)/National _Ref.  No.  (4 digit)  and  (.optionally) 
a letter,  if used  in the national  system 
For  part c.  the scheme  Is the same,  but  B  is replaced  by c. 
Examples: 
Examples: 
I 
\ 
(Part  B) 
(Part  C) 
.• 
B/NL/91/5  A (Netherlands) 
C/UK/92/1  (UK) 
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· · .  ~ GUIDANce  ON  1NF0RuAT I  oN. NOT  TO  BE .KEPT. CONFIDENT I  AI.., 
!  .  UNDER .  DIRECTIVE -90/220/EEC  .  ·  .  ~  ~ 
. -~ ... ·;,:  ~:~  ~:.-~.~~; ._ ..  :  ··. ~: :  . .  :.· .. 
!~  ; 
.·  ·: 
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Directive.  90/220/EEC  on.: the  Oel iberate.  Release  of ·-.GMOs  to  -the,_.:-_ ... ~-.'  _,-,; 
:  env  1  ronment  foresee  a:.·  ·system  -·tor  IdentIfyIng  . ·.:and  ·.  '.pr-otectIng  ·;.:  -~· ·.: .>  ..  ~ . .-.. ·  ~;  .. · 
·:confidential  Information while at the same .time. l.t  foresees that· in the··.>·  :  <  .. ·  .·::·,. 
int'ert.st. of traosparency.  a  certain  amount  of ·basic  tl'\formation  cannot.  ·. 
·be  ~ept· ·  conf  l den~  I a I •  The  DIrectIve  does  not  .  foresee  whether . 
.  lnformat ion ·Is made  a vat I able act  iv~  ~Y or not.  It should be not.ed  1;hat 
·a  considerable  ainount  of  Information  .concerning  ·specific  GMOs  :.and· 
releases  Is· publicly available  In scientific literature.-. but especl.ally  ..  _ 
in the ·patent ·app' lcat_ions which  are often pubii'Shed pr.ior  to. or ··at :the."  .. 
same  time as  releases are made. 
As  ·regards .confidentiality,  Articles  19.1,  19.2  and  19.3  ·Of.  the 
Pirectlve  establish  a  procedure  whereby,  following  a  dialogue  between·· 
the notlfler and  the  authorities,  c~rtain  information can  be  agreed  to 
be  confIdent i a I.  If there  Is  a  request  from  the  not if  ler.  and  if there 
Is verlffabie ·Justification.  It  Is  _implied  that  information  cannot  be 
automatically  considered  or  a·ccepted  as  confidentia·a.  and  in -practice 
In  most  cases  it  is·  expected·  that  little  Information  will  be  of  a 
confidentlal-nature.  • 
lJriaer  Art  I c1 e  19.4,  a  n~ber  · of  i terns . are  1 a$ted  as  the  information 
which  the  app I i cant  and . the  authorities  cannot  keep  confident i a I • 
These  are: 
Description of  the  GMo·or  GMOs •. name  and  address  of  the no\ifier, 
purpose of  the  release and•locatlon of release. 
Methods  .and  plans  for  monitoring' of  the  GMO  or  ·GMOs  antt  fo·r·. · 
emergency  response. 
-
The  evaluation of foreseeable effects,  in particular-any pathogenic 
and/o.r  ecologi_caii-Y  di_sruptive effects. 
.  .  .  . 
As  ·regards  this  .minimum  set  of  information  wh.lch  ..  cannot  ·be  kept. 
confIdent l_a.l.  a  numb.er  of experts· have·  repeatedly  ·express~d the. wisli. to 
discuss .further·:what  Is  me~nt .by Article :19.4  and .a  first exctuinge ·of 
views  took  place  at  the  meeting  of  N~t,onal  ..  Experts  1n  October  199.1 !' 
Even  though  It  Is  up .to  the-competent  authorities  :to  examine,  :on .a 
case-by-case  basis,  confidentl"ality,  it  was  '(e1t  ·that .some  ·gui.dance 
would  be  useful  for  interpreting  Article  19.4:,  .ih  order· .to  avoid 
divergent national  approaches. 
·"  ....  · ....  This._· guidance  Is  . Intended  .to  assist  in  the  understanding  and 
lilp l.entat  lon  ·of  . the  01 rect I ve: ·.  It  Is  not  intended  to  be  an 
authoritative  Interpretation of .the  Directive;  su~h  Interpretation  can 
only be made  by the European -cou~cil ·of Justice. 
·a •. · Guidance on· lnterpretat  lon 
·.It  .should.  be  ·emphasised  that. It  Is  in  the  discretion  of  the 
authorities.  In  consultation  with  the  appllc~nt  to  discuss  What  ·is 
r~ally confidential.  as outllned under  Article ·19  .• 1,  1s.2·· and  19.3 and 
What  Is not,  with  due  respect  to." Art-Icle  19.~ of Course.  What  must 
also·be .ade clear  Is that· once a· competent  authority has  agreed with a 
netlfler on What  Is to be kept confldenfial, no other authority has  the 
· r_lght ·to disclose  this  lnformat ion,  .as  indicated  under  Article  19.1.  ·· 
1·1  another  Member-state  authority  feels that  the_provistons of Article 
19.~·-have not  been  respected,· then  a  complaint .should. be  sent  to  the 
Commission  for  non-comJ)IIance  .with .Art lcle  19.~.  In  such  cases..  the 
""Commission  Is obliged  to  Investigate  the  matter.  in  dialogue  with  the 
~tent  ·authority  responsib.le  for  the.classiflcation of  i"nformation, 
and.clarlfy whether  Article  19.4  has  been  _llreached.or  not.  In  cases 
where,  fot  whatever  reason,  the  notification  is  withdrawn, 
··  ·confidentiality must  b~ respected,  as outlined  in Article 19.5. 
Taking  each  point  under  Art  1cle  -:!:' .4  in  turn,  the  following  more 
·detailed  guidance  is  suggested  for  discussion.  As  noted  ear 1 ier. tn 
this  paper.  it  should  be  kept  In  mind  that.  a  v.e~y  large  amount  of 
"Information,  often ·much  more  than  out  I ined  in  Article  19.4,  is often 
publicly aval table.  ·tte.vertheless,  the  information  provided  should  riot 
prejudice the possibility of patenting. 
1.  Description of the  GMO  or  GNOs 
This  is  the  point  for  which  it  is  perhaps  most  difficult  to  lay  down 
·general~Y  applicable  guidance,  as  there  may  be  specific  conditions 
app1 icable  in  certain  cases.  However.  in  principle,  the  following 
points are suggested  as  providing  a  description of  the  GMO(s)  not  to be 
considered confidential.·  · 
For  d~liberate release uncar  Par!~ 
Identity of each  GMO  contained  i.n  the product;  introduced/modi f  i ed 
traits  and  genes  responsible  for  these  trait~;  complete  name  of· 
the  recipient  or  of  each  parental  organism;  complete  name  of  the 
organism from which  the  Insert  Is derived;  information relating .to 
the  genetic  modification:  function  of  each  inserted  DNA  or  RNA 
seQUence  or  of ·deleted  seQu·ences;  for  modifications  where  base 
substitution  occurs,  description  of  the  original  function  of  the 
gene  in which  the base.substitution occured  and ·the  function of  the 
modified gene. 
For  deliberate release under  Part  B 
Identity of  GUO,  including  trait;  complete  name  of  the·  recipient 
or  of  each  parental  organism;  information  relating  to  the  method  · 
of genetic modification;  for modifications where  base  substitution 
occurs,  description of  the  original  function  of  the. gene  i(l  wh_ich 
the  base  substitution  occured  and  the  function  of  the  modified 
gene. 
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Whenever ·possible •.  tnforaatlon shOUld also t?e  .. kept  non....co~fidential: 
on: ·.the name  of organism _froaa  which  Insert ·Js·  der,i~ed;  and  on  th~.· 
•  J  ciE!scrlptlon of the function of eac:'h  insert~d"ONA or RNA  seQuence.:or 
··of  dele~ed sequences.  . , 
2.  Naale  and address of notlfler 
.  :  ·.· 
.:. . .-The  ·  na.e  and_.  :  offIcI~  1..  ·.  address  ·  of ·  the  research 
institute/company/manufacturer/Importer.  etc.  Is  to  be  understood· 
here~.  Names  of  Individual  persons can be.kept confidential. 
3. ·PurpoSe 
(1.)  For  a  release  under  Part .e.  Reasqns  for  wfaich ·it  Is made. 
objectlves.of the release  •. parameters  tested •. 
'  <  1·1)  For· a. release  .t.hrough  a  oroduct  (Part  C).  the  use  the 
product'  Is to be  put  to.  and  the  type of users  it is  a~med 
at. 
•·  Location of the releases 
·Depending  on  the  type  of  release.  this  could  be  the  .settlement· 
where  the site  is (If a  small  pt~t  In a  town/village or.  attached to 
a  specific· installation).  the  bordering  village(s)  ·(if  it  is  a 
field  release  In  the  mid~le  of  .  the  countryside)  or 
countrles/reg_ions  (for.  the  _sale/testing  of  a  product).  An 
Indication  of  the  size  of  the  release  site  or  area  and  an 
Indication of  t~e expected  spread  Qf  the  organism  may  be  relevant: 
bere.  In  some·cases.where  the  release  is  not  ·taking  place  at  a 
test site (e.g.  vaccinated animals).  the  information npt  to be  kept 
confidential  should  be  such  as  to eriabte  an  estimate ~f  the  "wider 
site  ..  (e.g ..  numbers  of  GMOs  or  GMO-infected  individuals,  the _area 
within which  they  are  expected  to be  found,  etc.,  as  wei I  the  area 
where,  e.g.  the bait  has  been  laid, etc.).  · 
5.  Uethods and  plans  fo~··monitorlng.of the  GUO 
In  pr inc ip le,  a11  the  information  submitted  · .,  the  .competent 
authorities~ 
6.  Uethods and pI  ans for emergency  response 
In  prfnciple,  all  the  Information  submitted  to  the  competent 
authorities  . 
.  . 
7.  The  evaluation of foreseeable effects.  in  par~lcular any  pathogenic 
and/or ecologically disruptive effects 
The  main  idea  behind  thls-"point  is  ttiat  the  summary  of  the  risk 
asses~ment  carried  out  and  the  ~nclusions  reached  as  regards 
foreseeable  effects  are  not  to  be  considered  confi_dential •. It  is 
also  important  to  have  transparency  concerning  _any  co~ditions 
Imposed  on  the  release  •.  in·order  to avoid any  potential  undesirable 
effects.  ·  · 
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More  specifically,  as  regards  pathogenic  effects.  information  not 
.to be  kept  confidential  shoUld  Include  the abl11ty of the  GMO  and 
Its ex~racellular products to be pathogenic or  h~rmful  in •ny other 
way  to humans,.plants or anleals.  The  Information  submitted under 
Annex  II, -section  A  11.d  and  Section  c  2.1.  Is  ,)articularly 
pertinent. 
AS  regards  possible  ecologically  disruptive  effect.s,  lnformat ion 
··not  to·  be  kept  confidential  should  ·Include  Information  on  the 
likelihood- .of  post-release  selection  for  the- GMO.  on  _the 
significant  -Interactions  Ytlth  target. and  non-target  organisms.  on 
.the ecOsystems to which  th~ GMO  could be  disseminated  from the site 
of  release  and  In · whIch  it  cou  I d  become  estab II  shed.  on  the 
likelihood  of:  ge~tlc  ·exchange·  in  vivo.  and  the  relevant 
lnfor~natlon  on  potential  ecological. impact  (e.g.  from  simulated 
:  environments). 
: 
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SOiEUE  FOB  JHE  PRQTE¢r10H  OF  m.tfFIDENTIAl,  INfORMATION 
.  PROVIDED  lfflDER  D IBECT lYE "901220/EEC  •. 
Introduction 
Dlrec.tlve  90/220/EEC  on  the  deliberate  release  of  GMOs  contain 
prov.lslons ·for  the protection of confidential  Information  submitted by 
·notlflers~ .A  procedure  ts' established  for .deciding  which  information 
·Items shoUld  be .kept·confldenttal. under Article 19.2. 19.3 and· 19.4 of 
the  Dl rect lve.  Once  It  Is  clear . ·that  certain  lnformat ion ·  Is 
cOnfidential.  Article  19.1  places. the  CocNnlsslon  and  the  competent 
authorities under  the  legal  obligation not_  to divulge to third parties 
any  cxnfldentlal  Information  notified or  ot~erwlse provided  under  the 
Directive.  It  Is  l.mportant  that adequate provisions are.made  to ensure 
the. protection of confidential  lnfor~3tlon.  .  · 
The  scheme  of  lnform~tlon protection proposed  Is based  both  on  several 
years  successful ·experience with  handling  confidential  information  for 
chemicals  ·notified·  under  Directive  79/831/EEC  and  on  a  Commission 
Decision  SEC(86)1132  final.  dated  7  July  1986,  rela.tlng  to  classified 
documents  and security measures applicable to·such documents. 
Draft  Scheme 
The  different elements of  the scheme.are as  follows: 
1.  Clear  identification of confidential  information 
1.1  ·when  confidential. informatlon  is  transl.l\ltte.d  J)_y  a  Member  State 
authority  to  the  Commission  and  hence  t~· vtner  Member  States, 
the  submitting  authority  -must  communicate  thi$  fact  and 
·identify  the  confident-ial  items/paragraphs/documents  clearly, 
either  by  means  of -an  appropf"iate  stamp -.next- to  the  a·elevant 
Items  (e.g.  '!CONFIDENTIAL•,  •eot.QAERCIAL  IN  CONFIDENCE .. ,  "tc.), 
or  by  an  accompa.ny I  ng  note g l v 1  ng  conf i de!'t i a 1  i ty · i Ad _I cat ions. 
1.2  The  Commission  wr11  ensure  that  confidenta1fty  protection·. 
requirements  are  clear ty  high I ighted  wheri  transmi.tt ing  this 
information to other  Member  States. 
2.  Secure storage of ·information 
-Commission 
2.1  Information received by  the Commission  (OG  XI)  will  be  kept  in 
a  safe  with  a  combination  lock  in  a  Notificati.on  Room,  which 
will  be  fitted  with  a  special  t:ombination  door  lock  and  ·a 
special  sound and  flashing  li~ht alarm system.  Any  unauthorised 
entry sets off  the alarm  system which  is directly  connected  to 
the Commission  Security Office staffed on~ 24-hr.  basis. 
83. 2.2·· ·.  As  ·far . as  ~sslble  any  work 
confIdent Ia  1  ·lnformat I on  wl.l I 
noti·flcatlon room. 
that  needs  to  be  done  with 
be  carried  out  Inside  the 
. ' 
2.3 · .. 
.·  3 
-Member  States 
Eac;:h  . competent. author lty  In  every  'Member  State. ·should  make 
arrangements·· to  have  .a  safe . or  a  secur l·tY ·.cab.  I net  ·wl th  a 
combination  loek  In a  room .. that can  be  securely  locked,  so that 
·Information can be securely stored.  Work  using the confidential 
lnform~tton. sh~ld be done  und~r ~cu~lty conditions. 
Stricti~ llm~ted access  to  Information 
-commission 
3~1  . only  a  . ·limited. number  of  staff  with  specific  authortsat ion 
given by·  ~n Internal  Commission  procedure will  be  permitted  to 
enter  the Notification .Room  or handle confidential  Information·  .. 
··  This··.  authorls~tlon  Is  given  after  a  special  st.aff  secu~ity 
clearance  which  Involves  nationa·l  authorities,  and.  after· 
confidentiality protection undertakings have  been signed. 
3.2  If  In  future  a  computer  ~s  used  to  store  or  retrieve 
conf l·dent Ia  I  data,  It wt II·  be  situated  ins  I de ..  the notification 
room,  and  will  only  be  handled  by  the  au~hor  I sed  staff  with 
special  access  codes. 
3.3  Any .copies of· documents  which  are  authorised for· circulation to 
other  Uember  States  will  be  made  on  a  photocopier  ins.ide  the 
notification  room,  and  wilt  be  strictly controlled.  as  far  as 
possible. 
3.4  If a  translation or  typ·ing of documents  containing confidential 
Information  received  Is necessary,  it will  be  only  done  by  the 
authorised staff mentioned above. 
-Member  States 
3.·5  i.Cember  State competent  author it  les must  foresee  a  procedure  for 
providing·  spec~al  authorization  for  anyone  handling  or. having 
access  .to.·  confidential  Information,  and  must  keep  a  1 ist  of 
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·such .authortsed  persons,  who  must  have  signed  undertakings  to 
protect  conflden~lallty.  Provisions  for  limiting  access  to 
confldentla·l  .Information  similar  to  those  out  I ined. for  the 
~~s~ion  under points 3.2-3.4 should  be  mad~  • 
.StrJct h~. ·~ontrQUed transmiss •on  of  tnformat.ton 
. Notification  documents  containing  confidential  information 
transmitted  between  Member  States  and  ·eommtssion  must  be 
placed·  Inside  double  envelopes,  seated  and  m~rked  with  .a, 
spec i a I  I abe I • 
84. 
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J ~.2  Tra~sport·must be  done  by  diplomatic bag ·between  Member  States 
capttals.  and  the  Member  States  Permanent  Representations  in 
Brussels.  and  by  hand·between  the  COmmission  and.the  Permanent 
RepresentatIons.  To  ensure  that  the  pack,ges arrIve safe  I Y  •.  at 
the·  moment  of  dispatch·.  the  sender  (Member  State  au_thor lty or 
the  Commission,  as  appropriate)  should  send  a ··telex  announ~lng  .. 
the  ·dispatch  and  ·the  content  and,  on  receipt.  the.  M.S  .• 
author It  les  or  ·the .  Comm_lsslon.  as  appropr l_ate·,  must  send  a 
telex acknowledging safe arrival. 
5.  Str.lctly Controlled clrcul·atlon·of eonfldenflal  information 
5.1  Circulation·  of  conflde~tlal  ·Information  ·must  be  .extremely 
limited and on. a  need-to-tcnow··basls • 
.  5~2  Uember ·State· authorities  must  undertake ·to  provide  as  high ·a. 
l.evel  of  protection  to. Information  received  from  othet  Nember 
States.· as . they  do · to  In  format I on  rece·l ved  from  theIr  own 
notlflers.  and  thus  .limit  circulation  and.·  access  ·in  the  same 
way.  ThIs  _Is  p~rt  lnent  both  as  regards  the  staff  who  have 
access  to  the  ·information  ·and  as  regards  any  member  of  an 
a~vlsory committee. 
5.3  No  conf ldent'lal  lnformat lon  -:'lould  be  seen  by  anyone  who  has 
any  potential  commercial  or  other  personal  interest  in· that 
Information.  This potential  Interest must  be  determined by  the 
COmpetent  Authorities. 
6.  Control  of Member  State security procedures  and  faci1 ities 
6.1  Before  any  confidential  information  is sent  for  the- first  time 
to  a  Member  State  competent  authority.  the  Commission  w  i I I 
check  that  adequate provisions and  procedures,  are  in operat i·on 
In  t~at·  particular  Member  State  authority,  by  .on-the-spot 
Inspection  If  necessary.  Member  States  must  indicate  to  the 
~~~sion the state of  readiness  as  soon  _as  possi.bte. 
6.2  l_f  a  competent. author.lty  Is  considered  not  to  be  adeQuately 
eQuipped  to handle confidential  Information,  the  envelopes with 
the  relevant  documents  will  not  be  sent  to  it. The  information 
will  be  kept  on  behalf of  the  Member  State ·in  the  sat~ of· the 
Nofl  f lcat·ion  Room  In  Brusse  ~s,  unt H  such  tIme. as  the  ~ember 
State. authority  I~ ready  and  equJpped  to receive  it. 
6.3  ·Every  Member  State  authority  must  sign  ~  letter  addressed· to. 
the  commission,  undertaking  to  protect  ·  confidential 
·  lnformat ion,  verifying  that  the  necessary. measures  have  been 
taken,  and  indicating  the  names  of  the  persons  authorized  to 
see confidential  Information. 
6.4  The.COmml.sslon  wil1  keep  an  updated  list  of  all  the  those 
a_uthor.lse~ to hand·le  confidential  lnformati0'1  In all  the  Member 
States. 
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.  ~~- ......  ...  · CUIDANCE.  FOR  INTERPRETATION. OF .THE  .TERU  •PLACING  ON  THE  MARKET• 
. ..  .  . .  ·WITH "REFERENCE  TO  DIRECTIVE  90/220/EEC 
.. .....  _  .. ·  ..  • 
.•. 
·· \.- ·  ·'one.· ~of····.the·.·.obJect tves  of .·o1rect lve  90/220/EEC  i.s  to  establlstl  the 
~'-··._~  ..  -.. mechan-isms  for  ·ensuring  that'·-.human\ -he-alth.  and  the  envl_roriment  ..are 
~  ;  -protected  when  products  are  placed  on  ·-the  market  ~ritaJn~ng  or 
.  ·. eons  I stIng ·of genet"  l.ca II  y _IIOd If  I ed  organIsms~ 
. ·A  •product•  Is-defined as  •a preparation consisting of. or oontalniAg, 
..  a  G.«>.  or  combinat-Ion of GUOs,  which  Is placed  on ·the  market•  (~rtlcle 
.·  2.~) ·and  •placing  on  the  market•.  i::a  defined  as  •supplying  or  making 
available  to ·third  part  les•_  (Art-Icle  2.5).  ·The ·  procedures - for 
assessing these products and ·giving consent  Is established un.der  Part  C 
of  the  Directive  •Placing -on  the  market  of. products  containing  GUQs• 
(Articles 1Q-18). 
·  s~e confusion  has  arisen  from  the use of  ~he definition •suppiying or 
making  . available· to  third  parties•.  Apart_  ·from  . products  -freely 
·available  on  the  commercial  market  (•on  the  shelf•  or·  in  catalogut:s, 
for  example),  which  are clearly products  to be  approved  for  placing on 
the  market,  there  has  been  some  ambiguity  as  to  whether  this  c9vers  a 
range of other exchanges  such as:- non-commercial  exchanges  between ·two 
or  -several  research  Institutions.  bilateral  semi-commercial  or 
commercial  exchanges  between  companies  and· research  institutIons  or 
between parent ·companies  and  s_ubsidlar.les.  depasl:t:ing mi.r.roorganisms  at 
recognls~d depositary authorltles.for  the purposes of·patent pr.ocedure, 
supplying  microorgan~sms from cul.ture collect ions  • 
.  It has  the_refore  become  necessary  for  some  guidance  to  be  provide~ on· 
·the  lnterpretat  ion of  the  term  •placing  on  the  market~ ·in  the  context 
of  the·  Dlrectl¥e.  This  guld_ance  Is  Intended  to  assist  in  the 
understandtng  and.lmp_lementation of  the Directive.  It  is not  Intended 
to- be  an  authoritative  Interpretation  of  the  Directive;  such 
lnterpretatlon_can only be  made  by  the European court of Justice. 
The  statement·made  by  the  Commission  and  the.Nember  States at  the  time 
~of  adoption of  the  Dlrectlve gives ·some  first guidance  ~n this  issue. 
Thfs  stated. that  •material  specifically  developed  for  a  user  on  a 
·  .  bilateral  agreement  between  a  .supplier  and  a.  user  and·· which  wi 11  be 
·.  used  ~or·  :research  and :ctevelopmecit  .purpOses  will_ not ·be  cons·i.dered  as 
· requlr lng  consent  for · pla_clng -on ·the  marJcet ·  provided  its  use  in 
research·ls  subsequently~tlfled under  Part  B of  the Directive•.  This· 
therefore." Ind-icates  .that  If  a  "GMO  ·ts  developed  by  one  organisation 
·(research  institute  or ·company)  but  suppl~ed  in  order  to  be  tested 
under  P,art  ·a  by_  ·another •. it  is  not  considered  as  •ptacing  -on  the 
market•.  even though  it is •supplied• or  •made  available*. 
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- i. A  further.  ·que~.t  I. on  arIses  ..  as.  to  GMOs  exchanged  for  non-coaner  cia  I 
purpose~ between  t~  re~earch  lnst•tutl~ns. but which will be  used only 
for  •contained  use•  experlment~l  work  ·(as·  defined  In  Directive 
90/219/EEC)  .and  will  not  be  notified  under  Part  B ·of  Directive 
90/220/EEC.  In  the  letter ·of  Direct  lve  90/220/EEC  this  could  be 
Interpreted  to. fall  under .:the  term. •SUpplying ·or· uklng available  to 
third parties•.  However.  the· spirit of ·the. Directive Is to ensure  that 
no GMOs  are used without  adequate safeguards.  It Is Important that the 
-Contained -Use  and  the  Deliberate  Release  Directives  are  seen  ·as 
complementary and  that they are both  taken. ·Into account  In  l·nterpreting 
the  measures  necessary  for ·.the· protect  I on ·of  human  hea  I th  and  the 
env tronment.  If· the  research  lnst  I tut  Ions  In  such  an  exchange  have 
been duly notified and registered as suitable for undertaking work with 
GMUs·under  Directive  90/219/EEC~  ~hen the  non-commercial  exchange of  a 
GUM  (falling within  the  Group .for  which  the  receiving  Institution has 
·been  notified) could be consldered.as  not  being  required  to fulfil  the  . 
condltl.on of placing on the ur~et. 
'A  similar  Question  arises  as ·to  e.xchanges  within  subsldiarle~ of  the 
same  cOmpany  or  the  research  company  and  the  prodUction  company .within 
the  same  grouP  of  companies.  Th~re  again,  If  the  exchange  Is  by· 
bllate·al  agreement,  and  does  not  concern  a  GUM  to be  made  mcire·wlde.iy 
avait~ble  .. to  others  as  a  product.  and  provided  that  the  receiving 
companyisectlon of  the  company  has  been  duly  not~fied under  Directive 
90/219/EEC  as  an  Installation suitable  for  GUO  work with that  Group of 
. · GMOs •.  such  an  exchange  could  be  considered  a·s  not  being  reQuired  to 
fulfl  I  the condition of placing on  the market. 
Similar IY.  If a  .Q.CM  is dep9sited  at  a  recognised  depositary  authority 
for  the  purposes  of· patent  procedure.  as  foreseen  under  the  Budapest  · 
Convention.  provided  that  the  culture  bank  'Where  It  Is  deposited  and 
stored  Is  duly  notified  under  Directive  90/219/EEC.  the  deposition 
could  be  considered  as  not' being  required  to fulfi I  ,the  conditions  for 
placing on  the market. 
It  should  be  noted  that  the  Question  of  adequate  provisions  for  the 
transport  between  two  lnst_itutions undertaking  contained use operat·ions 
~s  important  and  that  the  gaps  existing  in  that  area  need  to  b.e 
covered.  There  Is  a  s·ignificant  gap  when  the  GMOs  exchanged  ~ave uvt 
been  cleared  for· placing on  the market. 
The  .Interpretation  of  what  constitutes  a  •producte4  also  app~ars  to 
cause  ~ome  confusion.  According  to  the  definition  in  the  Olre\.tive, 
produ~ts  are  GMOs  ·Placed  on  the  market  (Art iele  2.4),  but· Article  1, 
refers  to  the  pla~lng ·on  the  mar.ket  of  GMO  products  .. intended  .for 
subsequent  del i.berate  release  into  the  environment".  The  •del iberate· ..  · 
release"'  is  defined  as  •any  intentional  lntroducfion  of ·~os without  · 
provisions  for  containment  ••.•  to  I imit  their  contact  with  the  general 
populat lon  and. the  environment•.  A  statement  made  in  the  counci 1 -by 
the  Commission  and  the  Uember  ·States,  however,  further  defines 
•tntetit.lonal  Introduction•  as  "the  int("oductlon  by  whatever  .means; 
directly  or  Indirectly,  ·by  using,  storing,  disposing,  .or  making 
ava i I able ·to  a  third party-.  of  a  GMO  or  a ·combination of  Gt.COs" .•  ·Some 
terms,  such  as  •storing•  are  not  defined.· A  ~efinition of ·"use•  is 
given  in  the  Directive  as  ... the  deliberate  release  of  a  product  which 
has  been  placed on  the market•.  • 
87_ The  question  that  has  arisen  Is  •hether  a  c:ocmaerclally  avalla_ble  GUO, 
on Its own  or as part of a  preparatIon .or  a  lc It. •Ide  ly ava I  .lab le (e.g  •. 
through  a  catalogue>.  shoUld  be  considered as.a •product•  Jn  the·sense 
of  Direct lve · 90/220/EEC,  even  though  the  use  foreseen  Is  not  wide 
dissemination  ·In  a  field or. In  the  open  environment  b~t use  inside-a 
la~ratory.  hospital  or· ·tndeed  poss lbly  ~.a. pr lvate  hOme  or  other  · 
establishment. 
The  first  point  to note  Is  that  Article  11  places  an  obligation on  a 
..anufacturer  or  Importer  to  not 1 fy  the  Competent  Author It les  before 
placing on the market a  prodUct  for  the first time,  without any  mention 
of the purpose of the product  bel"ng made  in this article. 
Secondly.  the spirit as well  as· the  tetter of both Directives has to be 
examined.· Taking  all  the  provisions of  both  Directives  together,  the 
significant  element  Is  that  anyone  using  a  GAO  must· either  do  so  ln 
contained  use  conditions ··following  the  notlfica·tton -procedures  of 
D~rectlve 90/219/EEC,  or  under  the specific cOnsent  ..  conditions of  Part 
B  of  90/220/EEC,· or  otherwise,  can  purchase  and  use  a  GMQ-contalnlng 
product  freely,  .as. a  user,  If .the  product  has  received  the  consent 
under  Part ·c of Directive 90/220/EEC. 
It  Is clear  In  the  Olrectlv~ that  If  ~GUO-containing product,  whatever 
Its purpose,  has  not  received  consent  under  Part  C,  it cannot  be  used 
by  anyone  wl~hout  prior  notification  •.  It  Is  evidf!!nt  that,  unless  the 
_exchange  Is  the- result  of  specific  agreement  between  two  parties .(as 
- discussed earlier  In ·this text).  there  1s  no  possibility either  for  the 
authorities  or  the· person  placing  on  the  market  to  control  the 
purchaser  and  whether. the  installation  using  the  product  is  notified 
<e~g. when  a  product  is offered  in  a  catalogue). 
A  logical  conclusion  would  therefore  be  that  it  is  both  in  the  spirit 
and  the  letter of  the Directives  that  the  act  of  placing  a  GMO  or  GMO-
containlng  product  freely  on  the  marl<:et  constitutes  a  refea·se  and 
therefore  needs  to  fulfil  the  provisions  of  Part  C  or  Directive 
90/220/EEC. 
COne I  US i O~lS 
Despite  the  wide  definition· of  .. placing  ·on  the  marl<:et"  in 
Directive 90/220/EEC,  which  defines  it  as  ~supplying  or  making 
available  to third parties•  (Art.  2.5),  \here  are ·carefully considered 
cases  In  certain  circumstances,  where  a  GMO  containing  product  within 
the scope of 90/220/EEC which  is supplied or  made  available  to a  third. 
party  cou  l_d  none the 1  ess  be  considered  as  not  requiring  approva I  under 
Part C of Directive 90/220/EEC. 
The  following are such cases: 
(I)  Material  s·peciflcally ·developed  for  a  user  on  a  bilateral 
agreement  between  a  supp I i er  and  a  user,  prov i d~d  its  use  is. 
Intended to be  notIfIed under  Part B of o  i rectI ve  90/220/EEC  .. 
·-
88. • 
• 
(It)  GUMs  exchanged for  non-commercial  purposes between  two  research 
.·tnst l.tut Ions  bUt  which  wl  ~I  be  used  only. for  •contained  use  .. 
(as  def  .. ned  In  Directive ·90/219/EEC),  provided  that  both  the 
research  Institutions  In  such  an  exchange  have  been  duly 
·notified and  registered under .Directlve.90/219/EEC as suitable 
for  undertaking  work  with  GtACs,  and  prov·lded  that  the  non-
commerct~l exchange of the  GMM  f.alls within the group for  whi~h 
the receiving .Institute has  been notified., 
1.11)  ·exchange  of  a  .QAC ·within  subs.ldlar les of  the  same  company  or 
the research company  and  the production company  within the same 
gr()lU)  of  companies,  where  the  exchange  Is  by  bilateral 
agreement,  does  not  cc;>ncern  a  G.OA  to  be  saa<:fe  more  widely 
available  to  others  as_  a  product,  and  provided  that  the 
receiving  company/section  of  a  company  h~s been  duly  notified 
under  Dlrectlve.90/219/EEC as  an  Installation suitable for  GMM 
work  with that group of GMMs. 
IV)  . Deposition  of  a  GMM  at  a  depository  ~~thorlty,  Including 
·deposition  for  the  purposes  of  patent  procedure,  provided  that· 
th~ culture·bank where  the~ is stored  Is duly notified under 
Directive 90/219/EEC. 
v)  The  supply of  GYMs  (for  whi~~ an  administrative. charge· may  be 
made),  from  culture  collections,  which  ·are  notified 
installations  under  Directive  90/219/EEC.  to  other  centres 
which  hav~. also  been  duly  notified  under  01tectlve  90/219/EEC 
as  Installations suitable for  GMM  work  with  that  group of  GMMs. 
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The  Committee  on  the  release of genetically IIOdlfled organ·tsms  _to  the 
env  I rC?~nt.  · 
HAVING.REGARD·td.th~ Council  Directive 90/220/EEc<t>  of 23 April  1990 
on  the  deliberate  release  of ·genetlcaiJY ·IIOdtfled_ orgar:a_l8ms  ~o  ~he 
envIronment  and;  In part  I cuI ar. ArtIcle 21  t~ereof.  · · . 
. HAS  LAID ·OQWN  .ITs  RULES  OF  PROCEDURE  AS  FOLLOWS: 
. ·.  1.1·' 
Article 1 
The  Committee shall  be  convened  by  Its Chairman.  elther.on his· 
'own  Initiative or  at ·the  request  of  the  represe~tat·ive of  a 
Member  State·.· 
Artlr~e 2 
2.  1  The  Cha I rman  sha I I  draw  up  the  agenda . and  any  quest ion  •  the 
discussion  of  which  has  been  requeste~. in  writing  by  the 
representative  of  a  Member  State.  must  be  dealt  with  in  a_ 
CommIt tee  meetIng  as  soon  as  poss I  b fe  and  w l thIn  a  max 1  mum  of 
three months of receipt. 
2.2  In  the  case  where  the  Commission  must  ·carry  out  ext~nsive 
preparatory work  on  the d_raft  provisions which  are submitfed .to 
the Committee,  the maximum  time  l-imit  is six months. 
Article 3 
3.1  Letters  co~ven·ing  meetings,  the  agenda,  draft. provisions  and. 
any  ~ther  working  documents  sha  I I  be  sent  by  ·the, Cha i rnian  to·. · 
the  Member  states·  representatives  on  the  c~.i  ftee  in 
accordance  with  the  procedure  provided  for.  ·under  Article  11. 
Para.  2.  ·  These  documents  must  reach  the ·  Permanent 
Represenfa-~  Ions  of  the· Member  States  not :later  than  ·28  days 
before  the meeting  is.~ue to  take  place.  in  all ·the  Community 
languages. 
{1) O.J.  N.  L117 of 8.05.1990 
91. 3.2  In  urgent  cases.  at  the  reqt.iest  .of . the ·.r~presentat  ive  of  a · -
Member  State;or on  his·~ Initiative.  the Chairman  may  .~ed~ce 
this ·period -to  no· ·less· -tt1an  1~  days.  ·stating~ his  reasons 
3.3 
.  .  ..  .  . 
•  '  •  '# 
thereof  •. 
In  case  of .non  respect  of  these  iimlts.  the  meeting  shall  be  ..  .  . 
postponed by  the.Chalrman to a· later date  If  the representative 
of a  Member· State reQuests  It; 
Article  ~ 
4.1  The  Committee  dellvers.lts opinion ·on  the measures ·proposed  by 
the  Commission •. .according  to  the·  procedures  laid  down  In 
Article 21  of Dlrectlve 90/220/EEC. 
4.2  In  the ·event  that an  Opinion  is requested on  a  text  to which ·an 
amendment  Is made  during the ~iscussion. the Chairman: 
may  defer.  ~he  vote  to  the  end  of  the  meetIng  or  to  the 
fot.towlng  meeting,  whose  date must  then be  fixed; 
must  postpone  the  vote  until  the  following  meeting,  wh~se 
date  must  then  be  fixed.  If  requested  to  do  so  by  the 
representative of a  Member  State. 
Article 5 
5.1  Where  the  COmmittee  has  not  Issued  an  Opinion  within  the  time 
6.1 
llmrt  set  by  the  Chairman,  'the  latter  may  postpone  the  vote 
until  the following meeting. 
Article 6 
Each  Member  State  shall  appoint  its  representative  to  the 
·Committee.· The. Commission  wt II  only· cover  the e.xpenses  for  two 
representatives per. Member  State.  A Member  State can represent· 
one  other  Member  State.  The  Chairman  sha.ll  be  Informed  thereof 
by  . the  Permanent  Representa~  ion  of  ·the  Member  State  thus 
represented. 
,. .  "-
1 
92 .. 
• • 
t  I  1  -4  .. 
6.2 
. . .  .  .. 
The  Quorum  required  for  the.~~~1it>erati~s of  th~ Committee  to 
be  valid shall  be  that  requlred.to render  an opinion according 
.:  ~  .:  ., 
4 
•  •  • ..  :  ~.  ••  1 :  _;  . ~-. :  ~  .  :  .. 1  •  •  - ;  ~  •  .  ~  .  • 
to.  the  procedures· ·laid ·dOwn  lri  Article' ·21  of  Dl·rect lve · 
.. ,  ' • :!  : ; 4.: . 
. ·  . 
. ·.:.  ·.  .  ...  .. 
Article 7 
.. 
7.1  The  Secretariat  to  the  Cocmtittee  shall  be ·provided  by  the 
.. 
Commlsslon•s services  • 
.  · 
. Art lcle 8 
~.1  Before  any  -opinion  Is  requested  from  the  Committee.  any 
amendments  proposed  to  the  drafts  previously  circulated  as 
mentioned under Article 3  shall  be submitted to It in writing. 
8.2  A  I ist  of  the  decisions  made·  shall  be  presented  to  the · 
CommIt tee  before  the  end -of  the  meeting  for  approva·t •  In 
addition.  a  summar:y··of  the  conclusions of each  meeting  shalt  be 
prepared  ·and  submitted  to  the  COmmittee  for  al?proval  at  a 
subsequent  meeting. 
Arttcte 9 
9.1  The  ·Committe~  may  set  up  sub-Committees,  chaired  by  the 
Commlss~on,  to  prepare  its  work  or  carry  out  specific  tasks. 
The  Members  of  these  sub-committees  must· be  appointe~ :bY  the: 
Member  States.  Sub-commi.tt~es  wi I I  only  play  an  ~dvisory  role 
and  wi II  not have  power  to vote. 
Article 10 
. 
10.1  ·The  Committee  may  grant  a  hearing  to  non-governmental  experts 
If: there  Is no-opposition on  the  ~art of any  re'?resentat.ive of 
a  Member  State.  These  experts  shall  take  no part  in  ~ither  the 
.de·ttberat ions or  the  voting of  the Comnii ttee. 
93. Article 11 
~1.1  - All: correspondence  ~cernl~g  . the  Comml t_tee  sha  ~ ·l  be  addressed 
to the  Comml~slo~.  In  parti~1~r to  t~e Dl-~ecto.rate-General  for 
the  Envl"_ronment.  Nucle~r  Safety  and  Civil  .Protect ion,  for 
unless  ·the  uember  States  are  otherwise  advised  by  the 
Coarnlsslon  .. 
11 .. 2  Any  corresPondence  for  the  representative of  the  Uember  States 
and  the  Committee  shal I  .be  addressed  to  the  Permanent  .-
... Representations;  copies of ~nts  shall  be  sent directly  .and 
slmult.aneously.  to  a  1lm1ted  number  of  officials  appointed  by 
these  Member.  States.  provIded  the  Member  States  have· t:'\Ot t ~ i ed 
the Comrnfssion·of  the  names  and  addresses of' these officials. 
Article 12 
12.1  In  conformity  with  Article  214  of  the  Treaty,  and  without 
prejudice  to  Article  19  of  Directive  90/220/EEC,  the 
deliberations  of  the  Committee  shall  be  of  a  confident~al 
nature. 
Adopted  ·t n  Brusse Is on  25  March  1991 
94. 
• 
-t  .. 
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COMMISSION DECISION 
of 22 October 1993 
establisbiug the· cri'Caia for simplified procedures coacemiDg dle  · deliberate 
·release into ~e  euviroamcnt of  gcaetically moctificd plants pursuant to ~cle  6 
.  (5) of Couo.a, Dil"Cetive 90/22.0/EEC 
(93/584/EEC) 
1HE c:x>NWISSION  OF nrE EUROPEAN OONNUNITlES, 
Having Rgud to the·  T~aty establishing the European 
Eccnomic Community, 
Havin8  ttgard  to  Council  Directive · 90/220/EEC  of 
23 April 1990 on the deliberate release into the environ-
ment of ~etically modified ~  (1),  and in parti-
cular ~de  6·  (5) thereof, · 
Whereas.  where  a  competent  authority  con5iders  that 
sufficient  experience  bas  been  obtained  of  releases  of 
.  cemin genetically modified  oxpnisms (GMOs),  it may 
submit to the Commission a request for the application of 
simplified  pnx:edwes for  the release  for such  types  of 
GMOs, and whereas the Commission is teqUired to csta- · 
blish criteria based  on safety to human  health and the 
environment  and  on  the  exidence  available  on  such 
safety,  to enable  the  Commission  to decide whether a 
specific simplified  procedure should  be  approved ; 
\Vhereas there is  now accumulated  knowledge and data 
available concerning the necessary prerequisites for safety 
to human health and the environment for the release of 
certain types of GMOs ; 
Whereas it- is considered appropriate that given the diffe-
rent safety concerns for different types of organsims, sepa-
rate criteria should 6c ~blished for plants, animals and 
micro-organisms  and  that accordingly,  the criteria esta-
blished by this Decision are  ~pplicable only in relation to 
genetically ~odified plants, which is the ·group of  ·GMOs 
with which most of the experience has been acquired to 
date;. 
Whereas evidence from  releases  of genetically  modified 
plants has  indicated  that  the safety  of releases  of such 
plants  depends  on  the  chancteristics  of  the  recipient 
plant  species,  on  the  chan.cteristics. of· the  inserted 
· sequences  and  their  products,  and  on  the  receiving 
ecOsystem~; and  whereas  the  criteria  to  be  eStablished 
should  be  aimed  specifically  at  the  evaluation  of these 
chaacteristics ; 
(') OJ No  l  117. 8.  5.  1990.  p.  15. 
•  Whereas these aiteria form an objedne and harmonized 
basis  for  decisions  on  the  requests  for  application  of 
simp~p~~; 
Wheras is "is appropriate, in the interest of ~cy. 
to esmblish  a  .uni'form  piOCedure  for  the making of a 
request for simplified procedureS; 
Whaas, such a request should be ba¥d on expeneoce . 
with the GNOs under cxmsidemtion and on the evidence 
of safety  for  human  health  and  the  environment and 
whereas, to these ends, it is appropriate that this expe-
rience may include the competent authority's own expe-
rience  ~th releases  of the same GMOs and the expe-
rience in similar ecosystems whether within the Commu-
nity or internationally, of the GMOs u~der  consideration ; 
Whereas it is imponant, in the interests of the greatest 
possible applicability of uniform  procedu~U, compauble 
with  considcratio~ of safety  to huii)an  health and  t}:le 
environmen~ that  all  Member  States  should  have  the 
opponunity to join in any request for the application of 
simplified procedures and whereas to this effect an appro-
p~ate procedure should  b( established ; 
.Whereas this Decision is  in accordance with the opinion 
of the Committee established under Article 21  of Direc-
tive  90/220/EEC, 
HAS  ADOPTED nilS DECISION : 
. Artick I 
1.  The Commission shall take a .decision on the appli-
cation for simplified procedures for the deliberate release 
of genetically modifi~d plants, as required under Anlde 6 
(5)  of  Directive 90/120/EEC, by  r:eference  to the criteria 
set out in pan.graphs 2, 3 and 4  and by reference to the 
·sufficient.  ·experience and evidence thereof referred· to in 
Artide2. 
2.  The criteria relating to the characteristics of the reci-
pient p!ant species· shall  be  as  follows-: 
(a)  th~ taxonomic status and the biology (mode of repro-
duction  and  pollination,· ability  to  cross with  relat~d 
species). should  be  well-known.  . t  '  •  .  .  ... 
•  • 
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j 
and  . 
- - information should be available on any interactions of 
paticular aelcvaoce for the evaluation of risk.  iowl-
~  che teeipicnt plant species and odler organisms , 
ia .,ncuitural  eQOSyStemS  or  in  the  aperi~cntal 
tdease ecosystem. 
and 
(cl scieDtific data should be  available ~  the  sa£~ for 
1 h~m:m health and the environment of apcrimental 
Ri·;.ises involving genetically modified plants of the 
same  ~pient plant ~es. 
'The  aiteria  ~dating to  the  char3cteri.stics  of  the 
~  sequences and their expression products shall be 
-follows:· 
~ • the~  sequences and their cxprCssion  produCts 
should be safe for human health and the environment 
: under the c:ooditions of the experimental release, 
and 
th~ inserted sequences should be : 
- wc:ll  c;haracteriz~. and 
- intepted into the  plant nuclear genome. 
The  ait~rion relating to the characteristics  of the 
field. r~l~  expefim~nts  shall be that whenever necessary, 
- ~ appropriate practices for the management of risks will 
applied during or after the experimental  release,  to 
sure- the protection of human health and the environ-
ment. 
The criteria set out in paragraphs 2. and 3 should be 
plied in every case whereas the criteriort set out in para-
graph 4  should be  taken into account when examining a 
>posed simplified procedure and applied as appropriate. 
Artick 2 
A  request for  the  application  of si.mplified  proce-
rcs. shall be made in accordance  with  the  procedures 
laid- down  in  paragraphs  2  and 3  and  .Article  3: 
I 
2.  11w:  request sba1J  be submitted to the COmmission 
in writia~ aod shall be ~pmicd~by  a dossier .&ich 
shall  indudc  a  description of .the  proposed  simplifi~ 
p~ures.. the conditions (tf any) under .Web they are 
to be applied and information and data on· the sufficient 
experienoe which  bas been  obaincd of R~  of the 
GMOs under consideration.  · 
3.  Sufficient  experience  shall  show.  that  the  GMOs 
under consideration me safe for human· health aDd  the 
environment and ~  ~  based on the competent autho-
ricy•s  own. experienCe with  telease  of the ~e  GMOs, 
experience with  ~elcascs of the GMOs under conSidera-
tion i~1 similar ecosystems and international experience. 
.Artick .3 
i.  On teeeipt of the sequest and the accompanying . 
dossier. the Commission shall immediately fonnln:i to the 
· competent authorities of the other Member States a t:Dpy 
of the said  rcq~  and accompanying· dossier. 
2.  Within 4 5 days following th~ dispatch of the request 
and  accompanying.  dossier,  any  other  competent 
authority  may notify  the Commission  in writing  of its 
intention to join in ~e  request. To that end, the compe-
tent  authority  may·  submit  any  further  or  additional . 
~dencc in support of the original request. 
3.  Upon expiry o(thc time limit specifi~ in paragraph 
2, the Commission shall forthwith take a decision on the 
request in  accordance with the procedure  laid  down  in 
Article  21  of Direc.tive  90/220/EEC. 
Artide 4 
This  Dccisiop  is  addressed  to  the  Member States. 
Done  at  Brussels,  22  October  1993. 
For  tbe ·  Commissio12 
Yannis  PALEOKRASSAS 
Member of the Commission '  ' 
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COMMISSION 
COMMISSION  DECISION 
·  of 4  November 1994 
establishing simplified  procedures concerning  the deliberate  release into the 
environment of generically modified plants pursuant to Article 6 (5) of Council 
Directive  90/220/EEC 
(Only the Danish. Dutch. English. Fre.nch. German. Italian. Portuguese and Spanish  t~xts 
are authentic) 
(94/730/Eq 
fHE COMMISSION  OF THE  EUROPEAN  COMMUNITIES. 
Having  regard  to  the T  reary  establishing  the  European 
:ommunity. 
~-iaving  regard  to  Council  Directive  90/220/EEC  of  23 
i.pril 1990 on the deliberate rcl(ase into the environment 
)f genetically modified organisms (1). .as  last amended by 
Commission  Directive  94/15/EC (!)  •. and  in  panicular 
\rticle  6  (5)  thereof. 
Whereas.  where  a  competent  authority  considers  that 
·,u.fficien;  ..  ..,erience  -bas  been  obtained  of  releases  of 
:ertai.n  gen~~ically modified  organisms (GMOs),- it may 
.ubmit to the Commission a request for the application of 
simplified  procedures  for  the  release  for  such  types  of 
:;MOs; 
.  . 
Wher~ such  a request  has  been  submi~ted  by  the 
:ompctent authorities of the Member S.tates who consider 
hat sufficient experience has ~en  obtained .of  rcleas~s of 
:ertajn  genetic~lly .modified ·plants; 
X'hereas  Commission  Decision  93/584/EEC (i)  estab-
ishes the  ·criteria to enable the Commission to decide on· 
the application  of simplified  procedures :  whereas ·these 
·ritc:ria arc b,ascd on safer;y to human health and the envi-
onment and on the evidence ·available on such safety ; 
'") 01  Nn l. 117. 1t 5  1990.  r- 15. 
)  OJ  No  l  IOJ,  22.  -4.  1994. p.  20. 
I  ~)j  No  1.  17<J.  12.  11.  I<J<J.l.  p.  41. 
Whereas  the  Commission  has  examined  the  requests 
submitted  by the  United  Kingdom  and  France  for  the 
application of  ·simplified procedures for certain releases of. 
geneti~ally modified  plants and  the evidence  submitt~d. 
and has subsequently evaluated these requests in the ·light 
of the  criteria  already established ; 
Whereas  the  Commission  has  concluded · that  the 
requested  simplified  procedures  are  in conformity  with 
the established criteria, and that sufficient experience has 
been obtained of releases of  certaif)  GMOs to .justify  the 
introduction  of the  requested  simplified  procedures ; 
Whereas it is  impot:tant, in the  interests of the greatest 
possible applicability of uriiform  procedures, compatible 
-with  considerations  of ·safety  to  human ·h~alth and  the 
environment.  that  all  Member  States  should  have  the 
• opportunity to .join  in any request for the application of 
simplified  procedures; whereas  to  this  effect  an  appro-
priate  procedure  has  been ·established ;  · 
Whereas  in  accorda.nce  with  that  procedure  th~  compe~ 
tent authorities of France, the United·Kingdom, Belgium, 
ltaly9  Portugal, Ireland, Spain. Denmark, the  Netherla~ds 
and the  Federal Republic of Germany have  notified \he 
Commission  of their intention  to  apply  the  simplified 
procedures  foreseen  in  this .Decision ; 
Whereas this  Dec~sion is  in accordance with the opinion 
of the  <;ommittee established  pursuam 'to  Article  21  of 
Directivt:  90/220/EEC. No L  2921.32  Official Journal of  the  European  Communities  12 II. 94 
HAS ADOPTED nuS DECISION : 
Article  1 
The  requests  submitted  by  France  and  the  United 
Kingdom  pursuant  . to  Article  6 (5)  of  Directive 
90/llO!EEC and concerning the ~implified procedures set 
out in the Annex are approved. 
Article 2 
This Decision is  addressed to  the Kingdom of Belgium. 
the  Kingdom  of  Denmark.  the . Federal  Republic  of 
Gennany, the lGngdom of Spain. the  French  Republic, 
Ireland, the Italian Republic, the Kingdom of the Nethei-
lan~  the Portuguese Republic and the United Kingdom 
of Great Britain  and  Northern_  Ireland. 
Done at Brussels.  4  November 1994. 
For  the  Commission 
Yannis  PALEOKRASSAS 
Mem"ber  of the Commission 
•  0  .,. 
.• 
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ANNEX 
I.  The- simplified proccdur~ provides for a single n()(ification  do$si~r to ~  submiued pursuant to Part B of 
Oaf'f'Cti~ ~1220/EEC. for  mo~  rhan  on~ Rlease of ~tically modified planrs .which  have raulted 
·from  th~ same  ~pi~nt crop  plant species  but  whi<:h  may  diff~r in  any of dlc  insectcdldeleted 
Kq~~ccs or ha~ th~ same  inscn~dldclet~ ~ucnce bul differ in  phcnory~. 
2.  A  norifier can submit in a single notification  information on several  rd~ses of genetically modified 
crop pbnts. to ~  rcle~ on KVCraJ .  diUercnt sites, on  the  iollowing .:ond.itions : 
the  taxononic st2tus and biology of the  recipient  plants _speCies  is  well  known. 
infonnation is awilable on the interactions of the recipient p1ant species in the  _ecosystems in which·. 
th~ cxpcrimcntal and/or agricultur2l  relc~ arc  scheduled. 
scientific dau is available  on the safety  to human  health  and the environment of experimental 
releases  in~lving gm~tically modifi~ plants of the same recipient  plant speciCS:. 
the inserted sequences and their expression products should be safe for human hcalth and th~ envi-
ronment under  th~ conditions of the  experimental  release. 
the  inscned  scquenc~ ha~ been  well  characterized, 
all  the  inserted sequences arc  integrated  into the  plant  nuclear genome, 
all  the  ~kases ue for  3!1  a· priori specified  prbgramm<:  of work., 
all  the  releases  take  place  within  :m  :1  priori  specified  ;:ime  period. 
3.  The information required in the notification is that indicated in Annex 11  to Directive 90/220/EEC. 
4.  Only one single conserit is  re~uired for  :~ll the releases described in the single notification submitted to · 
the competent authority. The procedure to be used in granting that consent is  th_at outlined in Pan B of 
Directive  90/210/EEC.  ·  · 
5.  In order to obtain one  ~ingle consent covering several  releases. all  the necessary  information for each 
release should be indicated in the single notification, including sufficient information on the different 
sites of the releases and on the experimental design, as  well  as  indication  o{ any conditions for 'risk 
management for each different release. Clear reference to each release to be covered should. be made in 
the  notification,  and  the  appropriate  information  should  be  included  to  allow  completion  of  the 
summary  notification  information  format. 
6. ·  A  notificr an also submit a single notification covering a whole. a pnori specified. programme of deve-
lopment work with a  sinslc specific recipient plant species and a specified range  of insects/deletions 
~r  so~ral years at1d on several different sites, and receive a single consent (or the whole p~gramme  of 
work.  · 
6.1.  In such cases, detailed indications or descriptions ohhe different sites of the rdeascs, subsequent intra· 
spc.cific sexual crosses and/or the conditions of release  need not be given in the notification, as would 
be  r~uired.  under the conditions indicated in par2graph 5. However. the notification must contain suffi-
cient information to enable overall an evaluation o{ risk. and a detailed risk 'assessment to be  m::~de for at 
least th~ first  r~1easc in th~ programme pi  _work. Th~  information that n-eed not be given. may only relate 
to d}e  sites of the  rcleas~s  .. the  d~scription  ·of the sites  and their suriacc  area,  the  number o{  plants 
rel~ascd. and the subsequent  scxu:~l crosses of the initially ootiiicd  plants (including  progenies} with 
themselves and/or with .pl3nt lines of the initially  notifie~ recipient plant species (including the proge-
nies of  these  crossings).  · 
7.  In the cases referred to in paragcaph 6.1  the noti{icr will submit to the competent authority the addi-
tional information togeth-er  with a  statement indicatint whether the original  risk asse-Ssment  remains 
valid and if not. provid< iunher evaluation. This intormation should be  sent before the specific release. 
to  which  it  ~~fcrs is  c:arricd  out.  in  the  iorm  of a. ~implc addition:1l  notice  for  iniormation only. 
.  . 
7.1. The competent authority .;u  immcdi:u~ly smd to the Commission :any additional risk assessment asso-
ciated information rccc:iv('J  in applic3tion of  para~raph 7. TI1c C".ommission  will  circul:~te these to'the 
comp<:l<:nt  authoriti<.-s  oi  t1H·  ollwr  Mcml>t·r  St;tt<."S  t<n  inlorm:ttiun  (mly. No L  291134  Official  Journal of the  European Communities 
7~  1lK- aoti6c:r can ptooecd  with lbc release in quc:stioa after  IS days  from the _date  of receipt by the 
compet~t authority of  this additional  infonnation. unless  ~  receives  'Written  indication  from  the· . 
ccrr.pet~t a\J:(hority.  · 
I. 
7  .3.  It eny new information submitted is such  that the original consent under simplified proceduccs  ·is no 
lon~  applicable. then it is for the competent authority to indicat~ tO  rhe notificr within IS days of 
ft"C'Cipt of the_ aotificacioa that he may only proceed with the intended n::Jeasc if a  consent is granted 
und<:t  the standard  proccd~ laid down in  the  Directive. 
8.  ~n  me single conscat under simplified procedures is pnted. conditions caa be attached to each of 
the: rdc:::asc:s to which it refers. These conditions can subsequcndy be alten:d by the competent authority. 
as  indicated in Anide 6 (6) of the Dirccrive.  · 
9.  On completion of one or .~ore of the relcasc:s approved ·within the .simplified procedure. the notificr 
shall submit ro the competent ·authority a report with the results of the relc:asc(s) at the time specified in 
the <:nnsent. Such reports may be submitted separately. or as a dearly identifiable secti® in $Upport of a· 
notifiation  for. subsequent releases.  ·  ·  · 
10.  The competent" authority m2)' alter the conditions· of the original  consent or intervene· to  alter the 
conditions of spcci6c subsequent Jdeases on the basis of the rc:su.lt:s  indicated in the reports or on the 
basis  of infonn2tion obtained during inspections.. 
•. 
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ANNEX 
I.  The simplified proccd~  provides for a single notification doSsier to be submitted pursuant lO Pan B of 
Directive 90/22.0/EEC. for more than one release of genetically  modifi~ plants whach  ha~ resulted 
fs-om  the  same  recipient  crop  plant  species  but  which  may  differ  in  any of  the  inKrtcdldcJeted 
sequences or have  the  same inserted/deleted sequence  but differ  in  phenotypes. 
l.  A  notifier can submit in a single  notification  information on several  rde~  of gcnct•cally modified 
crop plants. co  be  released  on scvcr2l  diitercnt sites. on  the  following  conditions : 
the taxononic status  and  biology of the  recipient  plants species  is weil  known. 
information is available on the interactions of the recipient plant specic:s in the ecosystems in which 
the experimental and/or agricultural  releases  are  schedule-d. 
scientific data is  available  on the safety  to human  health and  the environment of ~rimenul 
releases  involving genetically modified  plants of the same recipient plant species. 
thc-insencd sequences a~d their expression products should be safe for-human health and the envi-
ronment under the conditions of the  experimental  release. 
the  insened sequences  have  been  well  characterized. 
all  the inserted  sequences arc  in"tegr:tte-d  into  the  plant  nuclear genome. 
all  the  releases  arc  for  an  a· pricn-i  ~pccified  programme  of work., 
an  the  releases  ukc place  within  an  3  priori  specified  time  period. 
3.  • The information required in the notification is that indicated in Annex II to ·Directive 90/llO/EEC. 
4.  Only one single consent is require-d tor a!l  the releases described in the single notification submitted 10 
the competent authority. The procedure to be used in granting that consent is that outlined in Pan B of 
Directive  90/220/EE<:;.  · · 
5.  In order to obtain one single consent covering several  relea-ses,  all  the necessary information for each 
release should be indicated in the single notification. including sufficient information on the different . 
sites of the releases and on the experimenul design. as wdl as  indication of any conditions for  risk 
management for each different release. Clear reference to each release to be covered should be made in 
the  notification,  :and  the  appropriate  iniormation  should  be  induded  to  allow  completion  of  the 
.  summary  notification  information  format. -
6.  A notificr can also submit a· single notification covering :a  whole, a priori specified. propmme of deve-
lopment work. with a  single specific recipient plant species and a  specified r.ange of inserts(  deletions 
over seveDl years and on sever2l different sites. :and receive a single consent (or the whole programme of 
~oc  . 
6.1 ~ ·In su~  cases., detailed indications or descriptions of the diffe~enr sites of the releases. subsequent in  en-
specific sexual crosses and/or th~ conditions of release need not be given in the notification. as ~uld 
be required under the conditions indicated in paDgraph 5.  However~ the notificati~n must conuin suffi-
cient informacion to enable ovcraiJ an evaluation of risk. and a detailed risk assessment to be made for at 
least tf:te first release in the programme of work. The information th~t need not be given "may only relate 
co  the sites of the releases.  the description of the sites and their surface a~  the number of plants • 
~lea~ed. and· the subsequent sexu:at  crosses of the  initially notiiied  pl:ants (including  pro~nies} with 
themselves and/or with pl3nt lines of the initially notified recipient plant species (including the  pro~-
. nics of  ~hc:sc crossings).  ·  ·  · 
7., · In 'tite ~  referred· to in  pa~gC'3ph 6.1  the  notifi~r will submit to th~ competent authority· the addi-
. tional information together with a  statement indicating whether the original· risk assessment remains 
valid and if not. provide further evaluation. This information. should be  sent before the specific release 
~o _which ·it  ~fcrs is  carri~d out. in  the  iorm of :a  simple  a~ditional notice -for  ir_docm:ation  o':l_ly.  . , .. 
.  · ··7.1_.  The competent authority v.'ill immcdiatdy send to the Commission. :a"ny additional risk ~mentasso: 
·  · . · :.  _ciated  information received  in application o{ paagr:aph 7. The Commission will  cir~late these to the 
:.:·:  ··.  ~:' ·  .cOmpetent  authoritic."S  oi rhc."  other Mcmhc-r  Stalc.-s  ior  infor•t:uion  only  . 